As filed with the Securities and Exchange Commission
on January 21, 2005 An Exhibit List can be found on
page II-11. Registration No. 333-_______
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
-----------------------------
FORM SB-2
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
-----------------------------
BRAVO! FOODS INTERNATIONAL CORP.
(Name of small business issuer in its charter)
DELAWARE 2020 62-1681831
(State or other (Primary Standard Industrial (I.R.S. Employer
Jurisdiction of Classification Code Number) Identification No.)
Incorporation or
Organization)
11300 US HIGHWAY 1
NORTH PALM BEACH, FLORIDA 33408
(561) 625-1411
(Address and telephone number of principal executive offices
and principal place of business)
ROY G. WARREN, CHIEF EXECUTIVE OFFICER
BRAVO! FOODS INTERNATIONAL CORP.
11300 US HIGHWAY 1
NORTH PALM BEACH, FLORIDA 33408
(561) 625-1411
(Name, address and telephone number of agent for service)
Copies to:
MARC ROSS, ESQ.
STEPHEN FLEMING, ESQ.
SICHENZIA ROSS FRIEDMAN FERENCE LLP
1065 AVENUE OF THE AMERICAS, 21ST FLR.
NEW YORK, NEW YORK 10018
(212) 930-9700
(212) 930-9725 (FAX)
APPROXIMATE DATE OF PROPOSED SALE TO THE PUBLIC:
From time to time after this Registration Statement becomes effective.
If any securities being registered on this Form are to be offered on a delayed
or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other
than securities offered only in connection with dividend or interest
reinvestment plans, check the following box: [X]
If this Form is filed to register additional securities for an offering pursuant
to Rule 462(b) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective
registration statement for the same offering. ________
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under
the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. _________
If this Form is a post-effective amendment filed pursuant to Rule 462(d) under
the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. _________
If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. _________
ii
CALCULATION OF REGISTRATION FEE
-------------------------------------------------------------------------------------------------------------
TITLE OF EACH CLASS OF AMOUNT TO BE PROPOSED PROPOSED AMOUNT OF
SECURITIES TO BE REGISTERED (1) MAXIMUM MAXIMUM REGISTRATION FEE
REGISTERED OFFERING AGGREGATE
PRICE PER OFFERING PRICE
SHARE
-------------------------------------------------------------------------------------------------------------
Common Stock issuable upon
conversion of convertible
debentures 28,212,500 $0.15(2) $4,231,875.00 $498.09
-------------------------------------------------------------------------------------------------------------
Common Stock issuable upon
exercise of warrants at $.15
per share 6,200,000 $0.15(3) $930,000.00 $109.47
-------------------------------------------------------------------------------------------------------------
Common Stock issuable upon
exercise of warrants at $.25
per share 2,000,000 $0.25(3) $500,000.00 $58.85
-------------------------------------------------------------------------------------------------------------
Common Stock issuable upon
exercise of warrants at
$2.00 per share 13,000,000 $2.00(3) $26,000,000.00 $3,060.20
-------------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------------
Total 49,412,500 $3,726.60
-------------------------------------------------------------------------------------------------------------
(1) Includes shares of our common stock, par value $0.001 per share, which may
be offered pursuant to this registration statement, which shares are issuable
upon conversion of convertible debentures and the exercise of warrants held by
the selling stockholders. In addition to the shares set forth in the table, the
amount to be registered includes an indeterminate number of shares issuable upon
conversion of the debentures as such number may be adjusted as a result of stock
splits, stock dividends and similar transactions in accordance with Rule 416.
The number of shares of common stock registered hereunder represents a good
faith estimate by us of the number of shares of common stock issuable upon
conversion of the debentures. For purposes of estimating the number of shares of
common stock to be included in this registration statement, we calculated a good
faith estimate of the number of shares of our common stock that we believe will
be issuable upon conversion of the debentures to account for market
fluctuations. Should the conversion ratio result in our having insufficient
shares, we will not rely upon Rule 416, but will file a new registration
statement to cover the resale of such additional shares should that become
necessary. In addition, should a decrease in the exercise price as a result of
an issuance or sale of shares below the then current market price, result in our
having insufficient shares, we will not rely upon Rule 416, but will file a new
registration statement to cover the resale of such additional shares should that
become necessary.
(2) Estimated solely for purposes of calculating the registration fee in
accordance with Rule 457(c) under the Securities Act of 1933, using the average
of the high and low price as reported on the Over-The-Counter Bulletin Board on
January 14, 2005, which was $.15 per share.
(3) Estimated solely for purposes of calculating the registration fee in
accordance with Rule 457(g) under the Securities Act of 1933, using the higher
of the exercise price of such warrants or the average of the high and low price
as reported on the Over-The-Counter Bulletin Board on January 14, 2005, which
was $.15 per share.
THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR
DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL
FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION
STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(A) OF
THE SECURITIES ACT OF 1933 OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME
EFFECTIVE ON SUCH DATE AS THE COMMISSION, ACTING PURSUANT TO SAID SECTION 8(A),
MAY DETERMINE.
iii
PRELIMINARY PROSPECTUS SUBJECT TO COMPLETION, DATED JANUARY 21, 2005
BRAVO! FOOD INTERNATIONAL CORP.
49,412,500 SHARES OF
COMMON STOCK
This prospectus relates to the resale by the selling stockholders up to
49,412,500 shares of our common stock, including the following:
o up to 28,212,500 shares of common stock underlying convertible
debentures,
o up to 6,200,000 shares issuable upon the exercise of common stock
purchase warrants at $.15,
o up to 2,000,000 shares issuable upon the exercise of common stock
purchase warrants at $.25,
and
o up to 13,000,000 shares issuable upon the exercise of common stock
purchase warrants at $2.00.
The convertible debentures issued in connection with our private placement
dated June 2004 are convertible into our common stock at $0.15 and the
convertible debentures issued in connection with our private placement dated
October 2004 and December 2004 are convertible into our common stock at $.10.
The selling stockholders may sell common stock from time to time in the
principal market on which the stock is traded at the prevailing market price or
in negotiated transactions. The selling stockholders may be deemed underwriters
of the shares of common stock, which they are offering. We will pay the expenses
of registering these shares.
Our common stock is registered under Section 12(g) of the Securities
Exchange Act of 1934 and is listed on the Over-The-Counter Bulletin Board under
the symbol "BRVO". The last reported sales price per share of our common stock
as reported by the Over-The-Counter Bulletin Board on January 14, 2005, was
$.15.
INVESTING IN THESE SECURITIES INVOLVES SIGNIFICANT RISKS. SEE "RISK
FACTORS" BEGINNING ON PAGE 4.
Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of these securities or determined if this
Prospectus is truthful or complete. Any representation to the contrary is a
criminal offense.
The date of this prospectus is _______, 2005.
The information in this Prospectus is not complete and may be changed.
This Prospectus is included in the Registration Statement that was filed by
Bravo! Foods International Corp., with the Securities and Exchange Commission.
The selling stockholders may not sell these securities until the registration
statement becomes effective. This Prospectus is not an offer to sell these
securities and is not soliciting an offer to buy these securities in any state
where the sale is not permitted.
1
PROSPECTUS SUMMARY
The following summary highlights selected information contained in this
prospectus. This summary does not contain all the information you should
consider before investing in the securities. Before making an investment
decision, you should read the entire prospectus carefully, including the "risk
factors" section, the financial statements and the notes to the financial
statements.
BRAVO! FOODS INTERNATIONAL CORP.
We are involved in the development and marketing of our Slammers(R)
trademarked brand, the obtaining of license rights from third party holders of
intellectual property rights to other trademarked brands, logos and characters,
and the granting of production and marketing rights to processor dairies to
produce branded flavored milk and generating revenue through the sale of "kits"
to these dairies outside of the United States and through wholesale sales within
the United States. The price of the "kits" consists of an invoiced price for a
fixed amount of flavor ingredients per kit used to produce the flavored milk and
a fee charged to the diaries for the production, promotion and sales rights for
the branded flavored milk. In the United States, we also generate revenue from
the unit sales of finished branded flavored milks to retail consumer outlets.
Our new product introduction and growth expansion continue to be
expensive and we reported a net loss of $3,016,987 for the year ended December
31, 2003 and a net loss of $2,882,131 for the nine months ended September 30,
2004. We have suffered operating losses and negative cash flows from operations
since inception and, at September 30, 2004, we had an accumulated deficit, a
capital deficit, are delinquent on certain debts and have negative working
capital. These conditions give rise to substantial doubt about our ability to
continue as a going concern.
Our principal offices are located at 11300 US Highway 1, North Palm Beach,
Florida 33408, and our telephone number is (561) 625-1411. We are a Delaware
corporation.
The Offering
Common stock offered by selling stockholders...................... Up to 49,412,500 shares, which
would represent 49.31% of our
then current outstanding shares
of common stock (assuming the
full conversion of all debentures
and exercise of warrants being
registered herewith), including
o up to 28,212,500 shares of
common stock underlying
convertible debentures in
the aggregate amount of
$2,250,000 based on current
conversion prices and
assuming full conversion of
the convertible debentures
(includes a good faith
estimate of the shares
underlying the convertible
debenture to account for a
decrease in the conversion
price); o up to 6,200,000
shares issuable upon the
exercise of common stock
purchase warrants at an
exercise price of $.15 per
share, assuming full
exercise of the warrants;
o up to 2,000,000 shares
issuable upon the exercise
of common stock purchase
warrants at an exercise
price of $0.25 per share,
assuming full exercise of
the warrants;
o up to 13,000,000 issuable
upon the exercise of common
stock purchase warrants at
an exercise price of $2.00
per share, assuming full
exercise of the warrants.
Common stock to be outstanding after the offering................. Up to 100,210,896 shares
Use of proceeds................................................... We will not receive any proceeds from
the sale of the common stock.
Over-The-Counter Bulletin Board Symbol............................ BRVO
2
The above information regarding common stock to be outstanding after the
offering is based on 50,798,396 shares of common stock outstanding as of
December 28, 2004 and assumes the subsequent conversion of our issued
convertible debentures, with interest, and exercise of warrants by our selling
stockholders.
To obtain funding for our ongoing operations, we entered into the
following two financing transactions.
June 2004
In June 2004, we entered into a Subscription Agreement with Longview Fund,
LP, Alpha Capital Aktiengesellschaft, Whalehaven Funds Limited, Stonestreet
Limited Partnership and Mid-Am Capital L.L.C for the issuance of convertible 10%
notes in the aggregate amount of $1,300,000 and five-year "A" warrants for the
purchase of, in the aggregate, 5,200,000 shares of common stock, at $0.25 per
share, and five-year "B" warrants for the purchase of, in the aggregate,
13,000,000 shares of common stock, at $2.00 per share. In connection with the
October 2004 financing, we subsequently amended the exercise price to $.15 for
the "A" warrants issued to Longview Fund, LP, Alpha Capital Aktiengesellschaft,
Whalehaven Funds Limited and Stonestreet Limited Partnership. The notes are
convertible into shares of common stock of the Company at $0.15 per common
share. The notes are payable in twelve equal monthly installments, commencing
January 1, 2005. The installment payments consist of principal and a "premium"
of 20% of the principal paid per installment. We have the option to defer such
payment until the note's maturity date on December 1, 2005, if our common stock
trades above $0.20 for the five trading days prior to the due date of an
installment payment. In connection with this transaction, we issued additional
notes in the aggregate amount of $40,000 to Gem Funding, LLC, Bi-Coastal
Consulting Corp., Stonestreet Limited Partnership and Libra Finance, S.A upon
identical terms as the principal notes, as a finder's fee, and paid $12,500 in
legal fees. The common stock underlying all notes and warrants carry
registration rights.
The selling stockholders have contractually agreed to restrict their
ability to convert or exercise their warrants and receive shares of our common
stock such that the number of shares of common stock held by them and their
affiliates after such conversion or exercise does not exceed 9.99% of the then
issued and outstanding shares of common stock. See the "Selling Stockholders"
and "Risk Factors" sections for a complete description of the convertible
debentures.
This prospectus relates to the resale of the shares of common stock and
the common stock underlying these convertible debentures and warrants.
October 2004
3
On October 29, 2004, we entered into Subscription Agreements with Longview
Fund, LP, Alpha Capital Aktiengesellschaft, Whalehaven Funds Limited and
Stonestreet Limited Partnership for the issuance of convertible 10% notes in the
aggregate amount of $550,000 and five-year "C" warrants for the purchase of, in
the aggregate, 2,200,000 shares of common stock, at $0.15 per share, and the
repricing of five-year "A" warrants, issued June 30, 2004 for the purchase of,
in the aggregate, 3,200,000 shares of common stock, from $0.25 to $0.15 per
share. The notes are convertible into shares of common stock at $0.10 per common
share. The notes are payable in twelve equal monthly installments, commencing
May 1, 2005. The installment payments consist of principal and a "premium" of
20% of the principal paid per installment. We have the option to defer such
payment until the note's maturity date on April 30, 2006, if our common stock
trades above $0.15 for the five trading days prior to the due date of an
installment payment and the underlying common stock is registered. In connection
with this transaction, we issued additional notes, without attached warrants, in
the aggregate amount of $27,500 to Gem Funding, LLC, Bi-Coastal Consulting
Corp., Stonestreet Limited Partnership and Libra Finance, S.A upon identical
terms as the principal notes, as a finder's fee, and paid $12,500 in legal fees.
The common stock underlying all notes and warrants carry registration rights.
The selling stockholders have contractually agreed to restrict their
ability to convert or exercise their warrants and receive shares of our common
stock such that the number of shares of common stock held by them and their
affiliates after such conversion or exercise does not exceed 9.99% of the then
issued and outstanding shares of common stock. See the "Selling Stockholders"
and "Risk Factors" sections for a complete description of the convertible
debentures.
December 2004
In December 2004, we entered into Subscription Agreements with Momona
Capital Corp. and Ellis International Ltd. for the issuance of convertible 10%
notes in the aggregate amount of $400,000 and five-year "C" warrants for the
purchase of, in the aggregate, 800,000 shares of common stock, at $0.15 per
share. The notes are convertible into shares of common stock at $0.10 per common
share. The notes are payable in twelve equal monthly installments, commencing
May 1, 2005. The installment payments consist of principal and a "premium" of
20% of the principal paid per installment. We have the option to defer such
payment until the note's maturity date on April 30, 2006, if our common stock
trades above $0.15 for the five trading days prior to the due date of an
installment payment and the underlying common stock is registered. In connection
with this transaction, we issued additional notes, without attached warrants, in
the aggregate amount of $10,000 to Momona Capital Corp. and Ellis International
Ltd. upon identical terms as the principal notes, as a finder's fee. The common
stock underlying all notes and warrants carry registration rights.
The selling stockholders have contractually agreed to restrict their
ability to convert or exercise their warrants and receive shares of our common
stock such that the number of shares of common stock held by them and their
affiliates after such conversion or exercise does not exceed 9.99% of the then
issued and outstanding shares of common stock. See the "Selling Stockholders"
and "Risk Factors" sections for a complete description of the convertible
debentures.
This prospectus relates to the resale of the shares of common stock and
the common stock underlying these convertible debentures and warrants.
4
RISK FACTORS
This investment has a high degree of risk. Before you invest you should
carefully consider the risks and uncertainties described below and the other
information in this prospectus. If any of the following risks actually occur,
our business, operating results and financial condition could be harmed and the
value of our stock could go down. This means you could lose all or a part of
your investment.
RISKS RELATING TO OUR BUSINESS:
WE HAVE A HISTORY OF LOSSES WHICH MAY CONTINUE, REQUIRING US TO SEEK ADDITIONAL
SOURCES OF CAPITAL WHICH MAY NOT BE AVAILABLE, REQUIRING US TO CURTAIL OR CEASE
OPERATIONS.
We incurred net losses of $3,016,987 for the year ended December 31, 2003
and $3,160,431 for the year ended December 31, 2002. In addition, we incurred
net losses for the nine months ended September 30, 2004 in the amount of
$2,882,131. We cannot assure you that we can achieve or sustain profitability on
a quarterly or annual basis in the future. If revenues grow more slowly than we
anticipate, or if operating expenses exceed our expectations or cannot be
adjusted accordingly, we will continue to incur losses. We will continue to
incur losses until we are able to establish significant sales. Our possible
success is dependent upon the successful development and marketing of our
services and products, as to which there is no assurance. Any future success
that we might enjoy will depend upon many factors, including factors out of our
control or which cannot be predicted at this time. These factors may include
changes in or increased levels of competition, including the entry of additional
competitors and increased success by existing competitors, changes in general
economic conditions, increases in operating costs, including costs of supplies,
personnel, marketing and promotions, reduced margins caused by competitive
pressures and other factors. These conditions may have a materially adverse
effect upon us or may force us to reduce or curtail operations. In addition, we
will require additional funds to sustain and expand our sales and marketing
activities, particularly if a well-financed competitor emerges. We anticipate
that we will require up to approximately $1,500,000 to fund our continued
operations for the next twelve months, depending on revenue from operations.
There can be no assurance that financing will be available in amounts or on
terms acceptable to us, if at all. The inability to obtain sufficient funds from
operations or external sources would require us to curtail or cease operations.
IF WE ARE UNABLE TO OBTAIN ADDITIONAL FUNDING OUR BUSINESS OPERATIONS WILL BE
HARMED AND IF WE DO OBTAIN ADDITIONAL FINANCING OUR THEN EXISTING SHAREHOLDERS
MAY SUFFER SUBSTANTIAL DILUTION.
Additional capital will be required to effectively support the operations
and to otherwise implement our overall business strategy. However, there can be
no assurance that financing will be available when needed on terms that are
acceptable to us. The inability to obtain additional capital will restrict our
ability to grow and may reduce our ability to continue to conduct business
operations. If we are unable to obtain additional financing, we will likely be
required to curtail our marketing and development plans and possibly cease our
operations. Any additional equity financing may involve substantial dilution to
our then existing shareholders.
OUR INDEPENDENT AUDITORS HAVE EXPRESSED SUBSTANTIAL DOUBT ABOUT OUR ABILITY TO
CONTINUE AS A GOING CONCERN, WHICH MAY HINDER OUR ABILITY TO OBTAIN FUTURE
FINANCING.
In their report dated April 2, 2004, our independent auditors stated that
our financial statements for the year ended December 31, 2003 were prepared
assuming that we would continue as a going concern. Our ability to continue as a
going concern is an issue raised as a result of a net loss for the year ended
December 31, 2003 in the amount of $3,016,987. We continue to experience net
operating losses. Our ability to continue as a going concern is subject to our
ability to generate a profit and/or obtain necessary funding from outside
sources, including obtaining additional funding from the sale of our securities,
increasing sales or obtaining loans and grants from various financial
institutions where possible. Our continued net operating losses increases the
difficulty in meeting such goals and there can be no assurances that such
methods will prove successful.
SINCE WE DEPEND UPON KEY PERSONNEL HAVING SIGNIFICANT BUSINESS CONTACTS IN THE
US AND INTERNATIONALLY, THE LOSS OF ONE OR MORE OF OUR MANAGEMENT TEAM MAY HAVE
A NEGATIVE EFFECT ON OUR BUSINESS.
5
The unexpected loss of the services of any member of the management team could
have a material adverse effect on our ability to conduct and grow both our US
and international business. We are and will be dependent on our current
management teams for the foreseeable future
o to obtain needed additional financing
o to develop and maintain critical business contacts for the
production of our branded milk products
o to develop and maintain third party licensor and brand development
contacts for the formulation of new brand development and branded
food products
WE FACE INTENSE COMPETITION IN OUR US MARKET THAT COULD NEGATIVELY IMPACT OUR
RESULTS OF OPERATIONS
Since we are smaller than our competitors in the US market and since we
have limited resources and sell our branded products at premium prices, we have
had difficulty in developing and maintaining our market share in the consumer
milk market. This difficulty could adversely affect our ability to achieve our
business goals to develop and increase the awareness of our branded products in
an effort to increase sales, while maintaining a premium price structure.
The ability of our competition to sell dairy and other food products at
prices below prices charged by us for our products may represent an obstacle to
our ability to secure a market share at revenue levels sufficient to achieve
profitability.
In our foreign business, we grant the rights to produce and sell branded
milk products to processor dairies under production agreements. Our role in
these agreements, in addition to granting the rights to produce the branded
milks as part of the sale of flavor ingredient packages to dairies, is limited
to marketing and promotion assistance and control over packaging and advertising
design issues. Such processors dairies have significant control over sales and
distribution of the branded milk products.. A reduction in sales effort or
discontinuance of sales of our products by our co-producerscould lead to reduced
sales.
RISKS RELATING TO OUR CURRENT FINANCING ARRANGEMENT:
THERE ARE A LARGE NUMBER OF SHARES UNDERLYING OUR CONVERTIBLE DEBENTURES AND
WARRANTS THAT MAY BE AVAILABLE FOR FUTURE SALE AND THE SALE OF THESE SHARES MAY
DEPRESS THE MARKET PRICE OF OUR COMMON STOCK.
As of December 28, 2004, we had 50,798,396 shares of common stock issued
and outstanding and convertible debentures outstanding that may be converted
into an estimated 41,700,000 shares of common stock at current market prices,
outstanding warrants to purchase 43,900,227 shares of common stock and options
to purchase 3,571,086 shares of common stock. Furthermore, there are currently
outstanding shares of Preferred Stock that are convertible into approximately
41,500,000 shares of common stock. In addition, the number of shares of common
stock issuable upon conversion of the outstanding convertible debentures may
increase if the market price of our stock declines. All of the shares, including
all of the shares issuable upon conversion of the debentures and upon exercise
of our warrants, may be sold without restriction. The sale of these shares may
adversely affect the market price of our common stock.
THE ISSUANCE OF SHARES UPON CONVERSION OF THE CONVERTIBLE DEBENTURES AND
EXERCISE OF OUTSTANDING WARRANTS MAY CAUSE IMMEDIATE AND SUBSTANTIAL DILUTION TO
OUR EXISTING STOCKHOLDERS.
The issuance of shares upon conversion of the convertible debentures and
exercise of warrants may result in substantial dilution to the interests of
other stockholders since the selling stockholders may ultimately convert and
sell the full amount issuable on conversion. Although the selling stockholders
may not convert their convertible debentures and/or exercise their warrants if
such conversion or exercise would cause them to own more than 9.99% of our
outstanding common stock, this restriction does not prevent the selling
stockholders from converting and/or exercising some of their holdings, selling
these shares and then converting the rest of their holdings. In this way, the
selling stockholders could sell more than this limit while never holding more
than this limit. There is no upper limit on the number of shares that may be
issued which will have the effect of further diluting the proportionate equity
interest and voting power of holders of our common stock, including investors in
this offering.
6
IF WE ARE REQUIRED FOR ANY REASON TO REPAY OUR OUTSTANDING CONVERTIBLE
DEBENTURES, WE WOULD BE REQUIRED TO DEPLETE OUR WORKING CAPITAL, IF AVAILABLE,
OR RAISE ADDITIONAL FUNDS. OUR FAILURE TO REPAY THE CONVERTIBLE DEBENTURES, IF
REQUIRED, COULD RESULT IN LEGAL ACTION AGAINST US, WHICH COULD REQUIRE THE SALE
OF SUBSTANTIAL ASSETS.
In November 2003, April 2004, June 2004, October 2004 and December 2004,
we entered into financing arrangements for the sale $3,150,000 principal amount
of convertible debentures. The convertible debentures issued in November 2003
are due and payable, with 8% interest, two years from the date of issuance,
unless sooner converted into shares of our common stock. In April 2004, we
entered into a Subscription Agreement with two accredited investors for the sale
of $500,000 in convertible debentures. The debentures issued in connection with
the April 2004 financing bear interest at 10%. The principal on the notes is due
in equal monthly installments commencing on November 1, 2004 until October 1,
2005. On October 1, 2005, all principal and interest shall become due. In June
2004, we issued convertible 10% notes in the aggregate amount of $1,300,000. The
notes are payable in twelve equal monthly installments, commencing January 1,
2005. The installment payments consist of principal and a "premium" of 20% of
the principal paid per installment. We have the option to defer such payment
until the note's maturity date on December 1, 2005, if our common stock trades
above $0.20 for the five trading days prior to the due date of an installment
payment. In October 2004, we issued convertible 10% notes in the aggregate
amount of $500,000. The notes are payable in twelve equal monthly installments,
commencing May 1, 2005. The installment payments consist of principal and a
"premium" of 20% of the principal paid per installment. We have the option to
defer such payment until the note's maturity date on April 30, 2006, if our
common stock trades above $0.20 for the five trading days prior to the due date
of an installment payment. In December 2004, we issued convertible 10% notes in
the aggregate amount of $400,000. The notes are payable in twelve equal monthly
installments, commencing May 1, 2005. The installment payments consist of
principal and a "premium" of 20% of the principal paid per installment. We have
the option to defer such payment until the note's maturity date on April 30,
2006, if our common stock trades above $0.20 for the five trading days prior to
the due date of an installment payment.
Any event of default could require the early repayment of the convertible
debentures, including a default interest rate if the default is not cured with
the specified grace period. We anticipate that the full amount of the
convertible debentures, together with accrued interest, will be converted into
shares of our common stock, in accordance with the terms of the convertible
debentures. If we are required to repay the convertible debentures, we would be
required to use our limited working capital and raise additional funds. If we
were unable to repay the debentures when required, the debenture holders could
commence legal action against us to recover the amounts due. Any such action
would require us to obtain additional financing or curtail or cease operations.
RISKS RELATING TO OUR COMMON STOCK:
IF WE FAIL TO REMAIN CURRENT ON OUR REPORTING REQUIREMENTS, WE COULD BE REMOVED
FROM THE OTC BULLETIN BOARD WHICH WOULD LIMIT THE ABILITY OF BROKER-DEALERS TO
SELL OUR SECURITIES AND THE ABILITY OF STOCKHOLDERS TO SELL THEIR SECURITIES IN
THE SECONDARY MARKET.
Companies trading on the OTC Bulletin Board, such as us, must be reporting
issuers under Section 12 of the Securities Exchange Act of 1934, as amended, and
must be current in their reports under Section 13, in order to maintain price
quotation privileges on the OTC Bulletin Board. If we fail to remain current on
our reporting requirements, we could be removed from the OTC Bulletin Board. As
a result, the market liquidity for our securities could be severely adversely
affected by limiting the ability of broker-dealers to sell our securities and
the ability of stockholders to sell their securities in the secondary market.
OUR COMMON STOCK IS SUBJECT TO THE "PENNY STOCK" RULES OF THE SEC AND THE
TRADING MARKET IN OUR SECURITIES IS LIMITED, WHICH MAKES TRANSACTIONS IN OUR
STOCK CUMBERSOME AND MAY REDUCE THE VALUE OF AN INVESTMENT IN OUR STOCK.
7
The Securities and Exchange Commission has adopted Rule 15g-9 which
establishes the definition of a "penny stock," for the purposes relevant to us,
as any equity security that has a market price of less than $5.00 per share or
with an exercise price of less than $5.00 per share, subject to certain
exceptions. For any transaction involving a penny stock, unless exempt, the
rules require:
o that a broker or dealer approve a person's account for transactions
in penny stocks; and
o the broker or dealer receive from the investor a written agreement
to the transaction, setting forth the identity and quantity of the
penny stock to be purchased.
In order to approve a person's account for transactions in penny stocks, the
broker or dealer must:
o obtain financial information and investment experience objectives of
the person; and
o make a reasonable determination that the transactions in penny
stocks are suitable for that person and the person has sufficient
knowledge and experience in financial matters to be capable of
evaluating the risks of transactions in penny stocks.
The broker or dealer must also deliver, prior to any transaction in a penny
stock, a disclosure schedule prescribed by the Commission relating to the penny
stock market, which, in highlight form:
o sets forth the basis on which the broker or dealer made the
suitability determination; and
o that the broker or dealer received a signed, written agreement from
the investor prior to the transaction.
Generally, brokers may be less willing to execute transactions in securities
subject to the "penny stock" rules. This may make it more difficult for
investors to dispose of our common stock and cause a decline in the market value
of our stock.
Disclosure also has to be made about the risks of investing in penny
stocks in both public offerings and in secondary trading and about the
commissions payable to both the broker-dealer and the registered representative,
current quotations for the securities and the rights and remedies available to
an investor in cases of fraud in penny stock transactions. Finally, monthly
statements have to be sent disclosing recent price information for the penny
stock held in the account and information on the limited market in penny stocks.
8
USE OF PROCEEDS
This prospectus relates to shares of our common stock that may be offered
and sold from time to time by the selling stockholders. We will not receive any
proceeds from the sale of shares of common stock in this offering. In the event
that we received proceeds from the exercise of the Class A, Class B Warrants and
other warrants, we will use these funds for working capital.
MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS
Our common stock is quoted on the OTC Bulletin Board under the symbol
"BRVO".
For the periods indicated, the following table sets forth the high and low
bid prices per share of common stock. These prices represent inter-dealer
quotations without retail markup, markdown, or commission and may not
necessarily represent actual transactions.
--------------------------------------------------------------------------------
High Low
--------------------------------------------------------------------------------
2001 $ $
--------------------------------------------------------------------------------
First Quarter .59 .27
--------------------------------------------------------------------------------
Second Quarter .51 .32
--------------------------------------------------------------------------------
Third Quarter .51 .20
--------------------------------------------------------------------------------
Fourth Quarter .50 .31
--------------------------------------------------------------------------------
2002
--------------------------------------------------------------------------------
First Quarter .52 .37
--------------------------------------------------------------------------------
Second Quarter .39 .21
--------------------------------------------------------------------------------
Third Quarter .38 .22
--------------------------------------------------------------------------------
Fourth Quarter .40 .24
--------------------------------------------------------------------------------
2003
--------------------------------------------------------------------------------
First Quarter .28 .19
--------------------------------------------------------------------------------
Second Quarter .23 .08
--------------------------------------------------------------------------------
Third Quarter .16 .09
--------------------------------------------------------------------------------
Fourth Quarter .14 .05
--------------------------------------------------------------------------------
2004
--------------------------------------------------------------------------------
First Quarter .17 .06
--------------------------------------------------------------------------------
Second Quarter .34 .14
--------------------------------------------------------------------------------
Third Quarter .27 .13
--------------------------------------------------------------------------------
Fourth Quarter .22 .09
--------------------------------------------------------------------------------
HOLDERS
As of January 14, 2005, we had approximately 460 holders of our common
stock. The number of record holders was determined from the records of our
transfer agent and does not include beneficial owners of common stock whose
shares are held in the names of various security brokers, dealers, and
registered clearing agencies. The transfer agent of our common stock is American
Stock Transfer & Trust Company, 59 Maiden Lane, Plaza Level, New York, NY 10038.
9
We have not paid dividends on our common stock and do not anticipate
paying dividends. Management intends to retain future earnings, if any, to
finance working capital, to expand our operations and to pursue our acquisition
strategy.
The holders of common stock are entitled to receive, pro rata, such
dividends and other distributions as and when declared by our board of directors
out of the assets and funds legally available therefor. The availability of
funds is dependent upon dividends or distribution of profits from our
subsidiaries and may be subject to regulatory control and approval by the
appropriate government authorities on either a regional or national level in the
People's Republic of China.
We have accrued dividends for our convertible preferred stock for 2001 in
the amount of $255,725, accrued $1,011,159 for the period ended December 31,
2002 and $902,468 for the period ended December 31, 2003.
SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS
The equity compensation reported in this section has been and will be
issued pursuant to individual compensation contracts and arrangements with
employees, directors, consultants, advisors, vendors, suppliers, lenders and
service providers. The equity is reported on an aggregate basis as of December
31, 2003. Our security holders have not approved the compensation contracts and
arrangements underlying the equity reported.
----------------------------------------------------------------------------------------------------------------------
Compensation Plan Number of securities to Weighted average price of Number of securities remaining
Category be issued upon exercise outstanding options, for future issuance under equity
of outstanding options, warrants and rights compensation plans
warrants and rights
----------------------------------------------------------------------------------------------------------------------
Directors 1,405,000 $0.72 350,000 director plan
----------------------------------------------------------------------------------------------------------------------
Management 1,036,667 $0.59 3,350,000 individual plans
----------------------------------------------------------------------------------------------------------------------
Founders 2,083,705 $1.00 0 individual plans
----------------------------------------------------------------------------------------------------------------------
Consultants 360,714 $0.54 0 individual plans
----------------------------------------------------------------------------------------------------------------------
Lender 25,000 $0.40 0 individual plan
----------------------------------------------------------------------------------------------------------------------
Total 4,911,086 $0.79 3,700,000
----------------------------------------------------------------------------------------------------------------------
COMPENSATION PLANS
Directors
On March 27, 2001, we issued options to our directors to purchase an
aggregate of 925,000 shares of our common stock. The options have an exercise
price of $0.75 and expire March 26, 2006. Directors received options for 35,000
shares for each full year of service and an additional 40,000 shares for service
on a board committee. On August 14, 2001, we issued 250,000 options to the Board
of Directors for services rendered as directors. Each director received options
for 25,000 shares of common stock at an exercise price of $0.60. The options can
be exercised for five years.
On January 13, 2004, the Board of Directors adopted a plan to convert on a
one for one basis the options granted to the present employees of the Company
and the directors currently serving on the Board into a like number of the
Company's restricted shares of common stock. The issuance of such common stock
to any individual director or employee is conditioned upon the execution of the
"lockup" agreement by such director or employee, pursuant to which the
recipients of such common stock shall not sell, transfer, pledge or hypothecate
such common stock for a six month period, commencing on the issue date of such
common stock. The conversion plan adopted by the Board of Directors will result
in the issuance of 5,200,000 shares of the Company's restricted common stock to
the Company's present directors and employees.
10
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS
Some of the information in this Form SB-2 contains forward-looking
statements that involve substantial risks and uncertainties. You can identify
these statements by forward-looking words such as "may," "will," "expect,"
"anticipate," "believe," "estimate" and "continue," or similar words. You should
read statements that contain these words carefully because they:
o discuss our future expectations;
o contain projections of our future results of operations or of our
financial condition; and
o state other "forward-looking" information.
We believe it is important to communicate our expectations. However, there
may be events in the future that we are not able to accurately predict or over
which we have no control. Our actual results and the timing of certain events
could differ materially from those anticipated in these forward-looking
statements as a result of certain factors, including those set forth under "Risk
Factors," "Business" and elsewhere in this prospectus. See "Risk Factors."
OVERVIEW
Our business model includes the development and marketing of our company
owned Slammers(R) trademarked brand, the obtaining of license rights from third
party holders of intellectual property rights to other trademarked brands, logos
and characters and the granting of production and marketing rights to processor
dairies to produce branded flavored milk. We generate revenue in our
international (non-US) business through the sale of "kits" to these dairies. The
price of the "kits" consists of an invoiced price for a fixed amount of flavor
ingredients per kit used to produce the flavored milk and a fee charged to the
dairy processors for the production, promotion and sales rights for the branded
flavored milk. In the United States, we generate revenue from the unit sales of
finished branded flavored milks to retail consumer outlets.
Our new product introduction and growth expansion continues to be
expensive, and we reported a net loss of $2,882,131 for the nine-month period
ended September 30, 2004, with a net loss of $1,120,992 for the three months
ended September 30, 2004. As shown in the accompanying financial statements, we
have suffered operating losses and negative cash flows from operations since
inception and at September 30, 2004 has an accumulated deficit, a capital
deficit, is delinquent on certain debts and has negative working capital. These
conditions give rise to substantial doubt about our ability to continue as a
going concern. As discussed herein, we plan to work toward profitability in our
U.S. and international business and obtain additional financing. While there is
no assurance that funding will be available or that we will be able to improve
our operating results, we are continuing to seek equity and/or debt financing.
No assurances can be given, however, that management will be successful in
carrying out our plans.
CORPORATE GOVERNANCE
The Board of Directors
Our board has positions for nine directors that are elected as Class A or
Class B directors at alternate annual meetings of our shareholders. We presently
have two mid-term vacancies on the board. Six of the seven current directors of
our board are independent. Our chairman and chief executive officer are
separate. The board meets regularly, at least four times a year, and all
directors have access to the information necessary to enable them to discharge
their duties. The board, as a whole, and the audit committee in particular,
review our financial condition and performance on an estimated vs. actual basis
and financial projections as a regular agenda item at scheduled periodic board
meetings, based upon separate reports submitted by our chief executive officer
and chief financial officer. Directors are elected by our shareholders after
nomination by the board or are appointed by the board when a vacancy arises
prior to an election. This year we have adopted a nomination procedure based
upon a rotating nomination committee made up of those members of the director
Class not up for election. The board presently is examining whether this
procedure, as well as the make up of the audit and compensation committees,
should be the subject of an amendment to the by-laws.
11
Audit Committee
Our audit committee is composed of three independent directors and
functions to assist the board in overseeing our accounting and reporting
practices. Our financial information is booked in house by our CFO's office,
from which we prepare financial reports. These financial reports are audited or
reviewed by Lazar Levine & Felix LLP, independent certified accountants and
auditors. Our chief financial officer reviews the preliminary financial and
non-financial information prepared in house with our securities counsel and the
reports of the auditors. The committee reviews the preparation of our audited
and unaudited periodic financial reporting and internal control reports prepared
by our chief financial officer. The committee reviews significant changes in
accounting policies and addresses issues and recommendations presented by our
internal and external certified accountants as well as the our auditors.
Currently, there is one vacancy on the audit committee.
Compensation Committee
Our compensation committee is composed of three independent directors and
reviews the compensation structure and policies concerning executive
compensation. The committee develops proposals and recommendations for executive
compensation and presents those recommendations to the full board for
consideration. The committee periodically reviews the performance of our other
members of management and the recommendations of the chief executive officer
with respect to the compensation of those individuals. Given the size of our
company, all such employment contracts are periodically reviewed by the board.
The board must approve all compensation packages that involve the issuance of
our stock or stock options. Currently, there is one vacancy on the compensation
committee.
Nominating Committee
The nominating committee was established in the second quarter 2002 and
consists of those members of the director Class not up for election. The
committee is charged with determining those individuals who will be presented to
the shareholders for election at the next scheduled annual meeting. The full
board fills any mid term vacancies by appointment.
CRITICAL ACCOUNTING POLICIES
Estimates
This discussion and analysis of our consolidated financial condition and
results of operations are based on our consolidated financial statements, which
have been prepared in accordance with accounting principles generally accepted
in the United States of America. The preparation of these financial statements
requires us to make estimates and disclosure of contingent assets and
liabilities at the date of the financial statements and the reported amounts of
revenues and expenses during the reporting period. On an on-going basis, we
evaluate our company's estimates, including those related to reserves for bad
debts and valuation allowance for deferred tax assets. We base our estimates on
historical experience and on various other assumptions that are believed to be
reasonable under the circumstances, the result of which forms the basis for
making judgments about the carrying values of assets and liabilities that are
not readily apparent from other sources. Actual results may differ materially
from these estimates under different assumptions or conditions. Our use of
estimates, however, is quite limited as we have adequate time to process and
record actual results from operations.
Revenue recognition
United States
We recognize revenue in the United States at the gross amount of our
invoices for the sale of finished product to wholesale buyers. We take title to
our branded flavored milks when they are shipped by our third party processors
and recognize as revenue the gross wholesale price charged to our wholesale
customers. Our gross margin is determined by the reported wholesale price less
the cost charged by Jasper Products, our third party processor, to produce the
branded milk products.
12
Prior to 2004, we reported revenue in the United States from our sale of
"kits" to third party processors and from the differential between the cost of
producing its finished product and the wholesale price of its finished product.
Commencing in the first quarter 2004, we report revenue from our sale of
finished product on the wholesale level. We report the cost of producing the
product charged by a third party processor as the cost of goods sold. This
change in revenue recognition has resulted in materially higher reported revenue
for our company, with a corresponding material increase in reported costs of
goods sold.
In certain circumstances in its U.S. business, we are required to pay
slotting fees, give promotional discounts or make marketing allowances in order
to secure wholesale customers. These payments, discounts and allowances reduce
our reported revenue in accordance with the guidelines set forth in EITF 01-9
and SEC Staff Accounting Bulletin No. 101.
International Sales
We recognize revenue in our international (non US) business at the gross
amount of our invoices for the sale of kits at the time of shipment of flavor
ingredients to processor dairies with whom we have production contracts for
extended shelf life and aseptic long life milk. We base this recognition on our
role as the principal in these transactions, our discretion in establishing kit
prices (including the price of flavor ingredients and production right fees),
our development and refinement of flavors and flavor modifications, our
discretion in supplier selection and our credit risk to pay for ingredients if
processors do not pay ingredient suppliers. The revenue generated by the
production contracts under this model consists of the cost of the processors'
purchase of flavor ingredients and fees charged by us to the processors for
production rights. The Company formulates the price of production rights to
cover our intellectual property licenses, which varies by licensor as a
percentage of the total cost of a kit sold to the processor dairy under the
production agreement. The Company recognizes revenue on the gross amount of
"kit" invoices to the dairy processors and simultaneously records as cost of
goods sold the cost of flavor ingredients paid by the processor dairies to
ingredients supplier. The recognition of revenue generated from the sale of
production rights associated with the flavor ingredients is complete upon
shipment of the ingredients to the processor, given the short utilization cycle
of the ingredients shipped.
Pursuant to EITF 99-19, international sales of kits made directly to
customers by us are reflected in the statements of operations on a gross basis,
whereby the total amount billed to the customer is recognized as revenue.
RESULTS OF OPERATIONS
Financial Condition at September 30, 2004
As of September 30, 2004, we had an accumulated deficit of $32,990,665,
cash on hand of $58,263 and reported total capital deficit of $3,108,608.
For this same period of time, we had revenue of $2,704,992 and general and
administrative expense of $2,213,326.
After interest expenses of $154,817, cost of goods sold of $1,893,834,
product development costs of $55,104 and selling expenses of $1,270,042 incurred
in the operations of our company, we had a net loss of $2,882,131.
Nine Months Ended September 30, 2004 Compared to Nine Months Ended September 30,
2003
Consolidated Revenue
We had revenues for the nine months ended September 30, 2004 of
$2,704,992, with cost of sales of $1,893,834, resulting in a gross margin of
$811,158. This revenue and resultant gross margin is net of slotting fees,
promotional discounts and marketing allowances for this period in the amount of
$126,469. Of the reported
13
$2,704,992, U.S. sales accounted for $2,301,844 with an additional $403,148 from
international sales. We did not have revenue in 2004 in Canada or for the three
months ended September 30, 2004 in the Middle East. Our reported revenue for the
nine months ended September 30, 2004 increased by $1,618,555, a 148.98% increase
compared to revenue of $1,086,437 for the same period in 2003. This increase is
the result of a change in our method of revenue recognition in the United
States, commencing January 1, 2004, when we began to act as the principal in
these transactions, rather than as an agent. In addition, in the first quarter
of 2004, we began to phase out our Looney Tunes(TM) flavored milk products and
to develop four new branded product lines in the United States, including the
launch of the Company's Slammers(R) line of Marvel Comics Super Heroes(TM)
branded flavored milks during the second quarter 2004. We also began to ship
kits to our third-party Middle East dairy processor during the second quarter
2004.
Consolidated Cost of Sales
We incurred cost of goods sold of $1,893,834 for the nine months ended
September 30, 2004, $1,820,432 of which was incurred in our U.S. business, and
$73,402 in connection with out international sales. Cost of goods sold in 2004
increased by $1,717,826, a 975.99% increase compared to $176,008 for the same
period in 2003. The increase in cost of goods sold reflects an increase in
sales, the change in our role from agent to principal during this period and the
concomitant increase in reported cost of goods sold associated with that change.
In countries except the United States, our revenue is generated by the
sale of kits to dairy processors. Each kit consists of flavor ingredients for
flavored milks and production rights to manufacture and sell the milks. In line
with our revenue recognition policies, we recognize the full invoiced kit price
as revenue, less the cost of production charged by the processor, which we
record as cost of goods sold.
In the United States, we are responsible for the sale of finished
Slammers(R) flavored milk (referred to as "unit sales") to retail outlets. For
these unit sales, we recognize as revenue the invoiced wholesale prices that we
charge to the retail outlets that purchase the Slammers(R) flavored milks. Our
reports as cost of goods sold the price charged to us by Jasper Products, a
third party processor under contract with our company, for producing the
finished Slammers(R) products.
Segmented revenues and costs of sales
The following table presents revenue by source and type against costs of
goods sold, as well as combined gross revenues and gross margins. In countries
other than the United States, revenues for the period ended September 30, 2004
were generated by kit sales to third party processors. Our revenue from the sale
of finished product to retail outlets is recorded as "unit sales" on the
following table.
Nine Months Ended Total
September 30, 2004 United States Canada Mexico Middle East Company
------------- ------ ------ ----------- -------
Revenue - unit sales $ 2,236,383 $ -- $ -- $ -- $ 2,236,383
Revenue - gross kit sales 65,461 -- 83,518 319,630 468,609
------------ ------------ ------------ ------------ ------------
Total revenue 2,301,844 -- 83,518 319,630 2,704,992
Cost of goods sold (1,820,432) -- (31,101) (42,301) (1,893,834)
------------ ------------ ------------ ------------ ------------
Gross margin $ 481,412 $ -- $ 52,417 $ 277,329 $ 811,158
============ ============ ============ ============ ============
Nine Months Ended Total
September 30, 2003 United States Canada Mexico China Company
------------- ------ ------ ----- -------
Revenue - unit sales $ 336,644 $ -- $ -- $ -- $ 336,644
Revenue - net kit sales 2,737 -- -- -- 2,737
Revenue - gross kit sales 556,490 43,745 111,463 35,358 747,056
----------- ----------- ----------- ----------- -----------
Total revenue 895,871 43,745 111,463 35,358 1,086,437
Cost of goods sold (111,869) (10,402) (35,610) (18,127) (176,008)
----------- ----------- ----------- ----------- -----------
Gross margin $ 784,002 $ 33,343 $ 75,853 $ 17,231 $ 910,429
=========== =========== =========== =========== ===========
14
United States
Revenues for the period ended September 30, 2004 from unit sales in the
United States increased from $336,644 for the same period in 2003 to $2,236,383
in 2004, a 564% increase. The increase is the result of a change in revenue
recognition and the introduction of our new product lines during this period.
In the period ended September 30, 2004, our gross margin for U.S. sales of
$481,412, decreased by $302,590, or by 38.6%, from $784,002 for the same period
in 2003. The decrease in gross margin was the result of our role change from
agent to principal in its US sales transactions, which required us to recognize
the entire cost of production of our milk products against revenues from the
wholesale sales for those products.
Foreign Sales
Revenues for the period ended September 30, 2004 from kit sales in foreign
countries increased from $190,566 for the same period in 2003 to $403,148, a
111.6 % increase. The increase is the result of sales growth in Mexico during
this period.
We recorded $73,402 in costs of kit sales in foreign countries for the
period ended September 30, 2004, an increase of $9,263 or 14.4% from $64,139 for
the same period in 2003. As a percentage of sales, the costs of goods sold
decreased to 18.21% for the period ended September 30, 2004, from 33.7% for the
same period in 2003. The reduction of cost of goods sold as a percentage of
sales was the result of greater efficiencies of shipment and lower costs in
sourcing the product ingredients in Europe, rather than the United States.
For the period ended September 30, 2004, our gross profit of $329,746 for
kit sales in foreign countries increased by $203,319, or 160.83%, from $126,427
for the same period in 2003. The increase in gross profit was consistent with
the increase in sales volume and the decease in cost of goods sold for this
period.
Consolidated Operating Expenses
We incurred selling expenses of $1,270,042 for the period ended September
30, 2004, of which the Company incurred $1,172,192 in its United States
operations. Our selling expense for this period increased by $232,128, a 22.36%
increase compared to selling expense of $1,037,914 for the same period in 2003.
The increase in selling expenses in the current period was due to increased
freight and promotional charges associated with our transition away from its
Looney Tunes(TM) product line and the development of four new product lines,
utilizing newly licensed and directly owned branded trademarks.
Our incurred general and administrative expenses for the period ended
September 30, 2004 of $2,213,326, most of which we incurred in its United States
business operations. Our general and administrative expenses for this period
increased by $444,074, a 25.1% increase compared to $1,769,252 for the same
period in 2003. The increase in general and administrative expenses for the
current period in 2004 is the result of the accrual of the compensation value of
the conversion of management's and directors' options to common stock, in the
amount of $431,600. This expense is a one time charge.
As a percentage of total revenue, our general and administrative expenses
decreased from 162.8% in the period ended September 30, 2003, to 81.8% for the
current period in 2004. We anticipate a continued effort to reduce these
expenses as a percentage of sales through revenue growth, cost cutting efforts
and the refinement of business operations.
15
Interest Expense
We incurred interest expense for the period ended September 30, 2004 of
$154,817. Our interest expense increased by $147,317, a 1,964% increase compared
to $7,500 for the same period in 2003. The increase was due to additional loans
in 2004 and utilizing debt to finance our operations during this period's
transition in licensors of intellectual property utilized by our company and the
development and launch of new product lines.
Loss Per Share
We accrued dividends payable of $291,460 to various series of preferred
stock during the period ended September 30, 2004. The Company's accrued
dividends increased for this period by $41,431, or 16.57%, from $250,029 for the
same period in 2003. The increase in net loss before accrued dividends of
$970,106, from $1,912,025 for the period ended September 30, 2003 to $2,882,131
for the current period, and the increase in accrued dividends, was offset by the
increase in the weighted average number of common shares outstanding, resulting
in a decrease in the Company's current period loss per share from $0.10 for the
same period in 2003, to a loss per share of $0.08 for the current period. The
net loss for the three month period ended September 30, 2004, represents a loss
per share of $0.03.
THREE MONTHS ENDED SEPTEMBER 30, 2004 COMPARED TO THE THREE MONTHS ENDED
SEPTEMBER 30, 2003
Revenue
We had revenues for the three months ended September 30, 2004 of $825,430,
with cost of sales of $628,747, resulting in a gross profit of $196,683, or
23.8% of sales. This revenue and resultant gross margin is net of slotting fees
and promotional discounts for this period in the amount of $57,366. Absent the
contra revenue effect of these fees and discounts, the Company's had a gross
margin of 28.78%. Of the reported $825,430, $768,250 was from sales in our U.S.
operations, and $57,150 from sales in Mexico. We did not report any sales for
Canada or the Middle East in the three months ended September 30, 2004. Our
reported revenue for the three months ended September 30, 2004 increased by
$490,893, a 146.74% increase compared to revenue of $334,537 for the three
months ended September 30, 2003. The increase in revenue in the United States
for the three months ended September 30, 2004 is the result of a change in
revenue recognition and the introduction of our new product lines during this
period. The lack of sales in the Middle East for the three months ended
September 30, 2004 was the result of pipeline effect purchases in the prior
quarter.
Cost of Goods Sold
We incurred cost of goods sold of $628,747 for the three months ended
September 30, 2004, most of which was incurred in our U.S. operations. Our cost
of goods sold for this period increased by $575,274, a 1,076% increase compared
to $53,473 for the three months ended September 30, 2003. The increase in cost
of goods sold in the United States for the three months ended September 30, 2004
is the result of a change in revenue recognition and the corresponding material
increase in the cost of good sold associated wit that change.
Operating Expense
We incurred selling expenses for the three months ended September 30, 2004
of $652,622 most of which was incurred in our U.S. operation. Selling expenses
increased for the three months ended September 30, 2004 by $295,238, an 82.61%
increase compared to the selling expense of $357,384 for the three months ended
September 30, 2003. The increase in selling expenses is the result of the
adoption of the refined business plan in the U.S. for our North America Bravo!
operations, including the costs associated with the sale of finished product to
retail establishments through brokers and distributors.
We incurred general and administrative expenses for the three months ended
September 30, 2004 of $551,299, all of which was incurred in the U.S.
operations. General and administrative expenses for the three months ended
September 30, 2004 increased by $73,178, a 15.3% increase compared to $478,121
for the same period in 2003. This increase was the result of the costs
associated with the development and launch of new product lines and licensing
costs.
16
Interest Expense
We incurred interest expense for the three months ended September 30, 2004
of $79,822. Interest expense for the three months ended September 30, 2004
increased by $76,401, a 2,233% increase compared to $3,421, for the same period
in 2003. This increase was the result of additional loans in this period and
utilizing debt to finance our operations during this period's transition in
licensors of intellectual property utilized by us and the development and launch
of new product lines.
Net Loss
We had a net loss in for the three months ended September 30, 2004 of
$1,120,992 compared with a net loss of $563,996 for the same period in 2003. The
net loss increased by $556,996 or 98.75% compared to the same period in 2003.
The increase in net loss resulted from the costs associated with the development
and launch of new product lines, licensing costs and the change in revenue
recognition with the associated increase in reported cost of goods sold and
decrease of the gross margin.
YEAR ENDED DECEMBER 31, 2003 COMPARED TO YEAR ENDED DECEMBER 31, 2002
CONSOLIDATED REVENUE
We had annual revenues in 2003 of $1,200,142, with a cost of goods sold of
$192,498, resulting in a gross profit of $1,007,644. Of the $1,200,142, $989,721
was generated in the U.S. and $21,314 from sales recognized by our wholly owned
subsidiary, China Premium Food Corp (Shanghai) Co., Ltd in China. Our revenue in
2003 decreased by $572,828, a 32.31% decrease compared to revenue of $1,772,970
in 2002, which consisted of $1,515,117 in the U.S. and $55,128 in China. This
decrease is the result of the reduction and ultimate cessation of the
penetration and distribution of Looney Tunes(TM) flavored milk products, as well
as the negotiation of new third party licenses to support the development of new
branded milk products, both domestically and internationally. In addition, our
China business experienced continuing difficulties with market penetration of
its Looney(TM) branded products, including what we perceived to be the
licensor's continuing overall lack of brand support in China.
In 2003, we combined gross margin of $1,007,644 decreased by $485,971, or
32.5%, from $1,493,615 in 2002.
CONSOLIDATED COST OF GOODS SOLD
We incurred cost of goods sold of $192,498 in 2003, consisting of $127,647
in its U.S operations and $55,650 in Mexico and Canada. Our cost of goods sold
in 2003 decreased by $86,857, a 31% decrease compared to $279,355 in 2002, of
which $184,022 was incurred in the U.S. and $42,291 was incurred in the Canada
and Mexico. The decrease in our cost of good sold resulted from decreased sales
in 2003.
In Mexico, Canada, China and the United States, our revenue is generated
in part by the sale of kits to dairy processors. Each kit consists of flavor
ingredients for our Slammers(R) Looney Tunes(TM) flavored milks and production
rights to manufacture and sell the milks. In line with our revenue recognition
policies, we recognized the full invoiced kit price as revenue and credits the
processor dairies with the cost of the raw flavor ingredients, which our records
as cost of goods sold. In addition to kit sales revenue, in the United States we
are responsible for the sale of finished Slammers(R) Looney Tunes(TM) flavored
milk (referred to as "units sales") to retail outlets. For these unit sales, we
also recognizes as revenue the difference between the prices charged by the
processor dairies to produce the milks and the price that we charges to the
retail outlets that purchase the milks directly from the processor dairies.
Since we benefit from only the difference between two prices, it does not record
any costs of goods sold against this revenue event.
17
Segmented revenues and costs of goods sold (2003 and 2002)
The following table presents revenue by source and type against costs of
goods sold, as well as combined gross revenues and gross margins. China sales
are attributed to the Company's wholly owned Chinese subsidiary, China Premium
Food Corp (Shanghai) Co., Ltd.; our North America operations generated the
remaining revenue. Revenues from Canada are generated by kit sales to Farmers
Dairy, a Halifax dairy processor. Revenues from Mexico are generated from kit
sales to Neolac, a dairy processor in central Mexico. In the United States,
revenues are generated by kit sales to Parmalat, which is responsible for
marketing and sales and kit sales to two dairy processors that produce extended
shelf life and aseptic long life Slammers(R) Looney Tunes(TM) product. Revenues
from these sales are recorded under "US Kit Sales" on the accompanying tables,
and our revenue from the sale of ESL and aseptic is recorded as "Unit Sales" on
the following table:
United Total
2003 States Canada Mexico China Company
------------ ----------- ----------- ----------- ------------
Revenue - unit sales $ 356,985 $ -- $ -- $ -- $ 356,985
Revenue - net kit sales 2,737 -- -- -- 2,737
Revenue - gross kit sales 629,999 43,745 145,362 21,314 840,420
----------- ----------- ----------- ----------- -----------
Total revenue 989,721 43,745 145,362 21,314 1,200,142
Cost of goods sold (127,647) (10,403) (45,247) (9,201) (192,498)
----------- ----------- ----------- ----------- -----------
Gross margin $ 862,074 $ 33,342 $ 100,115 $ 12,113 $ 1,007,644
=========== =========== =========== =========== ============
United Total
2002 States Canada Mexico China Company
------------ ----------- ----------- ----------- ------------
Revenue -unit sales $ 232,595 $ -- $ -- $ -- $ 232,595
Revenue -net kit sales 433,118 -- -- -- 433,118
Revenue -gross kit sales 849,404 112,700 90,025 55,128 1,107,257
----------- ----------- ----------- ----------- -----------
Total revenue 1,515,117 112,700 90,025 55,128 1,772,970
Cost of goods sold (184,022) (23,511) (18,780) (53,042) (279,355)
----------- ----------- ----------- ----------- -----------
Gross margin $ 1,331,095 $ 89,189 $ 71,245 $ 2,086 $ 1,493,615
=========== =========== =========== =========== ============
United States (Jasper, Shamrock and Parmalat Sales)
Revenues in 2003 from kit sales in the United States decreased 50% from
approximately $1,282,500 in 2002 to approximately $632,700 in 2003. In addition
to kit sales, in 2003 we had revenues of approximately $357,000 from selling
finished product unit sales to retail outlets, a 53.5% increase of $124,390 from
$232,595 in 2002. The decrease in revenues from kit sales was the result of two
factors:
o the reduction and ultimate cessation of the penetration and
distribution of Looney Tunes(TM) flavored milk products, which
resulted from the increasing weakness of the Looney Tunes(TM) brand,
and
o our transition away from Looney Tunes(TM) to the development of
other branded flavored milk products, which resulted in a period
during which processors did not purchase kits owing to our decrease
in and ultimate cessation of sales activities for the Looney
Tunes(TM) product, while generating marketing interest in the new
product line.
18
The increase in unit sales in 2003 was the result of the implementation of
greater efficiencies in the production and distribution of the branded flavored
milk and the reduced necessity to pay "slotting fees" to already established
wholesale customers. In 2002, certain production/distribution costs and entry
level slotting fees reduced the gross revenue reported by the Company for unit
sales owing to "contra-revenue" accounting considerations.
In 2003, our gross margin for U.S. sales of $862,074 decreased by
$469,021, or by 35.2%, from $1,331,095 in 2002. The decrease in gross profit was
the result of the decrease in overall sales, as discussed above.
Mexico and Canada
Revenues in 2003 from kit sales in Mexico increased 61% from approximately
$90,000 in 2002 to approximately $145,300 in 2003. The increase was the result
of greater market penetration and brand awareness in Mexico. The Company
incurred cost of goods sold of approximately $45,000 in 2003 in connection with
its Mexico sales, a 141% increase from approximately $19,000 in 2002. This
increase is consistent with the increase in sales volume.
In 2003, our gross profit of approximately $100,000 for kit sales in
Mexico increased by $29,000, or 41%, from approximately $71,000 in 2002. The
increase in gross profit is consistent with the increase in sales volume.
Canada sales decreased 61% from approximately $113,000 in 2002 to
approximately $44,000. The decrease in sales was the result of lower margins
experienced by the Canadian processor, with commensurately fewer resources
available for marketing efforts directed at brand growth. We incurred cost of
goods sold of approximately $10,400 in 2003 in connection with its Canada sales,
a 56% decrease from approximately $23,500 in 2002. This decrease is consistent
with the decrease in sales volume.
In 2003, our gross profit of approximately $ 33,300 for kit sales in
Canada decreased by $55,700, or 63%, from approximately $89,000 in 2002. The
decrease in gross profit is consistent with the decrease in sales volume.
China
Revenues in 2002 from kit sales in China decreased 61% from approximately
$55,000 in 2002 to approximately $21,300 in 2003. The decrease was the result of
the lack of sales in the retail area owing to competition, poor brand support
and production issues related to SARS. We incurred costs of goods sold of
approximately $9,200 in 2003 in connection with its China sales, an 83% decrease
from approximately $53,000 in 2002. This decrease is consistent with the
decrease in sales volume.
In 2003, our gross profit of approximately $12,000 for sales in China
increased by approximately $10,000, or 481%, from a gross profit of
approximately $2,000 in 2002.
CONSOLIDATED OPERATING EXPENSE
We incurred selling expenses in 2003 of approximately $1,740,000. Our
selling expense increased in 2003 by approximately $964,000, a 124% increase
compared to selling expense of approximately $776,000 in 2002. The increase in
selling expenses in 2003 was due in part to the fact that we continue to
implement its refined business plan in the U.S. with respect to unit sales,
where the majority of the selling expenses are incurred. Of the increase of
$964,000, approximately $232,000 was incurred for freight and delivery expense,
approximately $35,000 was related to marketing, approximately $380,000 for
various reclamation costs and approximately $320,000 for the write off of
product packaging costs resulting from the discontinuance of the Warner Bros.
Looney(TM) Tunes branded products. As a percentage of total revenue, our selling
expense increased from approximately 44% of total revenue in 2002 to
approximately 145% of total revenue in 2003. The increase was in part due to the
increase in reclamation costs in 2003.
We incurred product development costs in 2003 of approximately $5,500.
Product development expenses in 2003 decreased by approximately $233,728, or 98%
compared to approximately $239,000 in 2002. The decrease was mainly the result
of developing two new products and corresponding new packaging designs in 2002.
19
We incurred general and administrative expenses in 2003 of approximately
$2,250,000 consisting of $2,133,400 in its North America Bravo! operations and
$116,278 in its China operations. Our general and administrative expenses in
2003 decreased by approximately $1,366,000, a 38% decrease compared to
approximately $3,616,000 in 2002, of which approximately $3,424,000 was incurred
in our North America Bravo! operations and approximately $192,000 was incurred
in China. The decrease of approximately $1,290,000 in general and administrative
expenses in our North America Bravo! operations in 2003 is the result of a
reduction in expenses, including management salaries and the reclassification of
certain expense items as selling expenses that were reported for a portion of
2002 as general and administrative expenses. At the end of the first quarter
2003, two members of senior management left our company and were not replaced,
and in the last two quarters of 2003, three management personnel took an average
7% voluntary reduction in salary. As a percentage of total revenue, our general
and administrative expenses decreased from 204% in 2002 to 187% in 2003 due to
the reduction of 2003 expenses.
INTEREST EXPENSE
We incurred net interest expense in 2003 of approximately $29,500. Our
interest expense increased by approximately $6,500, a 29% increase, compared to
approximately $23,000 in 2002. The increase of $6,500 was due to outstanding and
additional loans in 2003.
LOSS PER SHARE
We recorded accrued dividends for approximately $902,000, including deemed
dividends, to various series of preferred stock during 2003. Compared to the
total accrued dividends on a consistent basis, we accrued dividends decreased by
approximately $110,000 due primarily to the conversion of preferred stock in
2003. With the decrease in net loss before accrued dividends of approximately
$143,000, our current year loss per share was $0.15 per share. Compared to loss
per share of $0.23 in 2002, the loss per share in 2003 decreased by $0.08, a 35%
decrease, mainly due to the increase of common stock in 2003 by 8,275,373 shares
in the weighted average number of common shares outstanding.
LIQUIDITY AND CAPITAL RESOURCES
As of September 30, 2004, we reported that net cash used in operating
activities was $3,392,948, net cash provided by financing activities was
$3,439,999 and net cash used in investing activities was $47,647. We had a
negative working capital of $2,473,031 as of September 30, 2004.
Compared to $1,118,564 of net cash used in operating activities in the
period ended September 30, 2003, our current year net cash used in operating
activities increased by $2,274,384 to $3,392,948. This increase was the result
of our utilization of cash rather than equity to pay service providers in this
current period, and changes in deferred product development costs, prepaid
expenses, accounts payable and accrued expenses. Included in the net loss in
this current period were depreciation and amortization and stock compensation
for a finder fee aggregating $364,995, compared to $102,843 for the same period
in 2003.
Changes in accounts receivable in this current period in 2004 resulted in
a cash decrease of $8,490, compared to a cash increase in receivables of
$132,635 for the same period in 2003, having a net result of a decrease of
$141,125. The changes in accounts payable and accrued liabilities in the period
ended September 30, 2003 contributed to a cash increase of $728,498, whereas the
changes in accounts payable and accrued liabilities for the current period in
2004 amounted to an decrease of $224,031. We have adopted and will keep
implementing cost-cutting measures to lower its costs and expenses and to pay
our company's accounts payable and accrued liabilities by using cash and equity
instruments. Our cash flow generated through operating activities was inadequate
to cover all of our cash disbursement needs in the period ended September 30,
2004, and we had to rely on equity and debt financing to cover expenses.
Our cash used in 2004 in investing activities for equipment was $47,647
for software, computer equipment and leasehold improvements in the U.S.,
compared to $31,362 for the same period in 2003.
Our net cash provided by financing activities for the period ended
September 30, 2004 was $3,439,999.
20
New cash provided by financing activities for the same period in 2003 was
$1,027,062, for a net increase of $2,412,937. The increase was due to issuing
Series K preferred stock with gross proceeds of $950,000 and debt in the
aggregate amount of $2,639,999 in this current period.
We used the proceeds of the current period financing for working capital
purposes and to repay approximately $1,128,386 under a note to Jasper Products.
Going forward, our primary requirements for cash consist of the following:
o the continued development of our business model in the United States
and on an international basis;
o general overhead expenses for personnel to support the new business
activities;
o development, launch and marketing costs for our line of new branded
flavored milk products, and
o the payment of guaranteed license royalties.
We estimate that our need for financing to meet cash needs for operations
will continue to the fourth quarter of 2004, when cash supplied by operating
activities will approach the anticipated cash requirements for operation
expenses. We anticipate the need for additional financing in 2004 to reduce our
liabilities, assist in marketing and to improve shareholders' equity status. No
assurances can be given that we will be able to obtain additional financing or
that operating cash flows will be sufficient to fund our operations.
We currently have monthly working capital needs of approximately $200,000.
We will continue to incur significant selling and other expenses in the
remainder of 2004 and into 2005 in order to derive more revenue in retail
markets, through the introduction and ongoing support of its new products.
Certain of these expenses, such as slotting fees and freight charges, will be
reduced as a function of unit sales costs as we expand our sales markets and
increases our sales within established markets. Freight charges will be reduced
as we are able to ship more full truck-loads of product given the reduced per
unit cost associated with full truck loads versus less than full truck loads.
Similarly, slotting fees, which are paid to warehouses or chain stores as
initial set up or shelf space fees, are essentially one-time charges per new
customer. We believe that along with the increase in our unit sales volume, the
average unit selling expense and associated costs will decrease, resulting in
gross margins sufficient to mitigate our cash needs. In addition, we are
actively seeking additional financing to support our operational needs and to
develop an expanded promotional program for our products.
We are continuing to explore new points of sale for our branded flavored
milk. Presently, we are aggressively pursuing the school and vending market
through trade/industry shows and individual direct contacts. The implementation
of such a school base program, if viable, could have an impact on the level of
our revenue during 2004. Similarly, we expect that the greater control over
sales resulting from its refined business model and the anticipated expansion
into bodega stores as well as national chains, such as 7-Eleven, will have a
positive impact on revenues in 2004.
NEW PRODUCT LINES
In the third quarter 2003, we commenced an analysis of the Looney
Tunes(TM) brand performance within the context of the possible renewal of its
Warner Bros. licenses for United States, Mexico, China and Canada. In the fourth
quarter 2003, we concluded that, as a function of the sales of flavored milks,
the Looney Tunes(TM) brand has not supported the guaranteed royalty structure
required by Warner Bros. for its licenses. In the fourth quarter 2003, we
decided not to renew its license agreements with Warner Bros., and began to
develop new products in anticipation of the consummation of other license
relationships with Marvel Comics and MoonPie for co-branded flavored milk, as
well as a new single Slammers(R) brand. We have developed new aseptic products
in anticipation of these licenses and its own singular brand. We launched its
Marvel branded Slammers(R) Ultimate Milkshake products in the second quarter
2004 and plans to launch the rest of the following new products in the third
quarter 2004.
21
---------------------------------------------------------------------------------------------------
Moon Pie-
Brand Marvel-Slammers Slammers Slim Slammers Pro-Slammers
---------------------------------------------------------------------------------------------------
Item Ultimate Milkshake Flavored milk; Low calorie, no Protein Shake
reduced fat 2% sugar added,
milk low carb 1%
milk
---------------------------------------------------------------------------------------------------
Licensed Marvel Super Hero MoonPie logo and Slim Slammers Extreme Sports
Property comic book trade dress, and trademark athletes, and Pro
characters and Slammers mark (owned by Slammers mark
Slammers mark (owned by Bravo! Bravo! Foods) (owned by
(owned by Bravo! Foods) Bravo! Foods)
Foods)
---------------------------------------------------------------------------------------------------
Packaging 16 oz bottles; 11.2 16 oz bottles; 11.2 16 oz bottles 16 oz bottles;
oz Tetra Prisma oz Tetra Prisma 11.2 oz Tetra
Prisma
---------------------------------------------------------------------------------------------------
Description Whole milk shake; 5 Chocolate and Chocolate Double protein
flavors; vitamin banana flavors; Fudge and shake; 4 flavors;
fortification matches fortified with 10 French Vanilla; fortified with 10
Marvel Super Hero essential vitamins calcium added essential
powers vitamins
---------------------------------------------------------------------------------------------------
Coincident with the Marvel license, we executed a production agreement
with Saudia Dairy & Foodstuff Company (SADAFCO), one of the largest Middle East
dairy processors, headquartered in Jeddah, Saudi Arabia. SADAFCO will process
our Slammers (R) branded flavored milks, including the Marvel line, for
distribution in eleven Middle East countries. SADAFCO has the capacity to
process our branded milk products for distribution throughout the European
Community. Our international business is facilitated by AsheTrade, our
international agent, with offices in Miami, FL and Jeddah, Saudi Arabia.
On September 21, 2004, wentered into a licensing agreement with
Masterfoods USA, a division of Mars, Incorporated, for the use of Masterfood's
Milky Way(R), Starburst(R) and 3 Musketeers(R) trademarks in connection with the
manufacture, marketing and sale of single serving flavored milk drinks in the
United States, our possessions and Territories, and US Military installations
worldwide. The license limits the relationship of the parties to separate
independent entities. The initial term of the license agreement expires December
31, 2007. We have agreed to pay a royalty based upon the total net sales value
of the licensed products sold and advance payments of certain agreed upon
guaranteed royalties. Ownership of the licensed marks and the specific milk
flavors to be utilized with the marks remains with Masterfoods. We have been
granted a right of first refusal for other milk beverage products utilizing the
Masterfoods marks within the license territory.
DEBT STRUCTURE
As of September 30, 2004, we have recorded $147,115 in guaranteed royalty
payments to Warner Bros. for the now expired China Looney Tunes license. The
China license had been extended to October 29, 2003 by agreement of the parties,
and we did not seek another license from Warner Bros. for China. This decision
was based upon the lack of sales in our China markets and what we perceived to
be the licensor's continuing overall lack of brand support in China. We dispute
with the contractual necessity of the payment of the balance owed on the China
license as a result of the above circumstances.
22
International Paper
During the process of acquiring from American Flavors China, Inc. the 52%
of equity interest in Hangzhou Meilijian, we issued an unsecured promissory note
to assume the American Flavors' debt owed to a supplier, International Paper.
The face value of that note was $282,637 at an interest rate of 10.5% per annum,
without collateral. The note had 23 monthly installment payments of $7,250 with
a balloon payment of $159,862 at the maturity date of July 15, 2000. On July 6,
2000, International Paper agreed to extend the note to July 1, 2001, and the
principal amount was adjusted due to a different interest calculation.
International Paper imposed a charge of $57,000 to renegotiate the note owing to
the failure of Hangzhou Meilijian to pay for certain packing material, worth
more than $57,000 made to order in 1999. The current outstanding balance on this
note is $187,743. We are delinquent in its payments under this note.
Individual Loans
On November 6 and 7, 2001, respectively, we received the proceeds of two
loans aggregating $100,000 from two offshore lenders. The two promissory notes,
one for $34,000 and the other for $66,000, were payable February 1, 2002 and
bear interest at the annual rate of 8%. These loans are secured by a general
security interest in all our assets. On February 1, 2002, the parties agreed to
extend the maturity dates until the completion of the anticipated Series H
financing. On September 18, 2002, the respective promissory note maturity dates
were extended by agreement of the parties to December 31, 2002. On September 18,
2002, we agreed to extend the expiration dates of warrants issued in connection
with our Series D and F preferred until September 17, 2005 and to reduce the
exercise price of certain of those warrants to $1.00, in partial consideration
for the maturity date extension. The holders of these notes have agreed to
extend the maturity dates and the notes are now payable on a demand basis.
On August 27, 2003, we received the proceeds of a loan from Mid-Am
Capital, L.L.C., in the amount of $150,000. The note was payable November 25,
2003 and bears interest at the annual rate of 10%. This loan was secured by a
general security interest in all our assets. On April 2, 2004, this note was
paid and cancelled.
On January 28, 2004, we converted accounts payable in the amount of
$1,128,386 by the issuance of a 10% short term promissory note to Jasper
Products, LLC, dated January 1, 2004, in the principal amount of $1,128,386 for
amounts owed to Jasper in connection with Jasper's processing and sale of our
products. As of March 31, 2004, we paid $200,000 in principal and was credited
an additional $11,350. On April 20, 2004, we paid an additional $200,000. On May
7, 2004, we paid $717,036 in full payment of the note's principal and accrued
interest.
On May 6, 2004, we issued a secured promissory note to Mid- Am Capital LLC
in the principal amount of $750,000. The note provides for 8% interest. The
note's original maturity date of September 4, 2004 has been extended to November
2, 2004. we issued warrants to purchase 3,000,000 shares of the Company's common
stock to Mid-Am in connection with this promissory note. The warrants are
exercisable for one year from issue at an exercise price of $0.25 per share. The
Company used the proceeds of this promissory note to pay the promissory note
issued to Jasper Products in January 2004.
Convertible Debentures
To obtain funding for our ongoing operations, we entered into the two
financing transactions.
November 2003
In November 2003, we entered into a Subscription Agreement with two
accredited investors in for the sale of (i) $400,000 in convertible debentures,
(ii) class A warrants to buy 2,000,000 shares of our common stock and (iii)
class B warrants to buy 10,000,000 shares of common stock. In connection with
this financing, we paid a fee, which included (i) 400,000 shares of common
stock, (ii) class A warrant to purchase 2,000,000 shares of common stock and
(iii) 10% of the proceeds received by us in connection with the exercise of the
class B warrants, which is payable in shares of common stock at the rate of one
share of common stock for every ten shares of common stock actually issued upon
exercise of the class B warrants.
23
The debentures issued in connection with the November 2003 financing bear
interest at 8%, mature on two years from the date of issuance, and are
convertible into our common stock, at the selling stockholders' option, at the
lower of (i) $0.05 or (ii) 75% of the average of the three lowest intraday
trading prices for the common stock on a principal market for the 30 trading
days before but not including the conversion date. However, during the six
months after the issuance of the convertible debenture, the conversion price
shall not be less than $.03 per share unless an event of default exists. The
conversion floor price of $.03 per share shall be extended indefinitely, if
during the six months after the issuance of the convertible debenture (i) the
closing trading price of our common stock for any consecutive 15 day trading
period is $.20 or higher, (ii) the daily trading volume for each such 15 trading
days is 300,000 or more shares of common stock and (iii) the registration
statement registering the shares issuable under the convertible debenture is
effective for each such 15 trading days, unless an event of default exists.
Accordingly, if the above factors are not satisfied, there is in fact no limit
on the number of shares into which the debentures may be converted. As of April
30, 2004, the average of the three lowest intraday trading prices for our common
stock during the preceding 30 trading days as reported on the Over-The-Counter
Bulletin Board was $.14 and, therefore, the conversion price for the convertible
debentures was $.05. Based on this conversion price, the $400,000 convertible
debentures, excluding interest, were convertible into 8,000,000 shares of our
common stock.
The selling stockholders have contractually agreed to restrict their
ability to convert or exercise their warrants and receive shares of our common
stock such that the number of shares of common stock held by them and their
affiliates after such conversion or exercise does not exceed 9.99% of the then
issued and outstanding shares of common stock.
April 2004
In April 2004, we entered into a Subscription Agreement with two
accredited investors for the sale of (i) $500,000 in convertible debentures and
(ii) warrants to buy 3,000,000 shares of our common stock. In connection with
this financing, we paid a fee, which included an aggregate of convertible
debentures in the amount of $50,000.
The debentures issued in connection with the April 2004 financing bear
interest at 10%. The principal on the notes is due in equal monthly installments
commencing on November 1, 2004 until October 1, 2005. On October 1, 2005, all
principal and interest shall become due. In the event that our common stock has
a closing price in excess of $.20 for the five days preceding the monthly
payment, then, within our discretion, the monthly payment may be deferred. The
notes are convertible into our common stock at $0.10 per share. Based on this
conversion price, the $550,000 convertible debentures, excluding interest, were
convertible into 5,500,000 shares of our common stock.
The selling stockholders have contractually agreed to restrict their
ability to convert or exercise their warrants and receive shares of our common
stock such that the number of shares of common stock held by them and their
affiliates after such conversion or exercise does not exceed 9.99% of the then
issued and outstanding shares of common stock.
June 2004
In June 2004, we entered into a Subscription Agreement with Longview Fund,
LP, Alpha Capital Aktiengesellschaft, Whalehaven Funds Limited, Stonestreet
Limited Partnership and Mid-Am Capital L.L.C for the issuance of convertible 10%
notes in the aggregate amount of $1,300,000 and five-year "A" warrants for the
purchase of, in the aggregate, 5,200,000 shares of common stock, at $0.25 per
share, and five-year "B" warrants for the purchase of, in the aggregate,
13,000,000 shares of common stock, at $2.00 per share. In connection with the
October 2004 financing, we subsequently amended the exercise price to $.15 for
the "A" warrants issued to Longview Fund, LP, Alpha Capital Aktiengesellschaft,
Whalehaven Funds Limited and Stonestreet Limited Partnership. The notes are
convertible into shares of common stock of the Company at $0.15 per common
share. The notes are payable in twelve equal monthly installments, commencing
January 1, 2005. The installment payments consist of principal and a "premium"
of 20% of the principal paid per installment. We have the option to defer such
payment until the note's maturity date on December 1, 2005, if our common stock
trades above $0.20 for the five trading days prior to the due date of an
installment payment. In connection with this transaction, we issued additional
notes in the aggregate amount of $40,000 to Gem Funding, LLC, Bi-Coastal
Consulting Corp., Stonestreet Limited Partnership and Libra Finance, S.A upon
identical terms as the principal notes, as a finder's fee, and paid $12,500 in
legal fees. The common stock underlying all notes and warrants carry
registration rights.
24
The selling stockholders have contractually agreed to restrict their
ability to convert or exercise their warrants and receive shares of our common
stock such that the number of shares of common stock held by them and their
affiliates after such conversion or exercise does not exceed 9.99% of the then
issued and outstanding shares of common stock. See the "Selling Stockholders"
and "Risk Factors" sections for a complete description of the convertible
debentures.
This prospectus relates to the resale of the shares of common stock and
the common stock underlying these convertible debentures and warrants.
October 2004
On October 29, 2004, we entered into Subscription Agreements with Longview
Fund, LP, Alpha Capital Aktiengesellschaft, Whalehaven Funds Limited and
Stonestreet Limited Partnership for the issuance of convertible 10% notes in the
aggregate amount of $550,000 and five-year "C" warrants for the purchase of, in
the aggregate, 2,200,000 shares of common stock, at $0.15 per share, and the
repricing of five-year "A" warrants, issued June 30, 2004 for the purchase of,
in the aggregate, 3,200,000 shares of common stock, from $0.25 to $0.15 per
share. The notes are convertible into shares of common stock at $0.10 per common
share. The notes are payable in twelve equal monthly installments, commencing
May 1, 2005. The installment payments consist of principal and a "premium" of
20% of the principal paid per installment. We have the option to defer such
payment until the note's maturity date on April 30, 2006, if our common stock
trades above $0.15 for the five trading days prior to the due date of an
installment payment and the underlying common stock is registered. In connection
with this transaction, we issued additional notes, without attached warrants, in
the aggregate amount of $27,500 to Gem Funding, LLC, Bi-Coastal Consulting
Corp., Stonestreet Limited Partnership and Libra Finance, S.A upon identical
terms as the principal notes, as a finder's fee, and paid $12,500 in legal fees.
The common stock underlying all notes and warrants carry registration rights.
The selling stockholders have contractually agreed to restrict their
ability to convert or exercise their warrants and receive shares of our common
stock such that the number of shares of common stock held by them and their
affiliates after such conversion or exercise does not exceed 9.99% of the then
issued and outstanding shares of common stock. See the "Selling Stockholders"
and "Risk Factors" sections for a complete description of the convertible
debentures.
December 2004
In December 2004, we entered into Subscription Agreements with Momona
Capital Corp. and Ellis International Ltd. for the issuance of convertible 10%
notes in the aggregate amount of $400,000 and five-year "C" warrants for the
purchase of, in the aggregate, 800,000 shares of common stock, at $0.15 per
share. The notes are convertible into shares of common stock at $0.10 per common
share. The notes are payable in twelve equal monthly installments, commencing
May 1, 2005. The installment payments consist of principal and a "premium" of
20% of the principal paid per installment. We have the option to defer such
payment until the note's maturity date on April 30, 2006, if our common stock
trades above $0.15 for the five trading days prior to the due date of an
installment payment and the underlying common stock is registered. In connection
with this transaction, we issued additional notes, without attached warrants, in
the aggregate amount of $10,000 to Momona Capital Corp. and Ellis International
Ltd. upon identical terms as the principal notes, as a finder's fee. The common
stock underlying all notes and warrants carry registration rights.
The selling stockholders have contractually agreed to restrict their
ability to convert or exercise their warrants and receive shares of our common
stock such that the number of shares of common stock held by them and their
affiliates after such conversion or exercise does not exceed 9.99% of the then
issued and outstanding shares of common stock. See the "Selling Stockholders"
and "Risk Factors" sections for a complete description of the convertible
debentures.
25
EFFECTS OF INFLATION
We believe that inflation has not had any material effect on its net sales
and results of operations.
EFFECT OF FLUCTUATION IN FOREIGN EXCHANGE RATES
Our Shanghai subsidiary is located in China. We buy and sell products in
China using Chinese renminbi as the functional currency. Based on Chinese
government regulation, all foreign currencies under the category of current
account are allowed to freely exchange with hard currencies. During the past two
years of operation, there were no significant changes in exchange rates.
However, there is no assurance that there will be no significant change in
exchange rates in the near future.
26
BUSINESS
OUR COMPANY
Our company is a Delaware corporation, which was formed on April 27, 1996.
Our company formerly owned the majority interest in two Sino-American joint
ventures in China, known as Green Food Peregrine Children's Food Co. Ltd. and
Hangzhou Meilijian Dairy Products Co., Ltd. These two joint ventures processed
milk products for local consumption in the areas of Shanghai and Hangzhou,
China, respectively. We closed Green Food Peregrine in December 1999 and sold
its interest in Hangzhou Meilijian Dairy in December 2000.
In December 1999, we obtained Chinese government approval for the
registration of a new wholly owned subsidiary in the Wai Gao Qiao "free trade
zone" in Shanghai, China. We formed this import-export company to import, export
and distribute food products on a wholesale level in China. In addition, China
Premium (Shanghai) is our legal presence in China with respect to contractual
arrangements for the development, marketing and distribution of branded food
products. We have ceased all business activities of this Chinese subsidiary in
the first quarter of 2003, owing to low sales volume and insufficient financial
or logistic resources to market our products profitably in mainland China.
In December of 1999, we formed Bravo! Foods, Inc., a wholly owned Delaware
subsidiary, which we utilized to advance the promotion and distribution of
branded Looney Tunes(TM) products in the United States, through production
agreements with local dairy processors. At the end of 2001, we assumed this
business, and our U.S. subsidiary ceased functioning as an operating company at
that time.
On February 1, 2000, we changed our name from China Peregrine Food
Corporation to China Premium Food Corporation, and on March 16, 2001 we changed
our name to Bravo! Foods International Corp.
THE BUSINESS
Our business involves the development and marketing of our owned
Slammers(R) trademarked brand, the obtaining of license rights from third party
holders of intellectual property rights to other trademarked brands, logos and
characters and the granting of production and marketing rights to processor
dairies to produce branded flavored milk utilizing our intellectual property. We
generate revenue primarily through the sale of "kits" to these processors. In
the United States, we also generates revenue from the unit sales of finished
branded flavored milks to retail consumer outlets.
"Kits" sold to processors consist of flavor ingredients that are developed
and refined by us and the grant of production rights to processors to produce
the flavored milks. The consideration paid to us under these production
contracts consists of fees charged for our grant of production rights for the
branded flavored milks plus a charge for flavor ingredients. The fees charged by
us for the production rights have been formulated to match our royalty costs for
our intellectual property licenses.
Warner Bros. Licenses
In January 1999, we commenced a licensing agreement with Warner Bros.
Consumer Products, permitting us to produce and distribute a line of high
quality, flavored milks branded with the Warner Bros. Looney TunesJ logos,
characters and names in the Shanghai and Hangzhou greater metropolitan areas. To
obtain this license, we agreed to pay 3% royalty fees of net invoiced price of
each licensed product with a minimum guaranteed royalty of $300,000. In the
summer of 2000, we agreed to pay an additional $100,000 for an expanded license
for all of mainland China and an extension of the expiration date to June 2003.
Thereafter, the parties agreed to extend the license to October 29, 2003, at
which time the license expired.
On July 27, 2000, we executed a licensing agreement with Warner Bros. to
use Looney TunesJ characters and names on milk products in the United States.
This licensing agreement obligated us to pay a guaranteed royalty of $500,000,
and granted us the right to use the cartoon characters of Bugs Bunny, Tweety,
Tasmanian Devil, Road Runner, Wile E Coyote, Lola Bunny, Marvin the Martian,
Sylvester and Daffy Duck on milk products for sale in specified retail outlets
in the fifty United States, Puerto Rico and the United States Virgin Islands.
The initial term of the agreement was for 3 years, from January 1, 2000 through
December 31, 2002. In early 2002, the parties agreed to extend the term of this
license for an additional year to December 31, 2003. This extension was part of
a promotional license for the Warner Bros. "Taz Atti-Tour" for the period March
13, 2002 to December 31, 2002, for which we paid an additional $250,000
guaranteed royalty.
27
On November 7, 2001, we executed a licensing agreement with Warner Bros.
to use Looney TunesJ characters and names on milk products in Mexico. This
licensing agreement grants us the right to use the Warner Bros. cartoon
characters on milk products for sale in specified retail outlets throughout
Mexico. The initial term of the agreement is for 3 years, from June 1, 2001
through May 31, 2004.
On May 28, 2002, we executed a licensing agreement with Warner Bros. to
use Looney TunesJ characters and names on milk products in Canada. This
licensing agreement grants us the right to use the Warner Bros. cartoon
characters on milk products for sale in specified retail outlets throughout
Canada. The initial term of the agreement was for 25 months, from March 1, 2002
through March 31, 2004.
All of our licensing agreements recognize that we will use third party
production agreements for the processing of flavored milk products, and that the
milk products will be produced and may be sold directly by those processors. Our
responsibilities under its third party production agreements are to design and
provide Warner Bros. approved packaging artwork, to help determine the best
tasting flavors for the particular market and to assist in the administration,
promotion and expansion of the Looney TunesJ branded milk program. Ingredients
for the flavored milks are formulated to the Company's specifications and
supplied on an exclusive basis by Givaudan Roure. In the United States, the
Company assumes the responsibility for sales and marketing of the Looney TunesJ
flavored milks produced by Jasper Products and Shamrock Farms.
Under our United States license, we agreed to a royalty rate of 5% on the
amount invoiced to the producer dairies for "kits". In Mexico, we agreed to a
sliding scale royalty rate initially equal to 5% on the amount invoiced, with
rate increases to 5% and 7%, respectively for the second and third contract
years. We agreed to a 5% royalty rate on the amount invoiced to the producers in
Canada and a 3% royalty rate in China.
Non-Renewal of Warner Bros. Licenses.
The history of our company with all of the Warner Bros. licenses, as a function
of sales of the flavored milks, has not supported the guaranteed royalty
structure required by Warner Bros. for its licenses. As a result, we developed
our own Slammers(R) brand in 2003 and executed licenses with Marvel Comics and
Moon Pie in 2004. For these reasons, in the fourth quarter 2003, we decided not
to seek the renewal for the China license and not accept the offer of Warner
Bros. to renew the U.S. license. In addition, we decided not to renew our
licenses with Warner Bros. for Canada and Mexico.
PRODUCTION CONTRACTS
Prior to 2000, our company's business primarily involved the production and
distribution of milk in China. In the third quarter of 2000, our company began
to refocus our company's business away from the production - distribution aspect
of the value chain by implementing a business model that involved the branding,
marketing, packaging design and promotion of flavored fresh milk in the United
States, branded with Looney Tunes(tm) characters. During the middle of 2001,
this refocused business was implemented in China, in December 2001 in Mexico,
and in the third quarter of 2002 in Canada.
United States
The initial dairy processors with which we had production contracts were members
of Quality Chekd Dairies, Inc., a national cooperative with over 40 member
dairies that process fresh milk on a regional basis. This business, while
viable, proved to have limited sales expansion capabilities in the US owing to
the inherent regional distribution limitations of a "fresh" milk product with a
short shelf life.
The advent of extended shelf life (ESL) and aseptic long life milk presented us
with the opportunity to dramatically increase sales on a national basis. In the
third quarter of 2001 and the first quarter of 2002, we entered into production
contracts with Shamrock Farms, located in Phoenix, Arizona and Jasper Products,
of Joplin, Missouri, and began to market branded ESL and aseptic flavored milks
to large national chain accounts.
28
Significantly, with ESL and aseptic milks, we are no longer dependent upon
regional processor dairies to promote the sale of our branded flavored milks.
Since distribution issues do not limit ESL and aseptic milk sales to the
accounts of regional dairy processors, we have assumed responsibility for
promoting sales either directly or through food brokers who represent us with
both national and regional accounts. This business model, coupled with the
production capacity of these two ESL dairy processors, allowed us to seek
national accounts in an aggressive fashion, resulting in arrangements to supply
flavored milk products to over 11,000 stores nationally at the end of 2002.
Under our current U.S. business model, our revenue source is derived not
only from "kit" sales, but also from the differential between the cost to our
company of producing the ESL and long life aseptic products and the wholesale
price to our accounts for unit sales of the finished Looney Tunes(TM) flavored
milks.
In June 2002, we entered into a production contract with a division of
Parmalat USA Corp. to produce, market and sell the Looney Tunes(TM) brand
flavored milks. Under this agreement, Parmalat is the exclusive producer and
distributor of Bravo! Foods' new Looney Tunes(TM) brand fortified aseptic milk,
packaged in Tetra-Brik(TM) format under our Slammers Fortified Reduced Fat
Milk(TM) logo in the United States. Our agreement with Parmalat gives us an
expanded presence in supermarkets through the use of shelf stable aseptic milk
that is processed, sold and distributed by Parmalat. In addition, under this
agreement we retained responsibility for aseptic product sales in the food
service sector, either directly or through food brokers who represented us with
both national and regional accounts. Our agreement with Parmalat expired with
the non-renewal of the Warner Bros. license for the United States.
Mexico
In December 2001, we commenced our contractual relationship with Neolac
S.A, a national dairy processor located in central Mexico. We sell kits to
Neolac, including production rights for its branded flavored milk for all of
Mexico. Our responsibilities are to design and provide approved packaging
artwork, to help determine the best tasting flavors for the particular market
and to assist in the administration, promotion and expansion of the branded
flavored milk program. Ingredients for the flavored milks are formulated to our
specifications and supplied on an exclusive basis by Givaudan Roure. We do not
have any responsibility for or participation in sales or distribution in Mexico.
Canada
In April 2002, we commenced our contractual relationship with Farmers
Dairy, a dairy processor located in Halifax, Nova Scotia, Canada. We sell kits
to Farmers Dairy, including production rights for the branded flavored milk
products. Our responsibilities are to design and provide approved packaging
artwork, to help determine the best tasting flavors for the particular market
and to assist in the administration, promotion and expansion of the branded
flavored milk program. Ingredients for the flavored milks are formulated to the
Company's specifications and supplied on an exclusive basis by Givaudan Roure.
We do not have any responsibility for or participation in sales or distribution
in Canada.
China
Our withdrawal from milk production in China in 2000 resulted in the
signing of supply agreements with Hangzhou Meilijian and Huai Nan Dairy to
produce branded traditional white and flavored milks, which the Company sold in
Shanghai, Hangzhou, Ningbo, Nanjing, Fuzhou, Wuxi and Suzhou. The administration
of supply, distribution, marketing and sales of the branded flavored milk
products in China was the responsibility of China Premium Food Corp Shanghai)
Co, Ltd., our wholly owned Chinese registered subsidiary.
In October 2001, China Premium Food Corp (Shanghai) Co, Ltd .began to
implement the Bravo! "kit sales" model with the execution of a production
contract with Kunming Xuelan Dairy, located in Kunming City in Southwest China.
From October 2001, through the third quarter 2002, Kunming Dairy produced the
Company's branded flavored milks in 250ml single serve gable top packaging. In
January 2002, Heilongjiang Wan Shan Dairy (Wonder Sun Dairy) began producing the
vanilla Looney Tunes(TM) flavored milk. This dairy is located in Harbin City in
Northeast China and has distribution rights to Heilongjiang, Jilin, Liaoning and
Hebei provinces as well as Beijing and Tianjin municipalities.
29
As of December 31, 2003, China Premium Food Corp (Shanghai) Co, Ltd.
ceased business activities in China. We closed all operations of this subsidiary
in the first quarter of 2004.
Products
Commencing in September of 2000, we implemented the "kit" sales program
with third party dairy processors in the United States, for the production and
sale of fresh branded flavored milk in single serve plastic bottles. This
product, as with all of our U.S. products up to September 2000, had a limited
shelf life of, generally, 21 days.
In early 2002, we developed branded extended shelf life and aseptic long
life flavored milk products. The extended shelf life product was sold in 11.5oz
single serve plastic bottles and must be refrigerated. The shelf life of this
product is 90 days. Our aseptic product does not require refrigeration and has a
shelf life of 8 months. This product is packaged in an 11.2oz Tetra Pak
Prisma(TM) sterile paper container. Both of these products were introduced to
the public in the second and third quarters of 2002.
Commencing in May 2002, we developed a new branded fortified flavored milk
product under the "Slammers Fortified Reduced Fat Milk(R)" brand name. Our
Slammers brand is used in conjunction with our licensed third party trademarks.
Slammers(R) is made from 2 percent fat milk and is fortified with 11 essential
vitamins. The introduction of this new product and the phase out of our
"regular" branded milks occurred in the fourth quarter of 2002. Our Slammers(R)
flavored milks are sold in the United States in single serve extended shelf life
11.5 oz plastic bottles, as well as the long life 11.2oz aseptic Tetra Pak
Prisma(TM) package. Our Slammers(R) flavored milks are sold in Mexico and Canada
in single serve extended shelf life 11.5 oz plastic bottles.
In October 2002, Parmalat introduced Looney Tunes(TM) brand fortified
aseptic milk, packaged in an 8oz Tetra-Brik(TM) format under our Slammers
Fortified Reduced Fat Milk(R) logo pursuant to a production agreement with us
executed in June 2002. The 8oz Tetra Brik Slammers(R) does not require
refrigeration and has a shelf life of 6 months. Currently, this product is no
longer available.
In November 2002, we introduced Slim Slammers Fortified Milk(R), a low
calorie version of our Slammers Fortified Reduced Fat Milk(R). Slim Slammers
Fortified Milk(R) has no sugar added and is sweetened with sucralose, a natural
sweetener made from sugar. Slim Slammers Fortified Milk(R) is made from 1
percent fat milk, is fortified with 11 essential vitamins and is available in
the same flavors as our Slammers(R) brand. We will reintroduce this product in
the United States with a new package and formulation in 2004.
New Products
In the third quarter 2003, we commenced an analysis of the Looney
Tunes(TM) brand performance within the context of the possible renewal of its
Warner Bros. licenses for United States, Mexico, China and Canada. In the fourth
quarter 2003, we concluded that, as a function of the sales of flavored milks,
the Looney Tunes(TM) brand has not supported the guaranteed royalty structure
required by Warner Bros. for its licenses. In the fourth quarter 2004, we
decided not to renew our license agreements with Warner Bros. and began to
develop new products in anticipation of the consummation of other license
relationships for co-branded flavored milk with Marvel Comics and MoonPie, as
well as a new single Slammers(R) brand. We plan to launch these products in the
second quarter 2004 on a co-branded basis with Marvel Comics and a separate
co-branded line with MoonPie.
INDUSTRY TRENDS
The dairy industry in the western world is a very mature industry with
slow growth and, to a large extent, commodity like margins. The "got milk"
campaign has helped heighten awareness of the nutritional benefits of dairy
products but, even with this promotion, the US consumption of milk was basically
flat two years ago.
30
Flavored milk was the only area of growth in the past two years and, when
promoted aggressively, the sales of flavored milk actually increased the sales
of traditional white milk. The International Dairy Foods Association reported
that flavored milks represent the only category for price and margin gains. As a
result, Nestles, Dean's, Hershey and Borden all promote their brand of
refreshment drinks. Sales of flavored milks for the last two years continued to
have a 7% gain in product volume and a 12% increase in sales measured in
dollars. Growth of this nature is welcome to this industry and validates the
interest by the trade in products like the Company's Slammers brand Looney
Tunes(TM) milk. The Beverage Marketing Corp. projects that growth in white milk
will be flat to .5%, with growth in flavored milks from 4% to 8% per year over
the next five years. Growth in the distribution of single serve milk products is
projected by this research group at from 10% to 20%.
MARKET ANALYSIS
The flavored milk business is a relatively new category in the dairy
field. The flavored "refreshment" segment is both the fastest growing and most
profitable category in the industry and is receiving the most attention in the
industry today. Pioneered by Nestle with the NesQuik line and Dean Foods with
the Chug brand, this "good for you" segment is in demand both in the U.S. and
internationally.
The International Dairy Foods Association reports that, although flavored
milk currently amounts to only 5 to 6 percent of milk sales, it represents over
59% of the growth in milk sales. With the total milk category exceeding $9.3
billion in 2002, the flavored segment was approximately $496 million.
Statistically, as the flavored segment grows, the entire category grows as well.
Selling more flavored milks has resulted in more sales of white milk as well.
In addition, the International Dairy Foods Association and Dairy
Management Inc. have reported on studies suggesting that dairy products may help
in weight loss efforts when coupled with a reduced calorie diet, based on data
associating adequate calcium intake with lower body weight and reduced body fat.
We continue to develop a niche in the single serve flavored milk business
by utilizing strong, national branding as part of the promotion of our
Slammers(R) and Slim Slammers(R) products. This niche has as its focus the
increased demand for single serve, healthy and refreshing drinks.
Market segment strategy
The Bravo! model addresses a very clear and concise target market. We know
from experience that the largest retailers of milk products are demanding new
and more diverse refreshment drinks, specifically in the dairy area in response
to consumer interest and demand. To that end, we have and will continue to
differentiate our products from those of our competitors through innovative
product formulations and packaging designs, such as those implemented in our
Slammers fortified milk product line and our Slim Slammers(R) low calorie, no
sugar added products.
Our Slammers(R) milk products have had promising results penetrating this
arena as consumers continue to look for healthy alternatives to carbonated
beverages. The positioning of our products as a healthy, fun and great tasting
alternative refreshment drink at competitive prices to more traditional
beverages creates value for the producer and the retailer alike. This "profit
orientation" for the trade puts old-fashioned milk products in a whole new
light. The consumer is happy, the retailer is happy and the producer is able to
take advantage of the value added by the brand and the resulting overall
increase in milk sales.
We have been and continue to pursue a strategic goal of placing our
Slammers(R) milks in elementary, middle and high schools through ala carte lunch
programs and vending facilities in school cafeterias and are promoting our Slim
Slammers milks as low calorie, non-sugar added alternatives to traditional soft
drinks Penetration of this market segment has been limited by logistic and
economic concerns of school administrators in the push to remove traditional
carbonated soft drinks from schools in favor of milk and milk based products.
COMPETITION
There are definite differences in the various competitors approach to this
new segment. The differences address packaging, processing, marketing and
distribution. Bravo! has taken the course of least resistance while producing a
product that is positioned to reward all involved economically.
31
Dean Foods based their market entrance five years ago on a new package
called the Chug. This was an innovative new way to market milk in a format that
made it convenient to drink milk "on the fly". The "chug" bottle was introduced
in 8 oz and 16 oz plastic milk bottles. These bottles have a wide mouth opening
and a very attractive screw top for convenience of sealing. The graphic label on
the bottle was a full wrap and was introduced in both white and chocolate
flavors. Currently, Dean is producing a flavored milk line under a license from
Hershey's.
Nestle launched their new line of flavored milks approximately four years
ago with a shaped bottle, the Nestle "bunny" and a broad line of flavors.
Nestle, branding Nesquick as a new name distinct from Nestle Quick, produces a
sterile aseptic product, which has long-life characteristics enabling fast
national penetration. This long shelf life configuration offers considerable
economic advantages in terms of shipping, storage, returns and production
economies but significantly impacts product quality and taste.
We have settled on the effort to develop and promote a taste tested ultra
quality fresh product, while enjoying the instant recognition of international
brands. We have sought and utilized what are believed to be well recognized
families of intellectual properties in the form of cartoon/comic book
characters. We have been able to enter into production contracts with several
national and international dairies and has moved from fresh milk to ESL and
aseptic long shelf life products to expand the market for our branded products.
Our resources for promotions have been limited, and we run significantly
less promotional activities in comparison to our competitors. Where we are in
direct competition with Nestles and Hershey's, however, we have been able to
maintain competitive sales levels.
Employees
We have seven full time employees located at our North Palm Beach
corporate offices. China Premium Food Corp (Shanghai) Co. Ltd., ceased
operations and does not maintain any employees in China.
DESCRIPTION OF PROPERTY
Neither our company nor our subsidiaries currently own any real property. As of
February 1, 1999, we moved our corporate offices from West Palm Beach to 11300
US Highway 1, Suite 202, North, Palm Beach, Florida, pursuant to a lease with
HCF Realty, Inc., having an initial term of five years. The term of this lease
has been extended for five years to May 31, 2009, at a 25% reduction in base
rent. The current monthly rent amounts to approximately $6,393.
We do not have a policy to acquire property for possible capital gains or
income generation. In addition, we do not invest in securities of real estate
entities or developed or underdeveloped properties.
32
MANAGEMENT
DIRECTORS AND EXECUTIVE OFFICERS
The directors, executive officers and significant employees/advisors are as of
December 15, 2004, as follows. Our directors serve for staggered terms of two
years or until their successors are elected. On March 6, 2003, the Board voted
to reduce the board positions by one to nine.
Name of Officer and Age Position with the Company Year
----------------------- ------------------------- -----
Appointed
---------
Bravo! Foods International Corp.
Stanley A. Hirschman 57 Chairman and Director 2000
Roy G. Warren 48 Director, Chief Executive Officer 1997/1999
Tommy E. Kee 55 Chief Financial Officer, Treasurer 2003
Roy D. Toulan, Jr. 58 Vice President, Corporate Secretary,
General Counsel 2003
Michael Edwards 44 Vice President Sales 2000
Benjamin Patipa 48 Vice President, Schools/Vending 2002
Arthur W. Blanding 76 Director 1999
Robert Cummings 61 Director 1997
Paul Downes 42 Director 1997
John McCormack 45 Director 1997
Phillip Pearce 73 Director 1997
China Premium Food Corp (Shanghai) Co., Ltd. - Chinese subsidiary
Roy G. Warren 47 Director , Chairman 1999
Roy D. Toulan, Jr. 58 Director 2003
Michael Edwards 44 Director 2003
The experience and background of the Company's executive officers follow:
Mr. Stanley A. Hirschman - Chairman and Director since September 2000
Mr. Hirschman is president of CPointe Associates, Inc., an executive
management and consulting firm specializing in solutions for emerging companies
with technology-based products. CPointe was formed in 1996. In addition, he is a
director of Redwood Grove Capital Management, LLC, Global Marketing Partners,
Inc. and AirNET Wireless, LLC. Prior to establishing CPointe Associates, Mr.
Hirschman was vice president of operations of Software, Etc., Inc., a retail
software chain, from 1989 until 1996. Mr. Hirschman has also held senior
management positions with retailers T.J. Maxx, Gap Stores and Banana Republic.
Mr. Hirschman currently serves on the Audit Committee of the Company's board of
directors.
Mr. Roy G. Warren - Chief Executive Officer since May 1999; Director since 1997
Mr. Warren serves as our Chief Executive Officer and as a director. As
Chief Executive Officer, Mr. Warren continues to develop strategy for our growth
and external financial matters.
For 15 years from 1981 through 1996, Mr. Warren was in the securities
brokerage industry. During those years, Mr. Warren acted as executive officer,
principal, securities broker and partner with brokerage firms in Florida, most
notably Kemper Financial Companies, Alex Brown & Sons and Laffer Warren &
Company. Mr. Warren currently serves on the Executive Committee of the Company's
board of directors.
Mr. Warren also serves as a director of our U.S. subsidiary, Bravo! Foods,
Inc. and our wholly owned Chinese subsidiary, China Premium Food Corp (Shanghai)
Co., Ltd.
33
Mr. Tommy E. Kee - Chief Financial Officer, Treasurer since 2003
Tommy Kee joined our company in March 2003 as Chief Financial Officer. He
graduated with an MBA from the University of Memphis and a BS degree in
accounting from the University of Tennessee. Before joining us, he served for
several years as CFO for Allied Interstate, Inc. in the West Palm Beach area.
Prior to that, Mr. Kee served as CFO and Treasurer for Hearx Ltd. a West Palm
Beach, Florida public company. He also served 18 years as International
Controller and Financial Director with the Holiday Inns Inc. organization in
Memphis and Orlando. Mr. Kee handles all financial management and reporting for
the Company and works closely with our external auditors and general counsel for
financial reporting and SEC compliance.
Roy D. Toulan, Jr. - Vice President, Corporate Secretary, General Counsel since
2003
Roy Toulan began with the original founders as outside corporate counsel
in 1997 and has been responsible for all of our corporate and business legal
work, including securities matters. Mr. Toulan became Corporate Counsel in
October 2002, when he left his private legal practice in Boston, and Vice
President in January 2003. He received his law degree from Catholic University
in Washington D.C., and for the first 15 years of his career practiced corporate
and securities litigation with large law firms in New York and Boston. Before
joining our company full time, he spent the last 18 years in private practice in
Boston, Massachusetts in general corporate and securities law helping companies
with corporate structure and funding, both domestically and internationally.
Mr. Michael Edwards - Vice President Sales since 2003
Mr. Edwards has been with our company in a sales and marketing capacity
since 2000. Prior to that time, he worked for 5 years in beverage marketing
research for Message Factors, Inc., a Memphis, Tennessee marketing research
firm. Mr. Edwards has a BS degree from Florida State University in Management
and Marketing and spent 13 years in the banking industry, leaving CitiBank to
join Message Factors in 1995.
Dr. Benjamin Patipa - Vice President, Schools/Vending since 2002
Dr. Patipa is a pediatrician with over fifteen years of experience in
directing operations, marketing, sales and facilitating growth in both public
and private companies. In 1987, Dr. Patipa founded and served as the chairman
and CEO of Weight For Me, Inc., a company that developed a proprietary program
which pioneered the delivery of weight control and nutrition services to the
over 12 million obese children and adolescents in America. Weight For Me earned
national and international recognition as the premier program for the control of
obesity in children and adolescents. Dr. Patipa also served at HEARx Ltd. as a
member of the Executive Operating Committee and Sonus USA, Inc., where he lead
the company's franchise licensing and buying group business in the Southeast
United States. Most recently, Dr. Patipa served as Senior Vice President and
Operational Head of eHDL/HealthNet Data Link, Inc., a national electronic
healthcare information company.
Mr. Arthur W. Blanding - Director Since November 1999
Mr. Blanding is president of The Omega Company, an international dairy
industry consulting company. Mr. Blanding has over 50 years experience in
management of dairy processing, sales and strategic planning consulting. He
graduated from Michigan State University in 1956, with a degree in food science,
and in 1964 from Oregon State University with a degree in Food Microbiology and
attended Harvard Business School.
As President of The Omega Company for the past 20 years, Mr. Blanding has
completed over 200 projects successfully, both in the U.S. and abroad. Clients
of The Omega Company include Abbott International, Cumberland Farms, Dairy Gold,
Farm Fresh, Inc., Haagen Dazs, Labatt, Ross Laboratories and Stop & Shop
Company, among others. Mr. Blanding was a consultant for the design and
construction of the dairy processing facility built in Shanghai by Green Food
Peregrine. The Omega Company is a party to a consulting contract with the
Company concerning technical and production issues.
Mr. Robert J. Cummings - Director Since 1997
Mr. Cummings' work experience includes ten years in purchasing at Ford
Motor Company. In 1975, he founded and currently operates J & J Production
Service, Inc., a manufacturing representative business, which is currently
responsible for over $300 million in annual sales.
34
Mr. Paul Downes - Director Since 1997
Mr. Downes is a director and, from August of 1997 to April of 1998, served
as our Chairman. For the past 12 years, Mr. Downes has managed his personal
diverse portfolio of international investments with concentration in the United
Kingdom, Eastern Europe, North Africa and Asia. In 1985, he founded a group of
nursing homes for the elderly in Great Britain, which he sold in 1990. Prior to
that time, Mr. Downes spent several years organizing golf tournaments and
international golf matches in Malaysia, Singapore, Thailand, Philippines,
Indonesia and Hong Kong, spending two years living in Southeast Asia. Mr. Downes
is one of our "founders" and played a leading role in our initial raising
efforts. From 2001, Mr. Downes has served as the Chairman of a start up software
company located in Delray Beach, Florida.
Mr. Phillip Pearce - Director Since 1997
Mr. Pearce is a "retired" member of the securities industry. Mr. Pearce
served as Chairman of the NASD during which time he was instrumental in the
founding of NASDAQ. Additionally, Mr. Pearce was a former Director of E.F.
Hutton and has served as Governor of the New York Stock Exchange. Since his
retirement in 1988, Mr. Pearce has remained active in the securities industry as
a corporate financial consultant. Mr. Pearce serves on the compensation
committee of our board of directors. Mr. Pearce also serves on our audit
committee. Mr. Pearce serves as a director of Xybernaut Corporation, a reporting
company, and Redwood Grove Capital Management, LLC.
Based upon a review of the appropriate Forms 3, 4 and 5 and any amendments
to such forms filed pursuant to Section 16(a), the Company reports the following
delinquent filings. On December 23 and 30, 2003, Mr. Warren purchased, in the
aggregate, 100,000 shares of our stock and reported those purchases on January 5
and 16, 2004, respectively. On December 30, 2003, Mr. Kee purchased 5,000 shares
of our stock and reported that purchase on January 21, 2004. Awaiting the
receipt of individual CIK numbers from the Commission caused a portion of the
delay in each instance. All officers and directors have been issued individual
CIK numbers for future reports.
Our directors and executive officers have not filed Form 4s for options
that have been authorized pursuant to compensation plans but not issued.
35
EXECUTIVE COMPENSATION
Compensation of directors
Directors were compensated for their travel expenses to and from board of
directors' meetings in 2001, 2002 and 2003. In 2002, there were four in person
meetings and three telephonic board meetings. In 2003, there were three in
person meetings and four telephonic board meetings. Directors received options
for 35,000 shares of common stock for each year as a director through 2001. Each
member of the executive committee has received options for an additional 40,000
shares of common stock for their services from 1998 through 2001. Directors
received additional options for 25,000 shares for 2002 and 2003
Compensation of executive officers
The following table sets forth the compensation paid during the last three
fiscal years to our Chief Executive Officer and the other executive officers of
our company:
Summary Compensation
Annual Compensation Long-Term
Compensation
-------------------------------------------------------------------
Name & Position Year Salary Bonus Other Restricted Stock All Other
(1) Awards and Options Compensation (2)
-----------------------------------------------------------------------------------------------------------------
Roy G. Warren President 2001 $180,000 4% $12,000 170,000 options (3) $220,000 salary
& CEO 2002 $180,000 EBITDA Medical 2,500,000 options (4) $12,000
Director 2003 $220,000 insurance (insurance)
Tommy E. Kee 2003 120,000 $12,000 300,000 options (5) $60,000 salary
Chief financial; Officer Medical $12,000
insurance (insurance)
Roy D. Toulan, Jr. 2003 180,000 $28,000 $8,900 300,000 options (6) $180,000 salary
Vice President Medical (part) $8,900
Secretary Life &
Corporate Counsel disability (insurance)
insurance
(1) Mr. Warren has waived the 4% EBITDA bonus provision in his employment
contract. Mr. Toulan was granted 100,000 shares of common stock as a
signing bonus, valued at $28,000.
(2) Amount paid for termination of employment owing to change of control.
(3) Five year options received as director; 145,000 options at $0.75, 25,000
options at $0.60.
(4) Employment agreement incentive options: 1,000,000 options at $0.50,
1,000,000 options at $1.50; 100,000 at $0.75, 100,000 at $2.00, 100,000 at
$3.00, 100,000 at $4.00, 100,000 at $5.00; all five year options; last
400,000 options vest at trading price trigger equal to exercise price.
(5) Employment agreement incentive options; 100,000 at $0.10; balance at
market price; vesting of three 100,000 share tranches at July 1, 2003,
December 31, 2003 and December 31, 2004, respectively.
(6) Employment agreement incentive options at $0.40; vesting of three 100,000
share tranches at January 1, 2003, December 31, 2003 and December 31,
2004, respectively.
36
OPTION GRANTS
The following table sets forth individual grants of stock options made
during the last completed fiscal year to each of the named executive officers.
OPTION GRANTS IN LAST FISCAL YEAR
INDIVIDUAL GRANTS
------------------------------------------------------------------------------------------------------------------
Name Number of Securities % of Total Options Exercise or Expiration Date
Underlying Options Granted to Employees Base Price
Granted in Fiscal Year (1) ($/Share)
------------------------------------------------------------------------------------------------------------------
Roy G. Warren President 25,000 $0.25 June 30, 2008
& CEO 100,000 Aggregate 58% 0.75 October 24, 2005
Director 100,000 2.00 5 yrs from vesting
100,000 3.00 5 yrs from vesting
100,000 4.00 5 yrs from vesting
100,000 5.00 5 yrs from vesting
1,000,000 0.50 December 31, 2007
1,000,000 1.50 December 31, 2007
Tommy E. Kee 100,000 $0.10 (100,000) June 30, 2008
Chief Financial Officer 100,000 Aggregate 1.1% Market price at December 30, 2008
Treasurer 100,000 vesting December 30, 2009
(200,000)
Roy D. Toulan, Jr. 100,000 $0.40 (300,000) December 31, 2007
Vice President Secretary 100,000 Aggregate 1.1% December 30, 2008
Corporate Counsel 100,000 December 30, 2009
(1) Includes options for 25,000 shares granted to Mr. Warren as a
director.
AGGREGATED OPTION EXERCISES TABLE
None of the named executive officers exercised any stock options during
2003. The following table provides information on the value of such officers'
unexercised options at December 31, 2003.
AGGREGATED OPTIONS EXERCISED IN LAST FISCAL YEAR
AND FISCAL YEAR-END OPTION VALUES
------------------------------------------------------------------------------------------------------------------
Name Shares Value Number of Securities Value of Unexercised
Acquired Realized Underlying Unexercised Options In-the-Money Options at 2003
on Exercise at 2003Fiscal Year-End Fiscal Year-End
Exercisable / Unexercisable Exercisable / Unexercisable
------------------------------------------------------------------------------------------------------------------
Roy G. Warren President 2,695.000
& CEO -- -- --
Director
------------------------------------------------------------------------------------------------------------------
2,295,000 400,000
exercisable unexercisable
------------------------------------------------------------------------------------------------------------------
Tommy E. Kee 300,000
Chief Financial Officer -- -- --
Treasurer
------------------------------------------------------------------------------------------------------------------
200,000 100,000
exercisable unexercisable
------------------------------------------------------------------------------------------------------------------
Roy D. Toulan, Jr. 300,000
Vice President Secretary -- -- --
Corporate Counsel
------------------------------------------------------------------------------------------------------------------
200,000 100,000
exercisable unexercisable
------------------------------------------------------------------------------------------------------------------
37
COMPENSATION PLANS
DIRECTORS
On March 27, 2001, we issued options to our directors, including Roy
Warren, to purchase the aggregate of 925,000 shares of our common stock. The
options have an exercise price of $0.75 and expire March 26, 2006. Directors
received options for 35,000 shares for each full year of service and an
additional 40,000 shares for service on a board committee. On July 1, 2002, we
issued 250,000 options to the Board of Directors, including Roy Warren, for
services rendered as directors. Each director received options for 25,000 shares
of common stock at an exercise price of $0.60. The options can be exercised for
five years.
On January 13, 2004, the Board of Directors adopted a plan to convert on a
one for one basis the options granted to the present employees of our and the
directors currently serving on the Board into a like number of our restricted
shares of common stock. The issuance of such common stock to any individual
director or employee is conditioned upon the execution of the "lockup" agreement
by such director or employee, pursuant to which the recipients of such common
stock shall not sell, transfer, pledge or hypothecate such common stock for a
six month period, commencing on the issue date of such common stock. The
conversion plan adopted by the Board of Directors will result in the issuance of
5,200,000 shares of our restricted common stock to our present directors and
employees.
Employment contracts
o Roy G. Warren Chief Executive Officer
We had a one-year contract with Mr. Warren commencing January 1, 2003, at
an annual base salary of $220,000. The contract provides for the grant of
options for 1,000,000 shares of common stock at $0.50 per share, options for
1,000,000 shares of common stock at $1.50 per share and options for 100,000
shares of common stock at $0.75 per share. During his employment, he also will
receive five-year incentive options for an additional 400,000 shares in tranches
of 100,000, as the public trading price for our stock reaches $2.00, $3.00,
$4.00 and $5.00, respectively. The exercise price for these options will track
the market price for our common stock when granted. Mr. Warren's employment
contract provides for the payment of one year's salary plus medical insurance
costs for termination of employment owing to change of control in our company.
Tommy E. Kee, Chief Financial Officer, Treasurer
Mr. Kee has an eighteen-month contract with our company commencing July 1,
2003 at an annual salary of $120,000. We granted options for 300,000 shares of
common stock as an incentive bonus pursuant to an employment contract. The first
100,000 share options tranche vested on July 1, 2003 at an exercise price of
$0.10 per share. The remaining options for 200,000 shares of common stock vest
as follows: options for 100,000 shares on each of December 31, 2003 and 2004,
respectively. All of these options expire five years from vesting. Mr. Kee's
employment contract provides for the payment of six months' salary plus medical
insurance costs for termination of employment owing to change of control in the
Company.
Roy D. Toulan, Jr., Vice President, General Counsel and Corporate
Secretary
Mr. Toulan has a two-year contract with our company commencing January 1,
2003 at an annual salary of $180,000. An incentive bonus of 100,000 common stock
shares was granted to Mr. Toulan in January 2003, valued at $0.28 per share. In
addition, we granted options for 100,000 shares of common stock as part of the
pursuant to an employment contract. These options vested immediately, expire on
December 30, 2007 and have an exercise price of $0.40 per share. We also granted
options for 200,000 shares of common stock at an exercise price of
38
$0.40 per share, which vest as follows: options for 100,000 shares on each of
December 31, 2003 and 2004. Options for 100,000 shares expire on each of
December 30, 2008 and 2009, respectively. Mr. Toulan's employment contract
provides for the payment of one year's salary plus medical insurance costs for
termination of employment owing to change of control in our company.
SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS
The equity compensation reported in this section has been and will be
issued pursuant to individual compensation contracts and arrangements with
employees, directors, consultants, advisors, vendors, suppliers, lenders and
service providers. The equity is reported on an aggregate basis as of December
31, 2003. our security holders have not approved the compensation contracts and
arrangements underlying the equity reported.
---------------------------------------------------------------------------------------------------------------------
Compensation Plan Number of securities to Weighted average price of Number of securities remaining
Category be issued upon exercise outstanding options, for future issuance under equity
of outstanding options, warrants and rights compensation plans
warrants and rights
---------------------------------------------------------------------------------------------------------------------
Directors 1,405,000 $0.72 350,000 director plan
---------------------------------------------------------------------------------------------------------------------
Management 1,036,667 $0.59 3,350,000 individual plans
---------------------------------------------------------------------------------------------------------------------
Founders 2,083,705 $1.00 0 individual plans
---------------------------------------------------------------------------------------------------------------------
Consultants 360,714 $0.54 0 individual plans
---------------------------------------------------------------------------------------------------------------------
Lender 25,000 $0.40 0 individual plan
---------------------------------------------------------------------------------------------------------------------
Total 4,911,086 $0.79 3,700,000
---------------------------------------------------------------------------------------------------------------------
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The following table sets forth the beneficial ownership of our company's common
stock as of January 14, 2005, as to
o each person known to beneficially own more than 5% of the Company's
common stock
o each of our directors
o each executive officer
o all directors and officers as a group
The following conditions apply to all of the following tables:
o except as otherwise noted, the named beneficial owners have direct
ownership of the stock and have sole voting and investment power
with respect to the shares shown
o the class listed as "common" includes the shares of common stock
underlying the Company's issued convertible preferred stock, options
and warrants
39
BENEFICIAL OWNERS
-------------------------------------------------------------------------------------------------------
TITLE OF NAME AND ADDRESS OF AMOUNT AND PERCENT OF
CLASS BENEFICIAL OWNER (1) NATURE OF CLASS (2)
BENEFICIAL
OWNERSHIP
-------------------------------------------------------------------------------------------------------
Common Amro International, SA (3) 5,074,759 9.99%
Grossmuenster Platz 26
P.O. Box 4401 Zurich,
Switzerland CH 8022 Austinvest
Anstalt Balzers Landstrasse
938 9494 Furstentums Balzers,
Liechtenstein Esquire Trade &
Finance Inc. Trident Chambers
P.O. Box 146
Road Town, Tortola, B.V.I.
---------------------------------------------------------------------------------------------------------
Common The Keshet Fund LP (4) 5,074,759 9.99%
Keshet L.P.
Nesher Ltd
Talbiya B. Invest ments Ltd.
Ragnall House, 18 Peel Road
Douglas, Isle of Man
1M1 4L2, United Kingdom
---------------------------------------------------------------------------------------------------------
Common Alpha Capital 5,074,759 9.99%
Aktiengesellschaft (5)
Pradafant 7, Furstentums
9490, Vaduz,
Liechtenstein
---------------------------------------------------------------------------------------------------------
Common Mid-Am Capital, L.L.C. (5) 5,074,759 9.99%
Northpointe Tower
10220 North Ambassador Drive
Kansas City, MO 64190
---------------------------------------------------------------------------------------------------------
Common Explorer Fund Management, LLC (5) 5,074,759 9.99%
444 N. Michigan Ave.
Chicago, IL 60611
---------------------------------------------------------------------------------------------------------
Common Longview Fund LP 3,633,333 7.15%
1325 Howard Avenue #422
Burlingame, CA 94010
Attn: S. Michael Rudolph
---------------------------------------------------------------------------------------------------------
Common Stonestreet Limited Partnership 5,074,759 9.99%
C/o Canaccord Capital Corporation
320 Bay Street, Suite 1300
Toronto, Ontario M5H 4A6, Canada
---------------------------------------------------------------------------------------------------------
Common Whalehaven Funds Limited 3,816,667 7.51%
3rd Floor, 14 Par-Laville Road
Hamilton, Bermuda HM08
---------------------------------------------------------------------------------------------------------
Common Dale Reese (6) 3,305,985 6.51%
125 Kingston Road
Media, PA
---------------------------------------------------------------------------------------------------------
Common Mr. Larry Frisman 2,702,500 5.32%
7533 Isle Verde Way
Delray Beach, FL 33446
---------------------------------------------------------------------------------------------------------
Common Longview Fund LP(5) 5,074,759 9.99%
1325 Howard Avenue #422
Burlingame, CA 94010
---------------------------------------------------------------------------------------------------------
Common Gamma Opportunity (5) 5,074,759 9.99%
Capital Partners LP
British Colonial Centre
of Commerce
One Bay Street, Suite 401
Nassau, The Bahamas
---------------------------------------------------------------------------------------------------------
(1) Beneficial Ownership is determined in accordance with the rules of the
Securities and Exchange Commission and generally includes voting or
investment power with respect to securities. Shares of common stock
subject to options or warrants currently exercisable or convertible, or
exercisable or convertible within 60 days of December 15, 2004 are deemed
outstanding for computing the percentage of the person holding such option
or warrant but are not deemed outstanding for computing the percentage of
any other person.
40
(2) Percentage based on 50,798,396 shares of common stock outstanding with
respect to the common stock.
(3) Amro International, S.A., Austinvest Anstalt Balzers and Esquire Trade &
Finance Inc. share a common investment representative, attorney and
subscription agreements for the Series D and Series F convertible
preferred stock and are treated as a group for beneficial ownership
purposes. This group is contractually limited to a beneficial ownership of
the Company's equity not to exceed 9.99%. All of the equity listed
consists of convertible preferred and warrants.
(4) The Keshet Fund L.P., Keshet L.P., Nesher Ltd. and Talbiya B. Investments
Ltd. share a common investment representative, attorney and subscription
agreements for the Series G convertible preferred stock and are treated as
a group for beneficial ownership purposes. This group is contractually
limited to a beneficial ownership of the Company's equity not to exceed
9.99%. All of the equity listed consists of convertible preferred and
warrants.
(5) This owner is contractually limited to a beneficial ownership of the
Company's equity not to exceed 9.99%. All of the equity listed consists of
convertible debentures, convertible preferred and warrants.
(6) The beneficial owner has the right to convert 107,440 shares of stock
preferred to 107,440 shares of common stock within 60 days.
MANAGEMENT OWNERS
MANAGEMENT OWNERS
----------------------------------------------------------------------------------------------------------
TITLE OF CLASS NAME AND ADDRESS AMOUNT AND PERCENT OF
ADDRESS OF NATURE OF CLASS (2)
MANAGEMENT OWNERSHIP
OWNER (1)
----------------------------------------------------------------------------------------------------------
Common Roy G. Warren 3,321,764 (3) 6.36%
11300 US Highway No.1
N. Palm Beach, FL
----------------------------------------------------------------------------------------------------------
Common Paul Downes 288,000 (4) *
Tamarind Management Ltd.
20579 S. Charlestown
Boca Raton, FL
33434
----------------------------------------------------------------------------------------------------------
Common Robert Cummings 565,000 (5) 1.04%
2829 N.E. 44th Street
Lighthouse Point,
FL 33064
----------------------------------------------------------------------------------------------------------
Common John McCormack 787,500 (6) 1.55%
8750 South Grant
Burridge, IL 60521
----------------------------------------------------------------------------------------------------------
Common Mr. Arthur W. 452,889 (7) *
Blanding
Janesville, WI
53545
----------------------------------------------------------------------------------------------------------
Common Phillip Pearce 256,000 (8) *
6624 Glenleaf Court
Charlotte, NC 28270
----------------------------------------------------------------------------------------------------------
Common Stanley Hirschman 369,670 (9) *
2600 Rutgers Court
Plano, Texas 75093
----------------------------------------------------------------------------------------------------------
Common Roy D. Toulan, Jr. 1,015,121 (10) 2.00%
VP, General Counsel
6 Wheelers Pt. Rd
Gloucester, MA
----------------------------------------------------------------------------------------------------------
Common Tommy Kee 442,385 (11) *
CFO, Treasurer
129 Eagleton Court
Palm Beach
Gardens, FL
----------------------------------------------------------------------------------------------------------
Common Executive officers 7,505,329 14.39%
and directors as a
group
----------------------------------------------------------------------------------------------------------
41
*less than one percent
(1) Beneficial Ownership is determined in accordance with the rules of the
Securities and Exchange Commission and generally includes voting or
investment power with respect to securities. Shares of common stock
subject to options or warrants currently exercisable or convertible, or
exercisable or convertible within 60 days of April 27, 2004 are deemed
outstanding for computing the percentage of the person holding such option
or warrant but are not deemed outstanding for computing the percentage of
any other person.
(2) Percentage based on 50,798,396 shares of common stock outstanding with
respect to the common stock.
(3) Includes 2,755,000shares of common stock resulting from the Board's
conversion of management options to common stock authorized by the Board
of Directors.
(4) Includes 205,000 shares of common stock resulting from the Board's
conversion of management options to common stock authorized by the Board
of Directors.
(5) Includes 255,000 shares of common stock resulting from the Board's
conversion of management options to common stock authorized by the Board
of Directors.
(6) Includes 205,000 shares of common stock resulting from the Board's
conversion of management options to common stock authorized by the Board
of Directors.
(7) Includes 170,000 shares of common stock resulting from the Board's
conversion of management options to common stock authorized by the Board
of Directors.
(8) Includes 205,000 shares of common stock resulting from the Board's
conversion of management options to common stock authorized by the Board
of Directors.
(9) Includes 100,000 shares of common stock resulting from the Board's
conversion of management options to common stock authorized by the Board
of Directors.
(10) Includes options for 400,000 shares of common stock authorized by the
Board of Directors.
(11) Includes options for 300,000 shares of common stock authorized by the
Board of Directors.
There currently are no arrangements that may result in a change of
ownership or control of our company.
CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
In April 2004, we entered into a Subscription Agreement with two
accredited investors for the sale of (i) $500,000 in convertible debentures and
(ii) warrants to buy 3,000,000 shares of our common stock. Longview Fund LP
purchased a convertible debenture in the amount of $250,000 and warrants to buy
1,500,000 shares of common stock. In June 2004 and October 2004, Longview Fund
LP purchased a convertible debenture in the aggregate amount of $200,000 and
received an warrants to purchase an aggregate of 2,050,000 shares of common
stock.
42
Phillip Pearce, a director of our company and Stanley Hirschman, our Chairman,
serve on the Board of Directors of Redwood Grove Capital Management, LLC, which
has a management agreement with Longview Fund LP. In addition, Mr. Pearce and
Mr. Hirschman each own .05% of the outstanding membership interest of Redwood
Grove Capital Management, LLC.
DESCRIPTION OF SECURITIES TO BE REGISTERED
COMMON STOCK
We are authorized to issue up to 300,000,000 shares of Common Stock, par
value $.001. As of December 28, 2004, there were 50,798,396 shares of common
stock outstanding. Holders of the common stock are entitled to one vote per
share on all matters to be voted upon by the stockholders. Holders of common
stock are entitled to receive ratably such dividends, if any, as may be declared
by the Board of Directors out of funds legally available therefor. Upon the
liquidation, dissolution, or winding up of our company, the holders of common
stock are entitled to share ratably in all of our assets which are legally
available for distribution after payment of all debts and other liabilities and
liquidation preference of any outstanding common stock. Holders of common stock
have no preemptive, subscription, redemption or conversion rights. The
outstanding shares of common stock are validly issued, fully paid and
nonassessable.
We have engaged American Stock Transfer & Trust Company located at 59
Maiden Lane, Plaza Level, New York, NY 10038, as independent transfer agent or
registrar.
INDEMNIFICATION FOR SECURITIES ACT LIABILITIES
Our Articles of Incorporation, as amended, provide to the fullest extent
permitted by Delaware law, our directors or officers shall not be personally
liable to us or our shareholders for damages for breach of such director's or
officer's fiduciary duty. The effect of this provision of our Articles of
Incorporation, as amended, is to eliminate our rights and our shareholders
(through shareholders' derivative suits on behalf of our company) to recover
damages against a director or officer for breach of the fiduciary duty of care
as a director or officer (including breaches resulting from negligent or grossly
negligent behavior), except under certain situations defined by statute. We
believe that the indemnification provisions in our Articles of Incorporation, as
amended, are necessary to attract and retain qualified persons as directors and
officers.
Insofar as indemnification for liabilities arising under the Securities
Act of 1933 (the "Act" or "Securities Act") may be permitted to directors,
officers or persons controlling us pursuant to the foregoing provisions, or
otherwise, we have been advised that in the opinion of the Securities and
Exchange Commission, such indemnification is against public policy as expressed
in the Act and is, therefore, unenforceable.
PLAN OF DISTRIBUTION
The selling stockholders and any of their respective pledgees, donees,
assignees and other successors-in-interest may, from time to time, sell any or
all of their shares of common stock on any stock exchange, market or trading
facility on which the shares are traded or in private transactions. These sales
may be at fixed or negotiated prices. The selling stockholders may use any one
or more of the following methods when selling shares:
o ordinary brokerage transactions and transactions in which the
broker-dealer solicits the purchaser;
o block trades in which the broker-dealer will attempt to sell the
shares as agent but may position and resell a portion of the block
as principal to facilitate the transaction;
o purchases by a broker-dealer as principal and resale by the
broker-dealer for its account;
o an exchange distribution in accordance with the rules of the
applicable exchange;
o privately-negotiated transactions;
o short sales that are not violations of the laws and regulations of
any state or the United States;
o broker-dealers may agree with the selling stockholders to sell a
specified number of such shares at a stipulated price per share;
o through the writing of options on the shares
o a combination of any such methods of sale; and
o any other method permitted pursuant to applicable law.
43
The selling stockholders may also sell shares under Rule 144 under the
Securities Act, if available, rather than under this prospectus. The selling
stockholders shall have the sole and absolute discretion not to accept any
purchase offer or make any sale of shares if they deem the purchase price to be
unsatisfactory at any particular time.
The selling stockholders may also engage in short sales against the box,
puts and calls and other transactions in our securities or derivatives of our
securities and may sell or deliver shares in connection with these trades.
The selling stockholders or their respective pledgees, donees, transferees
or other successors in interest, may also sell the shares directly to market
makers acting as principals and/or broker-dealers acting as agents for
themselves or their customers. Such broker-dealers may receive compensation in
the form of discounts, concessions or commissions from the selling stockholders
and/or the purchasers of shares for whom such broker-dealers may act as agents
or to whom they sell as principal or both, which compensation as to a particular
broker-dealer might be in excess of customary commissions. Market makers and
block purchasers purchasing the shares will do so for their own account and at
their own risk. It is possible that a selling stockholder will attempt to sell
shares of common stock in block transactions to market makers or other
purchasers at a price per share which may be below the then market price. The
selling stockholders cannot assure that all or any of the shares offered in this
prospectus will be issued to, or sold by, the selling stockholders. The selling
stockholders and any brokers, dealers or agents, upon effecting the sale of any
of the shares offered in this prospectus, may be deemed to be "underwriters" as
that term is defined under the Securities Act of 1933, as amended, or the
Securities Exchange Act of 1934, as amended, or the rules and regulations under
such acts. In such event, any commissions received by such broker-dealers or
agents and any profit on the resale of the shares purchased by them may be
deemed to be underwriting commissions or discounts under the Securities Act.
We are required to pay all fees and expenses incident to the registration
of the shares, including fees and disbursements of counsel to the selling
stockholders, but excluding brokerage commissions or underwriter discounts.
The selling stockholders, alternatively, may sell all or any part of the
shares offered in this prospectus through an underwriter. No selling stockholder
has entered into any agreement with a prospective underwriter and there is no
assurance that any such agreement will be entered into.
The selling stockholders may pledge their shares to their brokers under
the margin provisions of customer agreements. If a selling stockholders defaults
on a margin loan, the broker may, from time to time, offer and sell the pledged
shares. The selling stockholders and any other persons participating in the sale
or distribution of the shares will be subject to applicable provisions of the
Securities Exchange Act of 1934, as amended, and the rules and regulations under
such act, including, without limitation, Regulation M. These provisions may
restrict certain activities of, and limit the timing of purchases and sales of
any of the shares by, the selling stockholders or any other such person. In the
event that the selling stockholders are deemed affiliated purchasers or
distribution participants within the meaning of Regulation M, then the selling
stockholders will not be permitted to engage in short sales of common stock.
Furthermore, under Regulation M, persons engaged in a distribution of securities
are prohibited from simultaneously engaging in market making and certain other
activities with respect to such securities for a specified period of time prior
to the commencement of such distributions, subject to specified exceptions or
exemptions. In regards to short sells, the selling stockholder can only cover
its short position with the securities they receive from us upon conversion. In
addition, if such short sale is deemed to be a stabilizing activity, then the
selling stockholder will not be permitted to engage in a short sale of our
common stock. All of these limitations may affect the marketability of the
shares.
We have agreed to indemnify the selling stockholders, or their transferees
or assignees, against certain liabilities, including liabilities under the
Securities Act of 1933, as amended, or to contribute to payments the selling
stockholders or their respective pledgees, donees, transferees or other
successors in interest, may be required to make in respect of such liabilities.
If the selling stockholders notify us that they have a material
arrangement with a broker-dealer for the resale of the common stock, then we
would be required to amend the registration statement of which this prospectus
is a part, and file a prospectus supplement to describe the agreements between
the selling stockholders and the broker-dealer.
44
PENNY STOCK
The Securities and Exchange Commission has adopted Rule 15g-9 which
establishes the definition of a "penny stock," for the purposes relevant to us,
as any equity security that has a market price of less than $5.00 per share or
with an exercise price of less than $5.00 per share, subject to certain
exceptions. For any transaction involving a penny stock, unless exempt, the
rules require:
o that a broker or dealer approve a person's account for transactions
in penny stocks; and
o the broker or dealer receive from the investor a written agreement
to the transaction, setting forth the identity and quantity of the
penny stock to be purchased.
In order to approve a person's account for transactions in penny stocks,
the broker or dealer must
o obtain financial information and investment experience objectives of
the person; and
o make a reasonable determination that the transactions in penny
stocks are suitable for that person and the person has sufficient
knowledge and experience in financial matters to be capable of
evaluating the risks of transactions in penny stocks.
The broker or dealer must also deliver, prior to any transaction in a
penny stock, a disclosure schedule prescribed by the Commission relating to the
penny stock market, which, in highlight form:
o sets forth the basis on which the broker or dealer made the
suitability determination; and
o that the broker or dealer received a signed, written agreement from
the investor prior to the transaction.
Disclosure also has to be made about the risks of investing in penny
stocks in both public offerings and in secondary trading and about the
commissions payable to both the broker-dealer and the registered representative,
current quotations for the securities and the rights and remedies available to
an investor in cases of fraud in penny stock transactions. Finally, monthly
statements have to be sent disclosing recent price information for the penny
stock held in the account and information on the limited market in penny stocks.
45
SELLING STOCKHOLDERS
The table below sets forth information concerning the resale of the shares
of common stock by the selling stockholders. We will not receive any proceeds
from the resale of the common stock by the selling stockholders. We will receive
proceeds from the exercise of the warrants. Assuming all the shares registered
below are sold by the selling stockholders, none of the selling stockholders
will continue to own any shares of our common stock.
The following table also sets forth the name of each person who is
offering the resale of shares of common stock by this prospectus, the number of
shares of common stock beneficially owned by each person, the number of shares
of common stock that may be sold in this offering and the number of shares of
common stock each person will own after the offering, assuming they sell all of
the shares offered.
---------------------------------------------------------------------------------------------------------------------
Total
Shares of
Common
Stock Total
issuable Percentage Shares of
Upon of Common Common Beneficial Percentage Percentage
Conversion Stock, Stock Ownership of Common Beneficial of Common
of Assuming Included Included in Stock Ownership Stock
Debentures Full in Prospectus Owned After the Owned
and/or Conversion Prospectus ** Before Offering(3) After
Name(2) Warrants (1) Offering Offering
(3)
---------------------------------------------------------------------------------------------------------------------
Alpha Capital 6,916,667 15.35% Up to 5,076,557 9.99% -- --
Aktiengesellschaft 8,375,000
shares of
common
stock
---------------------------------------------------------------------------------------------------------------------
Longview Fund LP 3,633,333 8.74% Up to 4,425,000 8.74% -- --
4,425,000
shares of
common
stock
---------------------------------------------------------------------------------------------------------------------
Stonestreet Limited 7,283,333 16.42% Up to 5,076,557 9.99% -- --
Partnership 9,075,000
shares of
common
stock
---------------------------------------------------------------------------------------------------------------------
Whalehaven Funds 3,816,667 9.37% Up to 4,775,000 9.37% -- --
Limited 4,775,000
shares of
common
stock
---------------------------------------------------------------------------------------------------------------------
Gamma Opportunity 2,583,333 6.10% Up to 3,000,000 6.10% -- --
Capital Partners, LP 3,000,000
shares of
common
stock
---------------------------------------------------------------------------------------------------------------------
MID-AM Capital, L.L.C. 10,333,333 20.62% Up to 5,076,557 9.99% -- --
12,000,000
shares of
common
stock
---------------------------------------------------------------------------------------------------------------------
Libra Finance, S.A 218,750 *** Up to 218,750 *** -- --
218,750
shares of
common
stock
---------------------------------------------------------------------------------------------------------------------
Bi-Coastal Consulting 120,833 *** Up to 181,250 *** -- --
Corp. 181,250
shares of
common
stock
---------------------------------------------------------------------------------------------------------------------
Stonestreet Corporation 179,167 *** Up to 268,750 *** -- --
268,750
shares of
common
stock
---------------------------------------------------------------------------------------------------------------------
Gem Funding LLC 95,833 *** Up to 143,750 *** -- --
143,750
shares of
common
stock
---------------------------------------------------------------------------------------------------------------------
Momona Capital Corp. 2,450,000 7.00% Up to 3,475,000 7.00* -- --
3,475,000
shares of
common
stock
---------------------------------------------------------------------------------------------------------------------
Ellis International 2,450,000 7.00% Up to 3,475,000 7.00* -- --
Ltd. 3,475,000
shares of
common
stock
---------------------------------------------------------------------------------------------------------------------
46
* This column represents an estimated number based on a conversion price as of a
recent date of January 14, 2005 of $.15 with respect to the convertible
debentures issued in June 2004 and $.10 with respect to the convertible
debentures issued in October 2004 and December 2004, divided into the principal
amount.
** These columns represents the aggregate maximum number and percentage of
shares that the selling stockholders can own at one time (and therefore, offer
for resale at any one time) due to their 9.99% limitation.
***Less than one percent.
The number and percentage of shares beneficially owned is determined in
accordance with Rule 13d-3 of the Securities Exchange Act of 1934, and the
information is not necessarily indicative of beneficial ownership for any other
purpose. Under such rule, beneficial ownership includes any shares as to which
the selling stockholders has sole or shared voting power or investment power and
also any shares, which the selling stockholders has the right to acquire within
60 days. The actual number of shares of common stock issuable upon the
conversion of the convertible debentures is subject to adjustment depending on,
among other factors, the future market price of the common stock, and could be
materially less or more than the number estimated in the table.
(1) The actual number of shares of common stock offered in this prospectus, and
included in the registration statement of which this prospectus is a part,
includes such additional number of shares of common stock as may be issued or
issuable upon conversion of the convertible debentures and exercise of the
related warrants by reason of any stock split, stock dividend or similar
transaction involving the common stock, in accordance with Rule 416 under the
Securities Act of 1933. However the selling stockholders have contractually
agreed to restrict their ability to convert their convertible debentures or
exercise their warrants and receive shares of our common stock such that the
number of shares of common stock held by them in the aggregate and their
affiliates after such conversion or exercise does not exceed 9.9% of the then
issued and outstanding shares of common stock as determined in accordance with
Section 13(d) of the Exchange Act. Accordingly, the number of shares of common
stock set forth in the table for the selling stockholders exceeds the number of
shares of common stock that the selling stockholders could own beneficially at
any given time through their ownership of the convertible debentures and the
warrants. In that regard, the beneficial ownership of the common stock by the
selling stockholder set forth in the table is not determined in accordance with
Rule 13d-3 under the Securities Exchange Act of 1934, as amended.
47
(2) Seymour Braun has investment authority and voting power over all securities,
including the shares of common stock underlying any convertible debenture,
convertible preferred stock and warrants held by Libra Finance, S.A. Among other
investment activities, Libra advises investors on financially assisting small
companies in need of capital. Gamma Capital Advisors, Ltd., an Anguilla, British
West Indies company, is the general partner to the stockholder Gamma Opportunity
Capital Partners, LP, a Cayman Islands registered limited partnership, with the
power to vote and dispose of the common shares being registered on behalf of the
stockholder. As such, Gamma Capital Advisors, Ltd. may be deemed the beneficial
owner of said shares. Jonathan P. Knight, PhD. is a Director to Gamma Capital
Advisors, Ltd., possessing the power to act on its behalf. Gamma Capital
Advisors, Ltd., and Jonathan P. Knight, PhD. disclaim beneficial ownership of
the shares of common stock being registered hereto. Mid-Am, a limited liability
company headquartered in Kansas City, Missouri, is a finance affiliate of Dairy
Farmers of America, Inc. Gerald L. Bos, the CEO and Treasurer of Mid-Am, has
voting and dispositive control over securities held by Mid-Am. Longview Fund LP
is a California limited partnership. S. Michael Rudolph may be deemed the
control person of the shares owned by such entity, with final voting power and
investment control over such shares. Alpha Capital Aktiengesellschaft is a
private investment fund that is owned by all its investors and managed by Mr.
Konrad Ackerman. Mr. Konrad Ackerman may be deemed the control person of the
shares owned by such entity, with final voting power and investment control over
such shares. Bicoastal Consulting Corp is a New Jersey corporation. Peter Benz
may be deemed the control person of the shares owned by such entity, with final
voting power and investment control over such shares. Stonestreet Limited
Partnership is a private investment fund that is owned by all its investors and
managed by Ms. Libby Leonard and Mr. Michael Finkelstein. Ms. Libby Leonard and
Mr. Michael Finkelstein may be deemed control persons of the shares owned by
such entity, with final voting power and investment control over such shares.
Whalehaven Funds Limited is a professional hedge fund incorporated in Bermuda.
The control persons are Evan Schemenauer, Arthur Jones, and Jennifer Kelly,
directors. Michael Finklestein, the President of Stonestreet Corporation, may be
deemed the control person of the shares owned by Stonestreet Corporation with
final voting power and investment control over such shares. Gem Funding LLC is a
Limited Liability Company, and Cory Weisblum, President may be deemed the
control person of the shares owned by such entity, with final voting power and
investment control over such shares. Arie Rabinovitz, the President of Momona
Capital Corp., may be deemed the control person of the shares owned by Momona
Capital Corp. with final voting power and investment control over such shares..
Wilhelm Ungar may be deemed the control person of the shares owned by Ellis
International Ltd. with final voting power and investment control over such
shares.
(3) Assumes that all securities registered will be sold.
TERMS OF CONVERTIBLE DEBENTURES
November 2003
To obtain funding for our ongoing operations, we entered into a
Subscription Agreement with an accredited investor on November 21, 2003 for the
sale of (i) $400,000 in convertible debentures, (ii) class A warrants to buy
2,000,000 shares of our common stock and (iii) class B warrants to buy
10,000,000 shares of common stock. In connection with this financing, we paid a
fee, which included (i) 400,000 shares of common stock, (ii) class A warrant to
purchase 2,000,000 shares of common stock and (iii) 10% of the proceeds received
by us in connection with the exercise of the class B warrants, which is payable
in shares of common stock at the rate of one share of common stock for every ten
shares of common stock actually issued upon exercise of the class B warrants.
This prospectus relates to the resale of the shares of common stock and
the common stock underlying these convertible debentures and warrants.
The debentures bear interest at 8%, mature on two years from the date of
issuance, and are convertible into our common stock, at the selling
stockholders' option, at the lower of (i) $0.05 or (ii) 75% of the average of
the three lowest intraday trading prices for the common stock on a principal
market for the 30 trading days before but not including the conversion date.
However, during the six months after the issuance of the convertible debenture,
the conversion price shall not be less than $.03 per share unless an event of
default exists. The conversion floor price of $.03 per share shall be extended
indefinitely, if during the six months after the issuance of the convertible
debenture (i) the closing trading price of our common stock for any consecutive
15 day trading period is $.20 or higher, (ii) the daily trading volume for each
such 15 trading days is 300,000 or more shares of common stock and (iii) the
registration statement registering the shares issuable under the convertible
debenture is effective for each such 15 trading days, unless an event of default
exists. Accordingly, the above factors are not satisfied, there is in fact no
limit on the number of shares into which the debentures may be converted. As of
April 27, 2004, the trading prices for our common stock during the preceding 30
trading days as reported on the Over-The-Counter Bulletin Board was $.14 and,
therefore, the conversion price for the convertible debentures was $.05. Based
on this conversion price, the $400,000 convertible debentures, excluding
interest, were convertible into 8,000,000 shares of our common stock. The full
principal amount of the convertible debentures are due upon default under the
terms of convertible debentures.
48
In connection with a Securities Purchase Agreement dated November 2003, we
have issued 4,000,000 class A and 10,000,000 class B warrants to purchase shares
of common stock. The A warrants are exercisable until three years from the date
of issuance at a purchase price of $0.05 per share. The B warrants are
exercisable until three years from the date of issuance at a purchase price of
$1.00 per share. In 2004, we entered into an agreement with holders of the B
warrants whereby we amended 5,000,000 of the B Warrants to have an exercise
price of $.10 per share.
The conversion price of the debentures and the exercise price of the
warrants may be adjusted in certain circumstances such as if we pay a stock
dividend, subdivide or combine outstanding shares of common stock into a greater
or lesser number of shares, or take such other actions as would otherwise result
in dilution of the selling stockholder's position.
The selling stockholders have contractually agreed to restrict their
ability to convert their convertible debentures or exercise their warrants and
receive shares of our common stock such that the number of shares of common
stock held by them in the aggregate and their affiliates after such conversion
or exercise does not exceed 9.9% of the then issued and outstanding shares of
common stock.
April 2004
In April 2004, we entered into a Subscription Agreement with two
accredited investors for the sale of (i) $500,000 in convertible debentures and
(ii) warrants to buy 3,000,000 shares of our common stock. In connection with
this financing, we paid a fee in the amount of a convertible debentures in the
amount of $50,000.
The debentures issued in connection with the April 2004 financing bear
interest at 10%. The principal on the notes is due in equal monthly installments
commencing on November 1, 2004 until October 1, 2005. On October 1, 2005, all
principal and interest shall become due. In the event that our common stock has
a closing price in excess of $.20 for the five days preceding the monthly
payment, then, within our discretion, the monthly payment may be deferred. and
the notes are convertible into our common stock at $0.10 per share. Based on
this conversion price, the $500,000 convertible debentures, excluding interest,
were convertible into 5,000,000 shares of our common stock.
The selling stockholders have contractually agreed to restrict their
ability to convert or exercise their warrants and receive shares of our common
stock such that the number of shares of common stock held by them and their
affiliates after such conversion or exercise does not exceed 9.99% of the then
issued and outstanding shares of common stock. See the "Selling Stockholders"
and "Risk Factors" sections for a complete description of the convertible
debentures.
June 2004
In June 2004, we entered into a Subscription Agreement with Longview Fund,
LP, Alpha Capital Aktiengesellschaft, Whalehaven Funds Limited, Stonestreet
Limited Partnership and Mid-Am Capital L.L.C for the issuance of convertible 10%
notes in the aggregate amount of $1,300,000 and five-year "A" warrants for the
purchase of, in the aggregate, 5,200,000 shares of common stock, at $0.25 per
share, and five-year "B" warrants for the purchase of, in the aggregate,
13,000,000 shares of common stock, at $2.00 per share. In connection with the
October 2004 financing, we subsequently amended the exercise price to $.15 for
the "A" warrants issued to Longview Fund, LP, Alpha Capital Aktiengesellschaft,
Whalehaven Funds Limited and Stonestreet Limited Partnership. The notes are
convertible into shares of common stock of the Company at $0.15 per common
share. The notes are payable in twelve equal monthly installments, commencing
January 1, 2005. The installment payments consist of principal and a "premium"
of 20% of the principal paid per installment. We have the option to defer such
payment until the note's maturity date on December 1, 2005, if our common stock
trades above $0.20 for the five trading days prior to the due date of an
installment payment. In connection with this transaction, we issued additional
notes in the aggregate amount of $40,000 to Gem Funding, LLC, Bi-Coastal
Consulting Corp., Stonestreet Limited Partnership and Libra Finance, S.A upon
identical terms as the principal notes, as a finder's fee, and paid $12,500 in
legal fees. The common stock underlying all notes and warrants carry
registration rights.
49
The selling stockholders have contractually agreed to restrict their
ability to convert or exercise their warrants and receive shares of our common
stock such that the number of shares of common stock held by them and their
affiliates after such conversion or exercise does not exceed 9.99% of the then
issued and outstanding shares of common stock. See the "Selling Stockholders"
and "Risk Factors" sections for a complete description of the convertible
debentures.
This prospectus relates to the resale of the shares of common stock and
the common stock underlying these convertible debentures and warrants.
October 2004
On October 29, 2004, we entered into Subscription Agreements with Longview
Fund, LP, Alpha Capital Aktiengesellschaft, Whalehaven Funds Limited and
Stonestreet Limited Partnership for the issuance of convertible 10% notes in the
aggregate amount of $550,000 and five-year "C" warrants for the purchase of, in
the aggregate, 2,200,000 shares of common stock, at $0.15 per share, and the
repricing of five-year "A" warrants, issued June 30, 2004 for the purchase of,
in the aggregate, 3,200,000 shares of common stock, from $0.25 to $0.15 per
share. The notes are convertible into shares of common stock at $0.10 per common
share. The notes are payable in twelve equal monthly installments, commencing
May 1, 2005. The installment payments consist of principal and a "premium" of
20% of the principal paid per installment. We have the option to defer such
payment until the note's maturity date on April 30, 2006, if our common stock
trades above $0.15 for the five trading days prior to the due date of an
installment payment and the underlying common stock is registered. In connection
with this transaction, we issued additional notes, without attached warrants, in
the aggregate amount of $27,500 to Gem Funding, LLC, Bi-Coastal Consulting
Corp., Stonestreet Limited Partnership and Libra Finance, S.A upon identical
terms as the principal notes, as a finder's fee, and paid $12,500 in legal fees.
The common stock underlying all notes and warrants carry registration rights.
The selling stockholders have contractually agreed to restrict their
ability to convert or exercise their warrants and receive shares of our common
stock such that the number of shares of common stock held by them and their
affiliates after such conversion or exercise does not exceed 9.99% of the then
issued and outstanding shares of common stock. See the "Selling Stockholders"
and "Risk Factors" sections for a complete description of the convertible
debentures.
December 2004
In December 2004, we entered into Subscription Agreements with Momona
Capital Corp. and Ellis International Ltd. for the issuance of convertible 10%
notes in the aggregate amount of $400,000 and five-year "C" warrants for the
purchase of, in the aggregate, 800,000 shares of common stock, at $0.15 per
share. The notes are convertible into shares of common stock at $0.10 per common
share. The notes are payable in twelve equal monthly installments, commencing
May 1, 2005. The installment payments consist of principal and a "premium" of
20% of the principal paid per installment. We have the option to defer such
payment until the note's maturity date on April 30, 2006, if our common stock
trades above $0.15 for the five trading days prior to the due date of an
installment payment and the underlying common stock is registered. In connection
with this transaction, we issued additional notes, without attached warrants, in
the aggregate amount of $10,000 to Momona Capital Corp. and Ellis International
Ltd. upon identical terms as the principal notes, as a finder's fee. The common
stock underlying all notes and warrants carry registration rights.
The selling stockholders have contractually agreed to restrict their
ability to convert or exercise their warrants and receive shares of our common
stock such that the number of shares of common stock held by them and their
affiliates after such conversion or exercise does not exceed 9.99% of the then
issued and outstanding shares of common stock. See the "Selling Stockholders"
and "Risk Factors" sections for a complete description of the convertible
debentures.
50
This prospectus relates to the resale of the shares of common stock and
the common stock underlying these convertible debentures and warrants.
SAMPLE CONVERSION CALCULATION
The number of shares of common stock issuable upon conversion of the
debentures is determined by dividing that portion of the principal of the
debenture to be converted and interest, if any, by the conversion price. For
example, assuming conversion of $400,000 of debentures issued in November 2003
on December 15, 2004, a conversion price of $0.05 per share, the number of
shares issuable upon conversion would be:
$1,300,000/$.15 = 8,666,6666 shares
LEGAL MATTERS
Sichenzia Ross Friedman Ference LLP, New York, New York will issue an
opinion with respect to the validity of the shares of common stock being offered
hereby.
EXPERTS
Lazar Levine & Felix LLP , Certified Public Accountants, have audited, as
set forth in their report thereon appearing elsewhere herein, our financial
statements at December 31, 2003 and for the year then ended that appears in the
prospectus. BDO SEIDMAN, LLP, Certified Public Accountants, have audited, as set
forth in their report thereon appearing elsewhere herein, our financial
statements at December 31, 2002 and for the year then ended that appears in the
prospectus. The financial statements referred to above are included in this
prospectus with reliance upon the auditors' opinion based on their expertise in
accounting and auditing.
AVAILABLE INFORMATION
We have filed a registration statement on Form SB-2 under the Securities
Act of 1933, as amended, relating to the shares of common stock being offered by
this prospectus, and reference is made to such registration statement. This
prospectus constitutes the prospectus of Bravo! Foods International Corp., filed
as part of the registration statement, and it does not contain all information
in the registration statement, as certain portions have been omitted in
accordance with the rules and regulations of the Securities and Exchange
Commission.
We are subject to the informational requirements of the Securities
Exchange Act of 1934 which requires us to file reports, proxy statements and
other information with the Securities and Exchange Commission. Such reports,
proxy statements and other information may be inspected at public reference
facilities of the SEC at Judiciary Plaza, 450 Fifth Street N.W., Washington D.C.
20549. Copies of such material can be obtained from the Public Reference Section
of the SEC at Judiciary Plaza, 450 Fifth Street N.W., Washington, D.C. 20549 at
prescribed rates. Because we file documents electronically with the SEC, you may
also obtain this information by visiting the SEC's Internet website at
http://www.sec.gov.
51
INDEX TO FINANCIAL STATEMENTS
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
FINANCIAL STATEMENTS
For the Nine Ended September 30, 2004 and September 30, 2003
Consolidated Balance Sheet F-1
Consolidated Statements of Operations F-3
Consolidated Statements of Cash Flow F-4
Notes to Unaudited Financial Statements F-5
For the Year Ended December 31, 2003 and December 31, 2002
Report of Independent Auditors F-15
Report of Independent Auditors F-16
Consolidated Balance Sheet F-17
Consolidated Statements of Operations F-19
Consolidated Statement of Capital Deficit F-20
Consolidated Statements of Cash Flow F-21
Notes to Consolidated Financial Statements F-22
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
CONSOLIDATED BALANCE SHEETS
December 31, September 30,
2003 2004
---------- ----------
(Unaudited)
Assets
Current assets:
Cash and cash equivalents $ 58,859 $ 58,263
Accounts receivable - net 25,921 34,411
Other receivables 6,331 6,331
Inventories 54,995 75,686
Prepaid expenses 201,617 468,694
---------- ----------
Total current assets 347,723 643,385
Furniture and equipment, net 68,623 95,586
License rights, net of accumulated amortization 24,065 114,204
Deferred product development costs 41,711 174,541
Deposits 10,736 14,982
---------- ----------
Total assets $ 492,858 $1,042,698
========== ==========
Liabilities and Capital Deficit
Current liabilities:
Note payable to International Paper $ 187,743 $ 187,743
Notes payable to Alpha Capital 100,000 120,328
Note payable to Mid-Am Capital LLC 150,000 62,559
Note payable to Libra Finance -- 29,166
Note payable to Longview -- 14,148
Note payable to Stonestreet -- 10,568
Note payable to Whalehaven -- 1,951
Note payable to Bi-Coastal -- 29,166
Note payable to Gem Funding -- 3,334
Note payable to Warner Brothers 147,115 147,115
Accounts payable 2,123,705 1,491,043
Accrued liabilities 610,665 1,019,295
---------- ----------
Total current liabilities 3,319,228 3,116,416
Dividends payable 582,823 831,207
Other notes payable 310,098 203,683
---------- ----------
Total liabilities 4,212,149 4,151,306
---------- ----------
F-1
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
CONSOLIDATED BALANCE SHEETS
December 31, September 30,
2003 2004
------------ -------------
(Unaudited)
Commitments and contingencies
Capital Deficit (Note 2):
Series B convertible, 9% cumulative, and
redeemable preferred stock, stated
value $1.00 per share, 1,260,000 shares
authorized, 107,440 shares issued
and outstanding, redeemable at $107,440 107,440 107,440
Series F convertible and redeemable
preferred stock, stated value $10.00
per share, 130,515 and 75,515 shares
issued and outstanding 1,205,444 697,461
Series G convertible, 8% cumulative and
redeemable preferred stock, stated
value $10.00 per share, 58,810 shares
issued and outstanding in 2003 520,604 -
Series H convertible, 7% cumulative and
redeemable preferred stock, stated
value $10.00 per share, 165,500 shares
issued and outstanding 895,591 895,591
Series I convertible, 8% cumulative and
redeemable preferred stock, stated
value $10.00 per share, 30,000 shares
issued and outstanding 72,192 72,192
Series J convertible, 8% cumulative and
redeemable preferred stock, stated
value $10.00 per share, 200,000 shares
issued and outstanding 1,854,279 1,854,279
Series K convertible, 8% cumulative and
redeemable preferred stock, stated
value $10.00 per share, 95,000 shares
issued and outstanding - 950,000
Common stock, par value $0.001 per share,
300,000,000 shares authorized,
28,047,542 and 44,951,792 shares issued
and outstanding 28,045 44,949
Additional paid-in capital 21,144,896 25,259,456
Accumulated deficit (29,548,471) (32,990,665)
Translation adjustment 689 689
----------- -----------
Total capital deficit (3,719,291) (3,108,608)
----------- -----------
Total liabilities and capital deficit $ 492,858 $ 1,042,698
=========== ===========
See accompanying notes.
F-2
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF OPERATIONS
Nine Months Ended September 30, Three Months Ended September 30,
2003 2004 2003 2004
----------- ----------- ----------- -----------
(unaudited) (unaudited) (unaudited) (unaudited)
Revenue - unit sales $ 336,644 $ 2,236,383 $ 110,584 $ 747,198
Revenue - net kit sales 2,737 - - -
Revenue - gross kit sales 747,056 468,609 223,953 78,232
----------- ----------- ----------- -----------
Total revenue 1,086,437 2,704,992 334,537 825,430
Cost of sales (176,008) (1,893,834) (53,473) (628,747)
----------- ----------- ----------- -----------
Gross margin 910,429 811,158 281,064 196,683
Selling expenses 1,037,914 1,270,042 357,384 652,622
Product development 7,788 55,104 6,134 33,932
General and administrative expense 1,769,252 2,213,326 478,121 551,299
----------- ----------- ----------- -----------
Loss from operations (1,904,525) (2,727,314) (560,575) (1,041,170)
Other (income) expense
Interest expense 7,500 154,817 3,421 79,822
----------- ----------- ----------- -----------
Loss before income taxes (1,912,025) (2,882,131) (563,996) (1,120,992)
Provision for income taxes - - - -
----------- ----------- ----------- -----------
Net loss (1,912,025) (2,882,131) (563,996) (1,120,992)
Dividends accrued for Series B preferred stock (7,232) (7,259) (2,437) (2,437)
Dividends accrued for Series G preferred stock (34,598) (15,633) (7,192) -
Dividends accrued for Series H preferred stock (91,617) (86,967) (30,697) (29,201)
Dividends accrued for Series I preferred stock (17,951) (18,017) (6,049) (6,049)
Dividends accrued for Series J preferred stock (98,631) (120,109) (40,329) (40,329)
Deemed dividend for Series J preferred stock (367,211) - - -
Dividends accrued for Series K preferred stock - (43,475) - (19,156)
----------- ----------- ----------- -----------
Net loss applicable to common shareholders $(2,529,265) $(3,173,591) $ (650,700) $(1,218,164)
=========== =========== =========== ===========
Weighted average number of common shares
outstanding 26,425,063 38,254,305 27,382,453 44,374,877
=========== =========== =========== ===========
Basic and diluted loss per share $ (0.10) $ (0.08) $ (0.02) $ (0.03)
=========== =========== =========== ===========
Comprehensive loss and its components
consist of the following:
Net loss $(1,912,025) $(2,882,131) $ (563,996) $(1,120,992)
Foreign currency translation adjustment (144) - 128 -
----------- ----------- ----------- -----------
Comprehensive loss $(1,912,169) (2,882,131) $ (563,868) $(1,120,992)
=========== =========== =========== ===========
See accompanying notes.
F-3
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF CASH FLOWS
Nine Months Ended September 30,
2003 2004
----------- -----------
(unaudited) (unaudited)
Cash flows from operating activities:
Net loss $(1,912,025) $(2,882,131)
Adjustments to reconcile net loss to net cash
used in operating activities:
Depreciation and amortization 74,843 248,995
Stock issuance for compensation and finder's fee 28,000 116,000
Registration costs for financing - (20,108)
Loss on disposal of fixed assets 15,853 -
Increase (decrease) from changes in:
Accounts receivable 132,635 (8,490)
Other receivable (93,100) -
Advance to vendors 8,719 -
Inventories (44) (20,691)
Prepaid expenses (101,943) (271,323)
Accounts payable and accrued expenses 728,498 (224,031)
Deferred product development costs - (331,169)
----------- -----------
Net cash used in operating activities (1,118,564) (3,392,948)
----------- -----------
Cash flows from investing activities:
Purchase of equipment (31,362) (47,647)
----------- -----------
Net cash used in investing activities (31,362) (47,647)
----------- -----------
Cash flows from financing activities:
Proceeds of Series J preferred stock 1,000,000 -
Proceeds of Series K preferred stock 150,000 950,000
Convert account payable into note payable - 1,128,386
Convertible notes payable - 2,639,999
Payment of note payable, bank loan and license fee payable (122,938) (1,278,386)
----------- -----------
Net cash provided by financing activities 1,027,062 3,439,999
----------- -----------
Effect of changes in exchange rates on cash (144) -
----------- -----------
Net (decrease) in cash and cash equivalents (123,008) (596)
Cash and cash equivalents, beginning of period 224,579 58,859
----------- -----------
Cash and cash equivalents, end of period $ 101,571 $ 58,263
=========== ===========
See accompanying notes.
F-4
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
NOTE 1 -INTERIM PERIODS
The accompanying unaudited consolidated financial statements include the
accounts of Bravo! Foods International, Corp. and its wholly owned subsidiary
China Premium Food Corp (Shanghai) Co., Ltd. (the "Company"). The Company is
engaged in the sale of flavored milk products and flavor ingredients in the
United States, Mexico and nine countries in the Middle East.
The accompanying unaudited consolidated financial statements have been prepared
in accordance with generally accepted accounting principles for interim
financial information and with the instructions to Form 10QSB and Article 10 of
Regulation S-X. All significant inter-company accounts and transactions have
been eliminated in consolidation. The consolidated financial statements are
presented in U.S. dollars. Accordingly, the accompanying financial statements do
not include all the information and footnotes required by generally accepted
accounting principles for complete financial statements. In the opinion of
management, all adjustments (consisting of normal recurring adjustments)
considered necessary for a fair presentation have been included. Operating
results for the period ended September 30, 2004 are not necessarily indicative
of the results that may be expected for the year ending December 31, 2004. For
further information, refer to the consolidated financial statements and
footnotes thereto included in the Company's annual report for the year ended
December 31, 2003.
As shown in the accompanying consolidated financial statements, the Company has
suffered operating losses and negative cash flow from operations since inception
and has an accumulated deficit of $32,990,665, a capital deficit of $3,108,608,
negative working capital of $2,473,031 and is delinquent on certain of its debts
at September 30, 2004. Further, the Company's auditors stated in their report on
the Company's Consolidated Financial Statements for the year ended December 31,
2003, that these conditions raise substantial doubt about the Company's ability
to continue as a going concern. Management plans to increase gross profit
margins in its U.S. business, grow its international business, obtain additional
financing and is in the process of repositioning its products with the launch of
four new product lines. While there is no assurance that funding will be
available or that the Company will be able to improve its profit margins, the
Company is continuing to actively seek equity and/or debt financing and has
raised $3,590,000 in the first three quarters 2004. No assurances can be given
that the Company will be successful in carrying out its plans. The consolidated
financial statements do not include any adjustments that might result from the
outcome of this uncertainty.
REVENUE RECOGNITION
The Company recognizes revenue in the United States at the gross amount of its
invoices for the sale of finished product to wholesale buyers. Commencing with
the first quarter 2004, the Company no longer uses the sale of "kits" as a
revenue event in the United States. Rather, the Company takes title to its
branded flavored milks when they are shipped by the Company's third party
processors and recognize as revenue the gross wholesale price charged to the
F-5
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
Company's wholesale customers. Expenses for slotting fees and certain promotions
are treated as a reduction of reported revenue. The Company determines gross
margin by deducting from the reported wholesale price the cost charged by the
Company's third party processors to produce the branded milk products. The sale
of "kits" will remain as the revenue model for the Company's international
business.
The Company recognizes revenue for its international business at the gross
amount of its invoices for the sale of flavor ingredients and production rights
(collectively referred to as "kits") at the time of shipment of flavor
ingredients to processor dairies with whom the Company has production contracts
for extended shelf life and aseptic long life milk. This recognition is based
upon the Company's role as the principal in these transactions, its discretion
in establishing kit prices (including the price of flavor ingredients and
production right fees), its development and refinement of flavors and flavor
modifications, its discretion in supplier selection and its credit risk to pay
for ingredients if processors do not pay ingredient suppliers. The revenue
generated by the production contracts under this model is allocated for the
processors' purchase of flavor ingredients and fees charged by the Company to
the processors for production rights. The Company formulates the price of
production rights to cover its royalties under intellectual property licenses,
which varies by licensor as a percentage of the total cost of a kit sold to the
processor dairy under the production agreement. The Company recognizes revenue
on the gross amount of "kit" invoices to the dairy processors and simultaneously
records as cost of goods sold the cost of flavor ingredients paid by the
processor dairies to ingredients suppliers. The recognition of revenue generated
from the sale of production rights associated with the flavor ingredients is
complete upon shipment of the ingredients to the processor, given the short
utilization cycle of the ingredients shipped. The criteria to meet this
guideline are: 1) persuasive evidence of an arrangement exists, 2) delivery has
occurred or services have been rendered, 3) the price to the buyer is fixed or
determinable and 4) collectibility is reasonably assured.
The Company follows the final consensus reached by the Emerging Issues Task
Force (EITF) 99-19, "Reporting Revenue Gross as a Principal versus Net as an
Agent". In certain circumstances in its U.S. business, the Company is required
to pay slotting fees, give promotional discounts or make marketing allowances in
order to secure wholesale customers. These payments, discounts and allowances
reduce the Company's reported revenue in accordance with the guidelines set
forth in EITF 01-9 and SEC Staff Accounting Bulletin No. 101. Pursuant to EITF
99-19, international sales of kits made directly to customers by the Company are
reflected in the statements of operations on a gross basis, whereby the total
amount billed to the customer is recognized as revenue.
STOCK-BASED COMPENSATION
The Company has adopted the intrinsic value method of accounting for employee
stock options as permitted by Statement of Financial Accounting Standards No.
123, "Accounting for Stock-based Compensation" (SFAS No. 123) and discloses the
pro forma effect on net loss and loss per share as if the fair value based
method had been applied. For equity instruments, including stock options issued
to non-employees, the fair value of the equity instruments or the fair value of
the
F-6
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
consideration received, whichever is more readily determinable, is used to
determine the value of services or goods received and the corresponding charge
to operations.
The following table illustrates the effect on net loss and loss per share as if
the Company had applied the fair value recognition provision of SFAS No. 123 to
stock-based employee compensation.
Nine Months Ended
September 30,
---------------------------
2003 2004
----------- -----------
Net loss applicable to common
shareholders as reported: $(2,529,265) $(3,173,591)
Add: total stock based employee
compensation expense determined
under fair value method for all awards (4,500) -
----------- -----------
Pro forma net loss $(2,533,765) $(3,173,591)
=========== ===========
Loss per share:
As reported $ (0.10) $ (0.08)
Pro forma $ (0.10) $ (0.08)
NOTE 2 - TRANSACTIONS IN CAPITAL DEFICIT
On February 1, 2004, the Company agreed to issue 750,000 shares of its common
stock and warrants to purchase an additional 750,000 shares of common stock to
Marvel Enterprises, Inc. The Company issued its equity in connection with the
grant of an intellectual property license by Marvel on January 17, 2004, giving
the Company the right to use certain Marvel Comics characters on the Company's
Slammers(R) line of flavored milks. The warrants have an exercise price of $0.10
per share for the first year and, upon the occurrence of certain conditions tied
to the royalty performance under the license, can be extended for an additional
year with an exercise price of $0.14 per share. The Company made this private
offering to Marvel Enterprises, an accredited investor, pursuant to Rule 506 of
Regulation D and Section 4(2) of the Securities Act of 1933.
On February 12, 2004, the Company held a special meeting of shareholders at
which the shareholders approved an increase of the Company's authorized common
stock from 50,000,000 shares to 300,000,000 shares.
On February 17, 2004, the Company converted 875 shares of Series G Convertible
Preferred Stock into 215,164 shares of common stock pursuant to a January 12,
2004 notice of conversion from Nesher, LP, at a conversion price of $0.0407. The
conversion did not include accrued and unpaid dividends on the converted
preferred. The Company and the holder delayed processing this notice in light of
the Company's special meeting of shareholders held February 12, 2004. The shares
of common stock issued pursuant to this conversion were retired and cancelled on
March 5, 2004 and issued to third parties on that date in accordance with the
instructions of Nesher, LP.
F-7
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
On February 17, 2004, the Company converted 1,400 shares of Series G Convertible
Preferred Stock into 343,980 shares of common stock pursuant to a January 12,
2004 notice of conversion from Talbiya Investments, Ltd., at a conversion price
of $0.0407. The conversion did not include accrued and unpaid dividends on the
converted preferred. The Company and the holder delayed processing this notice
in light of the Company's special meeting of shareholders held February 12,
2004. The shares of common stock issued pursuant to this conversion were retired
and cancelled on March 5, 2004 and issued to third parties on that date in
accordance with the instructions of Talbiya Investments, Ltd.
On February 17, 2004, the Company converted 700 shares of Series G Convertible
Preferred Stock into 172,162 shares of common stock pursuant to a January 12,
2004 notice of conversion from The Keshet Fund, LP, at a conversion price of
$0.0407. The conversion did not include accrued and unpaid dividends on the
converted preferred. The Company and the holder delayed processing this notice
in light of the Company's special meeting of shareholders held February 12,
2004. The shares of common stock issued pursuant to this conversion were retired
and cancelled on March 5, 2004 and issued to third parties on that date in
accordance with the instructions of The Keshet Fund, LP.
On February 17, 2004, the Company converted 2,025 shares of Series G Convertible
Preferred Stock into 497,951 shares of common stock pursuant to a January 12,
2004 notice of conversion from Keshet LP, at a conversion price of $0.0407. The
conversion did not include accrued and unpaid dividends on the converted
preferred. The Company and the holder delayed processing this notice in light of
the Company's special meeting of shareholders held February 12, 2004. The shares
of common stock issued pursuant to this conversion were retired and cancelled on
March 5, 2004 and issued to third parties on that date in accordance with the
instructions of Keshet, LP.
On March 1, 2004, the Company issued 80,000 shares of non-voting Series K 8%
Convertible Preferred stock, to Mid-Am Capital, LLC, having a stated value of
$10.00 per Preferred K share, for the aggregate purchase price of $800,000. Each
preferred share is convertible to 100 shares of the Company's common stock at a
conversion price of $0.10, representing 8,000,000 shares of common stock
underlying the preferred. In addition, the following adjustments were made to
prior issued warrants for the purpose of facilitating future fund raising by the
Company arising out of the exercise of the warrants by the holder. The purchase
price, as defined in the Warrant No. 2003-B-002, has been reduced to $0.10,
subject to further adjustment as described in the warrant. The expiration date,
as defined in the warrant, remains as stated. This private offering was made to
Mid-Am, an accredited investor, pursuant to Rule 506 of Regulation D and Section
4(2) of the Securities Act of 1933.
On March 1, 2004, the Company issued 750,000 shares of its common stock to
Knightsbridge in compensation for services to be rendered, pursuant to a
November 2003 engagement letter with Knightsbridge Holdings, LLC for business
and operational consulting services. The Company delayed the issuance of these
shares owing to the necessity of a special meeting of shareholders to increase
the Company's authorized shares, which took place in
F-8
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
February 2004. On March 1, 2004, Knightsbridge commenced its services and the
Company issued the shares of common stock.
On March 9, 2004, the Company converted 5,000 shares of Series F Convertible
Preferred Stock into 1,315,789 shares of common stock pursuant to a January 8,
2004 notice of conversion from Esquire Trade & Finance Inc., at a conversion
price of $0.038. The conversion did not include accrued and unpaid dividends on
the converted preferred. The Company and the holder delayed processing this
notice in light of the Company's special meeting of shareholders held February
12, 2004. The shares of common stock issued pursuant to this conversion were
issued to third parties in accordance with the instructions of Esquire Trade &
Finance Inc.
On April 1 2004, the Company converted 5,000 shares of Series F Convertible
Preferred Stock into 1,315,789 shares of common stock pursuant to a January 27,
2004 notice of conversion from Austinvest Anstalt Balzers, at a conversion price
of $0.038. The conversion did not include accrued and unpaid dividends on the
converted preferred. The Company and the holder delayed processing this notice
in light of the Company's special meeting of shareholders held February 12,
2004. The shares of common stock issued pursuant to this conversion were issued
to third parties on that date in accordance with the instructions of Austinvest
Anstalt Balzers. The Company issued the preferred and the underlying common
stock upon conversion to an accredited investor, pursuant to a Regulation D
offering.
On April 2, 2004, the Company and Mid-Am Capital, LLC entered into Supplement
No.1 to the Series K Convertible Preferred Subscription Agreement, by which the
Company sold an additional 15,000 shares of its Series K Convertible Preferred
Stock utilizing the proceeds from a certain promissory note issued by the
Company to Mid-Am in the face amount of $150,000. With the consummation of this
sale, the $150,000 promissory note was deemed paid in full by the Company. The
Company issued the preferred and the underlying common stock upon conversion to
an accredited investor, pursuant to a Regulation D offering.
On April 8, 2004, the Company converted 4,862 shares of Series G Convertible
Preferred Stock into 700,000 shares of common stock pursuant to a March 25, 2004
notice of conversion from Nesher, LP, at a conversion price of $0.0853. The
conversion included accrued and unpaid dividends of $11,089 on the preferred
converted. The Company issued the preferred and the underlying common stock upon
conversion to an accredited investor, pursuant to a Regulation D offering.
On April 8, 2004, the Company converted 4,478 shares of Series G Convertible
Preferred Stock into 650,000 shares of common stock pursuant to a March 25, 2004
notice of conversion from Talbiya B. Investments, Ltd., at a conversion price of
$0.0853. The conversion included accrued and unpaid dividends of $10,662 on the
preferred converted. The Company issued the preferred and the underlying common
stock upon conversion to an accredited investor, pursuant to a Regulation D
offering.
F-9
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
On April 8, 2004, the Company converted 1,919 shares of Series G Convertible
Preferred Stock into 275,000 shares of common stock pursuant to a March 25, 2004
notice of conversion from The Keshet Fund, LP, at a conversion price of $0.0853.
The conversion included accrued and unpaid dividends of $4,265 on the preferred
converted. The Company issued the preferred and the underlying common stock upon
conversion to an accredited investor, pursuant to a Regulation D offering.
On April 8, 2004, the Company converted 7,677 shares of Series G Convertible
Preferred Stock into 1,100,000 shares of common stock pursuant to a March 25,
2004 notice of conversion from Keshet, LP, at a conversion price of $0.0853. The
conversion included accrued and unpaid dividends of $17,060 on the preferred
converted. The Company issued the preferred and the underlying common stock upon
conversion to an accredited investor, pursuant to a Regulation D offering.
On April 20, 2004, the Company entered into a Subscription Agreement with
Longview Fund, LP and Alpha Capital Aktiengesellschaft for the issuance of two
convertible 10% notes in the amount of $250,000 each and five-year warrants for
the purchase of, in the aggregate, 3,000,000 shares of common stock, at $0.15
per share. The notes are convertible into shares of common stock of the Company
at $0.10 per common share. Conversions are limited to a maximum ownership of
9.99% of the underlying common stock at any one time. The notes are payable in
twelve equal monthly installments, commencing November 1, 2004. The installment
payments consist of principal and a "premium" of 20% of the principal paid per
installment. The Company has the option to defer such payment until the note's
maturity date on October 1, 2005, if the Company's common stock trades above
$0.20 for the five trading days prior to the due date of an installment payment.
In connection with this transaction, the Company issued two additional notes in
the aggregate amount of $50,000, upon identical terms as the principal notes, as
a finder's fee, and paid $20,000 in legal fees. The common stock underlying all
notes and warrants carry registration rights. The Company issued the convertible
notes and warrants to accredited investors, pursuant to a Regulation D offering.
On April 30, 2004, the Company converted 20,000 shares of Series F Convertible
Preferred Stock into 1,945,525 shares of common stock pursuant to an April 27,
2004 notice of conversion from Esquire Trade & Finance Inc., at a conversion
price of $0.1028. The Company issued the preferred and the underlying common
stock upon conversion to an accredited investor, pursuant to a Regulation D
offering.
On April 30, 2004, the Company converted 20,000 shares of Series F Convertible
Preferred Stock into 1,945,525 shares of common stock pursuant to an April 27,
2004 notice of conversion from Austinvest Anstalt Balzers, at a conversion price
of $0.1028. The Company issued the preferred and the underlying common stock
upon conversion to an accredited investor, pursuant to a Regulation D offering.
On April 30, 2004, the Company converted 2,500 shares of Series F Convertible
Preferred Stock into 243,191 shares of common stock pursuant to an April 27,
2004 notice of
F-10
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
conversion from Esquire Trade & Finance Inc., at a conversion price of $0.1028.
The Company issued the preferred and the underlying common stock upon conversion
to an accredited investor, pursuant to a Regulation D offering.
On April 30, 2004, the Company converted 2,500 shares of Series F Convertible
Preferred Stock into 243,191 shares of common stock pursuant to an April 27,
2004 notice of conversion from Austinvest Anstalt Balzers, at a conversion price
of $0.1028. The Company issued the preferred and the underlying common stock
upon conversion to an accredited investor, pursuant to a Regulation D offering.
On May 20, 2004, the Company converted 9,226 shares of Series G Convertible
Preferred Stock into 620,578 shares of common stock pursuant to a May 19, 2004
notice of conversion from Nesher, LP, at a conversion price of $0.148. The
conversion did not include accrued and unpaid dividends on the converted
preferred. The Company issued the preferred and the underlying common stock upon
conversion to an accredited investor, pursuant to a Regulation D offering.
On May 20, 2004, the Company converted 13,972 shares of Series G Convertible
Preferred Stock into 939,782 shares of common stock pursuant to a May 19, 2004
notice of conversion from Keshet, LP, at a conversion price of $0.148. The
conversion did not include accrued and unpaid dividends on the converted
preferred. The Company issued the preferred and the underlying common stock upon
conversion to an accredited investor, pursuant to a Regulation D offering.
On June 17, 2004, the Company issued 87,195 of its common stock to Stephen
Nollau, a former consultant, for services rendered. The Company issued the
common stock pursuant to a Form S-8 registration statement, filed by the Company
on June 16, 2004.
On June 29, the Company converted 234 shares of Series G Convertible Preferred
Stock into 13,604 shares of common stock pursuant to a June 15, 2004 notice of
conversion from Nesher, LP, at a conversion price of $0.172. The conversion did
not include accrued and unpaid dividends on the converted preferred. The Company
issued the preferred and the underlying common stock upon conversion to an
accredited investor, pursuant to a Regulation D offering. This conversion
exhausted the outstanding Series G convertible preferred.
On June 29, the Company converted 1,850 shares of Series G Convertible Preferred
Stock into 107,558 shares of common stock pursuant to a June 15, 2004 notice of
conversion from Keshet, LP, at a conversion price of $0.172. The conversion did
not include accrued and unpaid dividends on the converted preferred. The Company
issued the preferred and the underlying common stock upon conversion to an
accredited investor, pursuant to a Regulation D offering. This conversion
exhausted the outstanding Series G convertible preferred.
On June 29, the Company converted 3,472 shares of Series G Convertible Preferred
Stock into 201,860 shares of common stock pursuant to a June 15, 2004 notice of
conversion
F-11
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
from The Keshet Fund, LP, at a conversion price of $0.172. The conversion did
not include accrued and unpaid dividends on the converted preferred. The Company
issued the preferred and the underlying common stock upon conversion to an
accredited investor, pursuant to a Regulation D offering. This conversion
exhausted the outstanding Series G convertible preferred.
On June 29, the Company converted 8,091 shares of Series G Convertible Preferred
Stock into 470,406 shares of common stock pursuant to a June 15, 2004 notice of
conversion from Talbiya B. Investments, Ltd, at a conversion price of $0.172.
The conversion did not include accrued and unpaid dividends on the converted
preferred. The Company issued the preferred and the underlying common stock upon
conversion to an accredited investor, pursuant to a Regulation D offering. This
conversion exhausted the outstanding Series G convertible preferred.
On June 30, 2004, the Company entered into Subscription Agreements with Longview
Fund, LP, Alpha Capital Aktiengesellschaft, Whalehaven Funds Limited,
Stonestreet Limited Partnership and Mid-Am Capital L.L.C for the issuance of
convertible 10% notes in the aggregate amount of $1,300,000 and five-year "A"
warrants for the purchase of, in the aggregate, 5,200,000 shares of common
stock, at $0.25 per share, and five-year "B" warrants for the purchase of, in
the aggregate, 13,000,000 shares of common stock, at $2.00 per share. The notes
are convertible into shares of common stock of the Company at $0.15 per common
share. Conversions are limited to a maximum ownership of 9.99% of the underlying
common stock at any one time. The notes are payable in twelve equal monthly
installments, commencing January 1, 2005. The installment payments consist of
principal and a "premium" of 20% of the principal paid per installment. The
Company has the option to defer such payment until the note's maturity date on
December 1, 2005, if the Company's common stock trades above $0.20 for the five
trading days prior to the due date of an installment payment. In connection with
this transaction, the Company issued additional notes in the aggregate amount of
$40,000 to Gem Funding, LLC, Bi-Coastal Consulting Corp., Stonestreet Limited
Partnership and Libra Finance, S.A upon identical terms as the principal notes,
as a finder's fee, and paid $12,500 in legal fees. The common stock underlying
all notes and warrants carry registration rights. The Company issued the
convertible notes and warrants to accredited investors, pursuant to a Regulation
D offering.
On August 9, 2004, the Company converted $50,000 of its November 2003
Convertible Promissory Note into 1,000,000 shares of common stock pursuant to an
August 5, 2004 notice of conversion from Gamma Opportunity Capital Partners LP,
at a fixed conversion price of $0.05. The conversion did not include accrued and
unpaid interest on the converted amount. The Company issued the underlying
common stock upon conversion pursuant to the Company's SB-2 registration
statement, declared effective on August 3, 2004.
On August 23, 2004, the Company converted $50,000 of its April 2004 Convertible
Promissory Note into 500,000 shares of common stock pursuant to an August 5,
2004 notice of conversion from Longview Fund LP, at a fixed conversion price of
$0.10. The conversion did
F-12
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
not include accrued and unpaid interest on the converted amount. The Company
issued the underlying common stock upon conversion pursuant to the Company's
SB-2 registration statement, declared effective on August 3, 2004.
On September 27, 2004, the Company converted $50,000 of its April 2004
Convertible Promissory Note into 500,000 shares of common stock pursuant to a
September 21, 2004 notice of conversion from Longview Fund LP, at a fixed
conversion price of $0.10. The conversion did not include accrued and unpaid
interest on the converted amount. The Company issued the underlying common stock
upon conversion pursuant to the Company's SB-2 registration statement, declared
effective on August 3, 2004.
NOTE 3 - BUSINESS SEGMENT AND GEOGRAPHIC INFORMATION
The Company operates principally in the single serve flavored milk industry
segment, under two distinct business models. In the United States, the Company
is responsible for the sale of finished Slammers(R) flavored milk (referred to
as "unit sales") to retail outlets. For these unit sales, the Company recognizes
as revenue the invoiced wholesale prices that the Company charges to the retail
outlets that purchase the Slammers(R) flavored milks. In countries other than
the United States, the Company's revenue is generated by the sale of kits to
dairy processors. Each kit consists of flavor ingredients for the Company's
Slammers(R) flavored milks and production rights to manufacture and sell the
milks. In line with the Company's revenue recognition policies, the Company
recognizes the full invoiced kit price as revenue and credits the processor
dairies. The Company currently sells kits to SADAFCO, a third party dairy
processor located in Saudi Arabia, for distribution to eleven Middle Eastern
countries.
NOTE 4 - SUBSEQUENT EVENTS
On October 6, 2004, the Company converted $20,000 of its November 2003
Convertible Promissory Note into 500,000 shares of common stock pursuant to a
September 23, 2004 notice of conversion from Gamma Opportunity Capital Partners
LP, at a fixed conversion price of $0.05. The conversion did not include accrued
and unpaid interest on the converted amount. The Company issued the underlying
common stock upon conversion pursuant to the Company's SB-2 registration
statement, declared effective on August 3, 2004.
On October 6, 2004, the Company issued 500,000 shares of its common stock to
Knightsbridge Holdings, LLC, pursuant to a consulting agreement dated November
10, 2003. The Company issued the underlying common stock pursuant to the
Company's SB-2 registration statement, declared effective on August 3, 2004. The
issued and outstanding equity reported in the Company's Form 10QSB for the
period ended March 31, 2004 reflects these shares of common stock.
On October 13, 2004, the Company issued 250,000 shares of its common stock in a
private placement to Arthur Blanding, at the market price of $0.12 per share,
pursuant to Section
F-13
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
4(2) of the Securities Act of 1934. Mr. Blanding, who solicited the purchase, is
an accredited investor and has been a director of the Company since 1999.
On October 15, 2004, the Company issued 750,000 shares of its common stock to
Marvel Enterprises, Inc., as partial compensation under a license agreement
dated February 1, 2004. The Company issued the underlying common stock pursuant
to the Company's SB-2 registration statement, declared effective on August 3,
2004. The issued and outstanding equity reported in the Company's Form 10QSB for
the period ended March 31, 2004 reflects these shares of common stock.
On October 29, 2004, the Company entered into Subscription Agreements with
Longview Fund, LP, Alpha Capital Aktiengesellschaft, Whalehaven Funds Limited
and Stonestreet Limited Partnership for the issuance of convertible 10% notes in
the aggregate amount of $550,000 and five-year "C" warrants for the purchase of,
in the aggregate, 2,200,000 shares of common stock, at $0.15 per share, and the
repricing of five-year "A" warrants, issued June 30, 2004 for the purchase of,
in the aggregate, 3,200,000 shares of common stock, from $0.25 to $0.15 per
share. The notes are convertible into shares of common stock of the Company at
$0.10 per common share. Conversions are limited to a maximum ownership of 9.99%
of the underlying common stock at any one time. The notes are payable in twelve
equal monthly installments, commencing May 1, 2005. The installment payments
consist of principal and a "premium" of 20% of the principal paid per
installment. The Company has the option to defer such payment until the note's
maturity date on April 30, 2006, if the Company's common stock trades above
$0.15 for the five trading days prior to the due date of an installment payment
and the underlying common stock is registered. In connection with this
transaction, the Company issued additional notes, without attached warrants, in
the aggregate amount of $27,500 to Gem Funding, LLC, Bi-Coastal Consulting
Corp., Stonestreet Limited Partnership and Libra Finance, S.A upon identical
terms as the principal notes, as a finder's fee, and paid $12,500 in legal fees.
The common stock underlying all notes and warrants carry registration rights.
The Company issued the convertible notes and warrants to accredited investors,
pursuant to a Regulation D offering.
F-14
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Shareholders
Bravo! Foods International Corp.
North Palm Beach, Florida
We have audited the accompanying balance sheet of Bravo! Foods International
Corp. as of December 31, 2003 and the related statements of operations and
comprehensive loss, shareholders' deficit and cash flows for the year then
ended. These financial statements are the responsibility of the Company's
management. Our responsibility is to express an opinion on these financial
statements based on our audit.
We conducted our audit in accordance with the standards of the Public Company
Accounting Oversight Board (United States). Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audit provides a
reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in
all material respects, the financial position of Bravo! Foods International
Corp. as of December 31, 2003 and the results of its operations and its cash
flows for the year then ended in conformity with accounting principles generally
accepted in the United States of America.
The accompanying financial statements have been prepared assuming that the
Company will continue as a going concern. As shown in the financial statements,
the Company has incurred a net loss of $3,016,987 for the year ended December
31, 2003 and as of that date had a working capital deficiency of $2,971,505 and
a shareholders' deficit of $3,719,291. The Company also is delinquent in payment
of certain debts. These conditions raise substantial doubt about the Company's
ability to continue as a going concern. The financial statements do not include
any adjustments relating to the recoverability and classification of recorded
assets, or the amounts and classification of liabilities that might be necessary
in the event the Company cannot continue in existence. Management's actions in
regard to these matters are more fully described in Note 1.
LAZAR LEVINE & FELIX LLP
New York, New York
April 2, 2004
F-15
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors
Bravo! Foods International Corp.
We have audited the accompanying consolidated balance sheet of Bravo! Foods
International Corp. and subsidiary as of December 31, 2002, and the related
consolidated statements of operations and comprehensive loss, shareholders'
deficit and cash flows for the year ended December 31, 2002. These financial
statements are the responsibility of the Company's management. Our
responsibility is to express an opinion on these financial statements based on
our audit.
We conducted our audit in accordance with the standards of the Public Company
Accounting Oversight Board (United States). Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audit provides a
reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above present
fairly, in all material respects, the financial position of Bravo! Foods
International Corp. and subsidiary as of December 31, 2002, and the results of
their operations and their cash flows for the year ended December 31, 2002 in
conformity with accounting principles generally accepted in the United States of
America.
The accompanying consolidated financial statements have been prepared assuming
that the Company will continue as a going concern. As discussed in the summary
of accounting policies in the consolidated financial statements, the Company has
a limited operating history, has incurred substantial losses since its
inception, and at December 31, 2002, has a net working capital deficiency, is
delinquent on certain of its debts and has negative net assets, all of which
raise substantial doubt about the Company's ability to continue as a going
concern. Management's plans in regard to these matters are also described in the
same section. The consolidated financial statements do not include any
adjustments that might result from the outcome of this uncertainty.
BDO Seidman, LLP
Los Angeles, California
March 14, 2003
F-16
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
CONSOLIDATED BALANCE SHEETS
December 31,
---------------------
2002 2003
-------- --------
Assets
Current assets:
Cash and cash equivalents $224,579 $ 58,859
Accounts receivable, net 236,149 25,921
Other receivables 14,662 6,331
Advance to vendor 8,719 --
Inventories 55,062 54,995
Prepaid expenses 7,605 201,617
-------- --------
Total current assets 546,776 347,723
Furniture and equipment, net 89,602 68,623
License rights, net of accumulated amortization 88,104 24,065
Deferred product development costs -- 41,711
Deposits 15,000 10,736
-------- --------
Total assets $739,482 $492,858
======== ========
See accompanying notes
F-17
December 31,
------------------------------
2002 2003
------------ ------------
Liabilities and Capital Deficit
Current liabilities:
Note payable to International Paper $ 187,743 187,743
Notes payable to Alpha Capital 100,000 100,000
Notes payable to Mid-Am Capital LLC -- 150,000
License fee payable to Warner Brothers 270,053 147,115
Accounts payable 1,039,313 2,123,705
Accrued liabilities 409,615 610,665
------------ ------------
Total current liabilities 2,006,724 3,319,228
Dividends payable 266,666 582,823
Other notes payable -- 310,098
------------ ------------
Total liabilities 2,273,390 4,212,149
------------ ------------
Commitments and contingencies
Capital Deficit:
Series B convertible, 9% cumulative, and redeemable preferred stock, stated
value $1.00 per share, 1,260,000 shares authorized, 107,440
shares issued and outstanding, redeemable at $107,440 107,440 107,440
Series F convertible and redeemable preferred stock, stated value
$10.00 per share, 130,515 shares issued and outstanding 1,205,444 1,205,444
Series G convertible, 8% cumulative and redeemable preferred stock,
stated value $10.00 per share, 70,208 and 58,810 shares issued and
outstanding 624,115 520,604
Series H convertible, 7% cumulative and redeemable preferred stock,
stated value $10.00 per share, 175,500 and 165,500 shares issued
and outstanding 939,686 895,591
Series I convertible, 8% cumulative and redeemable preferred stock,
stated value $10.00 per share, 30,000 shares issued and outstanding 72,192 72,192
Series J convertible, 8% cumulative and redeemable preferred stock,
stated value $10.00 per share, 100,000 and 200,000 shares issued
and outstanding 854,279 1,854,279
Common stock, par value $0.001 per share, 50,000,000 shares
authorized, 25,732,854 and 28,047,542 shares issued and
outstanding 25,730 28,045
Additional paid-in capital 20,266,463 21,144,896
Accumulated deficit (25,629,016) (29,548,471)
Accumulated other comprehensive loss - translation adjustment (241) 689
------------ ------------
Total capital deficit (1,533,908) (3,719,291)
------------ ------------
Total liabilities and capital deficit $ 739,482 492,858
============ =======
See accompanying notes
F-18
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF OPERATIONS
AND COMPREHENSIVE LOSS
Years ended December 31,
--------------------------------
2002 2003
------------ ------------
Revenue - unit sales $ 232,595 $ 356,985
Revenue - net kit sales 433,118 2,737
Revenue - gross kit sales 1,107,257 840,420
------------ ------------
Total revenue 1,772,970 1,200,142
Cost of sales (279,355) (192,498)
------------ ------------
Gross margin 1,493,615 1,007,644
Selling expense 776,090 1,739,850
Product development 239,298 5,570
General and administrative expense 3,615,674 2,249,678
------------ ------------
Loss from operations (3,137,447) (2,987,454)
Other income (expense):
Interest expense, net 22,984 29,533
------------ ------------
Loss before income taxes (3,160,431) (3,016,987)
Provision for income taxes -- --
------------ ------------
Net loss (3,160,431) (3,016,987)
Dividends accrued for Series B preferred stock (9,803) (9,669)
Dividends accrued for Series D preferred stock (18,499) --
Dividends accrued for Series G preferred stock (60,279) (46,457)
Dividends accrued for Series H preferred stock (75,439) (120,818)
Dividends accrued for Series I preferred stock (7,817) (24,000)
Dividends accrued for Series J preferred stock (2,044) (138,960)
Deemed dividend on Series J preferred stock (305,724) (367,211)
Deemed dividend on Series F preferred stock -- (195,353)
------------ ------------
Deemed dividends on Sseries H preferred stock (236,764)
------------ ------------
Deemed dividends on Series I preferred stock (294,793)
------------ ------------
Net loss applicable to common shareholders $ (4,171,590) $ (3,919,455)
------------ ------------
Weighted average number of common shares outstanding 18,503,849 26,779,222
------------ ------------
Basic and diluted loss per share $ (0.23) $ (0.15)
------------ ------------
Comprehensive loss and its components consist of the following:
Net loss $ (3,160,431) $ (3,016,987)
Foreign currency translation adjustment 231 930
------------ ------------
Comprehensive loss $ (3,160,200) $ (3,016,057)
============ ============
See accompanying notes
F-19
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
STATEMENTS OF CAPITAL DEFICIT
FOR THE YEARS ENDED DECEMBER 31, 2002 and 2003
Preferred Stock Common Stock
---------------------------- ---------------------------
Shares Amount Shares Amount
------------ ------------ ------------ ------------
Balance, December 31, 2001 568,774 $ 3,872,078 14,681,008 $ 14,681
Issuance of common stock for service -- -- 999,112 999
Stock issued for options exercised -- -- 1,000,000 1,000
Conversion of preferred stock (155,111) (1,469,880) 8,952,734 8,950
Issuance of Series H preferred stock 70,000 474,487 100,000 100
Issuance of Series I preferred stock 30,000 72,192 -- --
Issuance of Series J preferred stock 100,000 854,279 -- --
Issuance of options to consultants -- -- -- --
Extension of option terms -- -- -- --
Issuance of warrants to a lender -- -- -- --
Beneficial conversion feature of Series H preferred stock -- -- -- --
Beneficial conversion feature of Series I preferred stock -- -- -- --
Beneficial conversion of Series J preferred stock -- -- -- --
Accrued Dividends - Series B -- -- -- --
Accrued Dividends - Series D -- -- -- --
Accrued Dividends - Series G -- -- -- --
Accrued Dividends - Series H -- -- -- --
Accrued Dividends - Series I -- -- -- --
Accrued Dividends - Series J -- -- -- --
Net Loss for 2002 -- -- -- --
Translation Adjustment -- -- -- --
------------ ------------ ------------ ------------
Balance, December 31, 2002 613,663 3,803,156 25,732,854 25,730
Issuance of common stock for services -- -- 100,000 100
Conversion preferred stock (21,398) (147,606) 1,814,688 1,815
Issuance of Series J preferred stock 100,000 1,000,000 -- --
Finders' fees for financing -- -- 400,000 400
Issuance of warrants for convertible notes -- -- -- --
Beneficial conversion feature of convertible notes -- -- -- --
SEC registration costs for financing -- -- -- --
Conversion price changes for warrants -- -- -- --
Accrued Dividends - Series B -- -- -- --
Accrued Dividends - Series G -- -- -- --
Accrued Dividends - Series H -- -- -- --
Accrued Dividends - Series I -- -- -- --
Accrued Dividends - Series J -- -- -- --
Net loss for 2003 -- -- -- --
Translation adjustment -- -- -- --
------------ ------------ ------------ ------------
Balance, December 31, 2003 692,265 $ 4,655,550 28,047,542 $ 28,045
============ ============ ============ ============
Additional Accumulated
Paid In Accumulated Comprehensive
Capital Deficit Loss Total
------------ ------------ ------------ ------------
Balance, December 31, 2001 $ 16,028,980 $(21,457,425) $ (472) $ (1,542,158)
Issuance of common stock for service 278,652 -- -- 279,751
Stock issued for options exercised 329,000 -- -- 330,000
Conversion of preferred stock 1,648,516 -- -- 187,586
Issuance of Series H preferred stock 225,513 -- -- 700,000
Issuance of Series I preferred stock 215,796 -- -- 287,988
Issuance of Series J preferred stock 145,721 -- -- 1,000,000
Issuance of options to consultants 161,612 -- -- 161,612
Extension of option terms 391,345 -- -- 391,345
Issuance of warrants to a lender 4,051 -- -- 4,051
Beneficial conversion feature of Series H preferred stock 236,764 (236,764) -- --
Beneficial conversion feature of Series I preferred stock 294,793 (294,793) -- --
Beneficial conversion of Series J preferred stock 305,721 (305,721) -- --
Accrued Dividends - Series B -- (9,803) -- (9,803)
Accrued Dividends - Series D -- (18,499) -- (18,499)
Accrued Dividends - Series G -- (60,279) -- (60,279)
Accrued Dividends - Series H -- (75,439) -- (75,439)
Accrued Dividends - Series I -- (7,817) -- (7,817)
Accrued Dividends - Series J -- (2,044) -- (2,044)
Net Loss for 2002 -- (3,160,431) -- (3,160,431)
Translation Adjustment -- -- 231 231
------------ ------------ ------------ ------------
Balance, December 31, 2002 20,266,464 (25,629,015) (241) (1,533,906)
Issuance of common stock for services 27,900 -- -- 28,000
Conversion preferred stock 169,538 -- -- 23,747
Issuance of Series J preferred stock 367,211 (367,211) -- 1,000,000
Finders' fees for financing 65,029 -- -- 65,429
Issuance of warrants for convertible notes 49,474 -- -- 49,474
Beneficial conversion feature of convertible notes 40,427 -- -- 40,427
SEC registration costs for financing (36,500) -- -- (36,500)
Conversion price changes for warrants 195,353 (195,353) -- --
Accrued Dividends - Series B -- (9,669) -- (9,669)
Accrued Dividends - Series G -- (46,457) -- (46,457)
Accrued Dividends - Series H -- (120,818) -- (120,818)
Accrued Dividends - Series I -- (24,000) -- (24,000)
Accrued Dividends - Series J -- (138,961) -- (138,961)
Net loss for 2003 -- (3,016,987) -- (3,016,987)
Translation adjustment -- -- 930 930
------------ ------------ ------------ ------------
Balance, December 31, 2003 $ 21,144,896 $(29,548,471) $ 689 $ (3,719,291)
============ ============ ============ ============
See accompanying notes
F-20
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
STATEMENTS OF CASH FLOWS
Years ended December 31,
----------------------------
2002 2003
----------- -----------
Cash flows from operating activities:
Net loss $(3,160,431) $(3,016,987)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization 671,243 101,207
Stock issuance for compensation and financing finder's fee 54,600 93,428
Options issued for compensation 557,008 --
Registration costs for financing -- (36,500)
Loss on disposal of fixed assets -- 15,134
Increase (decrease) from changes in:
Accounts receivable (83,467) 210,228
Other receivable (2,484) 8,331
Advance to vendors 12,279 8,719
Inventories 36,341 67
Prepaid expenses 16,501 (189,748)
Accounts payable and accrued expenses 293,652 1,285,443
Deferred product and development costs -- (41,711)
----------- -----------
Net cash used in operating activities (1,604,758) (1,562,389)
----------- -----------
Cash flows from investing activities:
Purchase of equipment (9,422) (31,323)
----------- -----------
Net cash used in investing activities (9,422) (31,323)
----------- -----------
Cash flows from financing activities:
Proceeds from issuance of Series H preferred stock 700,000 --
Proceeds from issuance of Series I preferred stock 287,988 --
Proceeds from issuance of Series J preferred stock 1,000,000 1,000,000
Proceeds from exercise of stock options 330,000 --
Short term borrowing -- 150,000
Notes payable -- 400,000
Borrowings repayment (250,000) --
Payment of note payable, bank loan and license fee payable (461,500) (122,938)
----------- -----------
Net cash provided by financing activities 1,606,488 1,427,062
----------- -----------
Effect of changes in exchange rate on cash 231 930
----------- -----------
Net (decrease) in cash and cash equivalents (7,461) (165,720)
Cash and cash equivalents, beginning of year 232,040 224,579
----------- -----------
Cash and cash equivalents, end of year $ 224,579 $ 58,859
----------- -----------
Supplemental cash flow information
Cash paid during the year for interest $ 7,988 $ --
----------- -----------
Non-cash investing and financing activities:
Stock granted in exchange of debt and payables and services $ 225,151 $ 93,428
Preferred stock and accrued dividends converted to common stock $ 1,657,466 $ 171,353
Beneficial conversion feature $ 837,278 $ 133,611
=========== ===========
See accompanying notes
F-21
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 1 - Organization, Businesses and Going Concern Uncertainty
Bravo! Foods International Corp. (the Company), formerly known as China Premium
Food Corporation, was incorporated under the laws of the State of Delaware on
April 26, 1996. The Company is engaged in the sale of flavored milk products and
flavor ingredients in the United States, Puerto Rico, the Middle East, Canada
and Mexico and the co-production, marketing and distribution of branded dairy
products in the People's Republic of China.
In December 1999, the Company obtained Chinese government approval for the
registration of China Premium Food Corp (Shanghai) Co. Ltd., a wholly owned
subsidiary, in the Wai Gao Qiao free trade zone in Shanghai, China. This
subsidiary was formed to import, export and distribute food products and
flavored milk ingredients on a wholesale level in China. The Company has
announced that it plans to cease all business activities of this Chinese
subsidiary in the second quarter 2004.
GOING CONCERN UNCERTAINTY
As shown in the accompanying consolidated financial statements, the Company has
suffered operating losses and negative cash flow from operations since inception
and has an accumulated deficit of $29,548,471, a capital deficit of $3,719,291,
negative working capital of $2,971,505 and is delinquent on certain of its debts
at December 31, 2003. Further, the Company's auditors stated in their report on
the Company's Consolidated Financial Statements for the year ended December 31,
2003, that these conditions raise substantial doubt about the Company's ability
to continue as a going concern. Management plans to increase gross profit
margins in its U.S. business and obtain additional financing and is in the
process of repositioning its products with the anticipated launch of four new
product lines in the second quarter 2004. While there is no assurance that
funding will be available or that the Company will be able to improve its profit
margins, the Company is continuing to actively seek equity and/or debt financing
and has raised $1,350,000 in the fourth quarter 2003 and first quarter 2004. No
assurances can be given that the Company will be successful in carrying out its
plans. The consolidated financial statements do not include any adjustments that
might result from the outcome of this uncertainty.
PRINCIPLES OF CONSOLIDATION
The consolidated financial statements include the accounts of Bravo! Foods
International Corp. and its wholly owned subsidiary China Premium Food Corp
(Shanghai) Co., Ltd. (the "Company"). All significant intercompany transactions
have been eliminated.
FOREIGN CURRENCY TRANSACTIONS AND TRANSLATIONS
Transaction gains and losses result from a change in exchange rates between the
functional currency and the currency in which a foreign currency transaction is
denominated. They represent an increase or decrease in (a) the actual functional
current cash flows realized upon settlement of foreign currency transactions and
(b) the expected functional currency cash flows on unsettled foreign currency
transactions. All transaction gains and losses are included in other income or
expense.
Assets and liabilities of China Premium Food Corp (Shanghai) Co., Ltd. are
translated into the US dollar at the prevailing exchange rate in effect at each
period end. Revenue and expenses are translated into the US dollar at the
average exchange rate during the reporting period. Contributed capital is
translated into the US dollar at the historical exchange rate when capital was
injected. Any difference resulting from using the current rate, historical rate
and average rate in determination of retained earnings is accounted for as a
translation adjustment and reported as part of comprehensive income or loss in
the equity section.
F-22
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
USE OF ESTIMATES
The preparation of financial statements in conformity with accounting principles
generally accepted in the United States of America requires management to make
estimates and assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the date of
the financial statements and the reported amounts of revenues and expenses
during the reporting period. Among the more significant estimates included in
these financial statements are the estimated allowance for doubtful accounts
receivable and the deferred income tax asset allowance. Actual results could
differ materially from those estimates.
FAIR VALUE OF FINANCIAL INSTRUMENTS
The carrying amount of cash, receivables, accrued liabilities and notes payable
are reasonable estimates of their fair value because of the short maturity of
these items.
CASH AND CASH EQUIVALENTS
The Company considers all highly liquid investments purchased with a remaining
maturity of three months or less to be cash equivalents.
ACCOUNTS RECEIVABLE AND CONCENTRATION OF CREDIT RISK
The Company's financial instruments that are exposed to concentrations of credit
risk primarily consist of cash and accounts receivable.
During the normal course of business, the Company extends unsecured credit to
its customers who are located in various geographical areas. Typically credit
terms require payments to be made by the thirtieth day following the sale. The
Company regularly evaluates and monitors the creditworthiness of each customer
on a case-by-case basis. The Company provides an allowance for doubtful accounts
based on its continuing evaluation of its customers' credit risk. As of December
31, 2003, the allowance of doubtful accounts aggregated $39,226. The Company
maintains its cash accounts with high credit quality financial institutions. The
FDIC insures total cash balances up to $100,000 per bank. Cash balances in any
one financial institution were not in excess of this limit at December 31, 2003.
INVENTORY
Inventory, which consists primarily of packing materials and other flavor
ingredients, is stated at the lower of cost on the first-in, first-out method or
market.
FURNITURE AND EQUIPMENT
Furniture and equipment are stated at cost. Depreciation is computed primarily
utilizing the straight-line method over a period of seven years for furniture
and five years for equipment.
Maintenance, repairs and minor renewals are charged directly to expenses as
incurred. Additions and betterment to property and equipment are capitalized.
When assets are disposed of, the related cost and accumulated depreciation
thereon are removed from the accounts, and any resulting gain or loss is
included in the statement of operations.
F-23
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
IMPAIRMENT OF LONG-LIVED ASSETS
Effective January 1, 2002, the Company began applying the provisions of
Statement of Financial Accounting Standard No. 144, "Accounting for the
Impairment or Disposal of Long-Lived Assets" ("SFAS No. 144"). SFAS No. 144
requires that long-lived assets be reviewed for impairment whenever events or
changes in circumstances indicate that the carrying amount of an asset may not
be recoverable through the estimated undiscounted cash flows expected to result
from the use and eventual disposition of the assets. Whenever any such
impairment exists, an impairment loss will be recognized for the amount by which
the carrying value exceeds the fair value. During 2002, the Company determined
that license rights in China having a net book value of $39,286 were impaired.
REVENUE RECOGNITION
The Company sells flavor ingredients and production rights (collectively
referred to as "kits") to processor dairies in the U.S., China, Canada and
Mexico and also sells flavored milk products in the U.S. Revenue is recognized
when the goods are shipped and title and the risk and reward of ownership have
been passed to the customer and possible return of goods can be reasonably
estimated. The criteria to meet this guideline are: 1) persuasive evidence of an
arrangement exists, 2) delivery has occurred or services have been rendered, 3)
the price to the buyer is fixed or determinable and 4) collectibility is
reasonably assured.
The Company follows the final consensus reached by the Emerging Issues Task
Force (EITF) 99-19, "Reporting Revenue Gross as a Principal versus Net as an
Agent". Pursuant to EITF 99-19, sales of kits made directly to customers by the
Company are reflected in the statement of operations on a gross basis, whereby
the total amount billed to the customer is recognized as revenue. Sales of kits
made through intermediaries, in which the Company's role is similar to that of
an agent, are reflected on a net basis, which represents the amount earned by
the Company in the transaction.
The Company has production agreements with processors of dairy products pursuant
to which the Company sells flavored milk products to retail stores (referred to
as "unit sales"). The Company benefits from the difference between the prices
charged by the dairy processor to produce the product for the Company and the
price paid by retail stores to purchase the product. The Company bears the
responsibility for paying food brokers fees, transportation and delivery
expenses and sample expense, etc. The Company recognizes revenue on the net
basis and recognizes the aforementioned expenses as selling expenses.
SHIPPING AND HANDLING COSTS
Shipping and handling costs incurred by the Company are included in selling
expenses and aggregated $273,362 and $504,971 for 2002 and 2003, respectively.
ADVERTISING AND PROMOTION COSTS
Advertising and promotion costs, which are included in selling expenses, are
expensed as incurred and aggregated $304,084 and $342,367 for 2002 and 2003,
respectively.
F-24
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
INCOME TAXES
The Company accounts for income taxes using the liability method, which requires
an entity to recognize deferred tax liabilities and assets. Deferred income
taxes are recognized based on the differences between the tax bases of assets
and liabilities and their reported amounts in the financial statements that will
result in taxable or deductible amounts in future years. Further, the effects of
enacted tax laws or rate changes are included as part of deferred tax expense or
benefit in the period that covers the enactment date. A valuation allowance is
recognized if it is more likely than not that some portion, or all, of a
deferred tax asset will not be realized.
EARNINGS (LOSS) PER SHARE
Basic earnings (loss) per common share is computed by dividing loss applicable
to common stockholders by the weighted average number of common shares
outstanding for the period.
For the years ended December 31, 2002 and 2003, potential common shares arising
from the Company's stock options, stock warrants and convertible preferred stock
of 19,074,098 and 39,611,363, respectively, were not included in the computation
of diluted earnings per share because their effect was antidilutive.
STOCK-BASED COMPENSATION
The Company has adopted the intrinsic value method of accounting for employee
stock options as permitted by Statement of Financial Accounting Standards No.
123, "Accounting for Stock-based Compensation" (SFAS No. 123) and discloses the
pro forma effect on net loss and loss per share as if the fair value based
method had been applied. For equity instruments, including stock options, issued
to non-employees, the fair value of the equity instruments or the fair value of
the consideration received, whichever is more readily determinable, is used to
determine the value of services or goods received and the corresponding charge
to operations.
The following table illustrates the effect on net loss and loss per share as if
the Company had applied the fair value recognition provision of SFAS No. 123 to
stock-based employee compensation.
Year ending December 31,
---------------------------
2002 2003
----------- -----------
Net loss applicable to common shareholders: as reported $(4,171,590) $(3,919,455)
Add: total stock based employee compensation expense determined
under fair value method for all awards -- --
----------- -----------
Pro forma net loss $(4,171,590) $(3,919,455)
=========== ===========
Loss per share:
As reported $ (0.23) $ (0.15)
Pro forma $ (0.23) $ (0.15)
F-25
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
RECENT ACCOUNTING PRONOUNCEMENTS
ADOPTION OF SFAS 150
In May 2003, Statement of Financial Accounting Standards ("SFAS") No. 150,
"Accounting for Certain Financial Instruments with Characteristics of both
Liabilities and Equity," was issued effective for financial instruments entered
into or modified after May 31, 2003, and otherwise is effective at the beginning
of the first interim period beginning after June 15, 2003. This statement
establishes standards for how an issuer classifies and measures certain
financial instruments with characteristics of both liabilities and equity. It
requires that an issuer classify a financial instrument that is within its scope
as a liability (or an asset in some circumstances). The adoption of SFAS No. 150
did not result in the reclassification of any financial instruments in the
Company's financial statements.
ADOPTION OF SFAS 149
In April 2003, SFAS No. 149, "Amendment of Statement 133 on Derivative
Instruments and Hedging Activities," was issued effective for contracts entered
into or modified after June 30, 2003, with certain exceptions. This statement
amends and clarifies financial accounting and reporting for derivative
instruments embedded in other contracts (collectively referred to as
derivatives) and for hedging activities under SFAS No. 133, "Accounting for
Derivative Instruments and Hedging Activity." The Company does not currently
engage in hedging activities, and the adoption of this statement did not have
any effect on its financial statements.
ADOPTION OF SFAS NO. 148
In December 2002, FASB issued Statement No. 148 (SFAS No. 148), "Accounting for
Stock-Based Compensation -- Transition and Disclosure -- an amendment of FASB
Statement No. 123." SFAS No. 148 amends SFAS No. 123, "Accounting for
Stock-Based Compensation," to provide alternative methods of transition for a
voluntary change to the fair value based method of accounting for stock-based
employee compensation. In addition, SFAS No. 148 amends the disclosure
requirements of SFAS No. 123 to require prominent disclosures in both annual and
interim financial statements about the method of accounting for stock-based
employee compensation and the effect of the method used on reported results.
SFAS No. 148 is effective for the Company's financial statements for the year
ending after December 15, 2002. As permitted by SFAS No. 148, the Company has
elected to retain the intrinsic value method of accounting for stock-based
awards granted to employees. Accordingly, the adoption of SFAS No. 148 did not
have a material effect on the Company's financial position or results of
operations.
ADOPTION OF SFAS NO. 146
In June 2002, FASB issued Statement No. 146 (SFAS No. 146), "Accounting for
Costs Associated with Exit or Disposal Activities," effective for activities
that are initiated after December 31, 2002, with early application encouraged.
This Statement addresses financial accounting and reporting for costs associated
with exit or disposal activities and nullifies Emerging Issues Task Force (EITF)
Issue No. 94-3, "Liability Recognition for Certain Employee Termination Benefits
and Other Costs to Exit an Activity (including Certain Costs Incurred in a
Restructuring)." The adoption of SFAS No. 146 did not have a material effect on
the Company's financial position or results of operations.
F-26
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
ADOPTION OF SFAS NO. 143
In June 2001, Financial Accounting Standards Board (FASB) issued Statement No.
143 (SFAS No. 143), "Accounting for Asset Retirement Obligations," effective for
fiscal years beginning after June 15, 2002. The Statement requires entities to
record the fair value of a liability for an asset retirement obligation in the
period in which it is incurred. When the liability is initially recorded, the
entity capitalizes a cost by increasing the carrying amount of the related
long-lived asset. Over time, the liability is accreted to its present value each
period, and the capitalized cost is depreciated over the useful life of the
related asset. Upon settlement of the liability, an entity either settles the
obligation for its recorded amount or incurs a gain or loss upon settlement. The
adoption of SFAS No. 143 did not have a material effect on the Company's
financial position or results of operations.
ADOPTION OF FIN NO. 46
In January 2003, the FASB issued FASB Interpretation No. 46 (FIN No. 46),
"Consolidation of Variable Interest Entities," an interpretation of Accounting
Research Bulletin No. 51, "Consolidated Financial Statements." FIN No. 46
explains how to identify variable interest entities and how an enterprise
assesses its interest in a variable entity to decide whether to consolidate that
entity. FIN No. 46 requires existing unconsolidated variable interest entities
to be consolidated by their primary beneficiaries if the entities do not
effectively disperse risks among parties involved. FIN No. 46 is effective
immediately for variable interest entities after January 31, 2003, and to
variable interest entities in which an enterprise obtained an interest after
that date. FIN No. 46 applies in the first fiscal year or interim period
beginning after June 15, 2003, to variable interest entities in which an
enterprise holds a variable interest that it acquired before February 1, 2003.
The adoption of FIN No. 46 did not have a material effect on the Company's
financial position and result of operations.
ADOPTION OF FIN NO. 45
In November 2002, the FASB issued Interpretation No. 45 ("FIN No. 45"),
"Guarantor's Accounting and Disclosure Requirements for Guarantees, Including
Indirect Guarantees of Indebtedness of Others." FIN No. 45 expands on the
accounting guidance of Statements No. 5, 57, and 107 and incorporates without
change the provisions of FASB Interpretation No. 34, which is being superseded.
FIN No. 45 will affect leasing transactions involving residual guarantees,
vendor and manufacturer guarantees and tax and environmental indemnities. All
such guarantees will need to be disclosed in the notes to the financial
statements starting with the period ending after December 15, 2002. For
guarantees issued after December 31, 2002, the fair value of the obligation must
be reported on the balance sheet. Existing guarantees will be grandfathered and
will not be recognized on the balance sheet. There is no impact on our financial
position and results of operations due to the application of FIN No. 45.
RECLASSIFICATIONS
Certain reclassifications have been made to the prior year consolidated
financial statements to conform to the 2003 presentation.
F-27
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 2 - FIXED ASSETS
Fixed assets are comprised of the following:
2002 2003
Furniture and fixtures $ 79,841 $ 79,841
Office equipment 164,099 166,179
Leasehold improvements 21,321 21,321
265,261 267,341
Less: accumulated depreciation and amortization (175,659) (198,718)
$ 89,602 $ 68,623
Depreciation and amortization expense aggregated $42,919 and $37,168 for 2002
and 2003, respectively.
NOTE 3 - LICENSING AGREEMENTS WITH WARNER BROTHERS CONSUMER PRODUCTS CO.
LICENSING AGREEMENT IN CHINA
On January 1, 1999, the Company entered into a licensing agreement (the Original
Agreement) with Warner Brothers Consumer Products Co. (Warner) for the right to
utilize Looney Tunes(TM) images and names, as defined in the Agreement, on its
products in Shanghai and Hangzhou, China. The Company agreed to pay a 3% royalty
fee on the net invoiced price of each licensed article with a minimum guaranteed
consideration of $300,000 of which $45,000 was paid at inception of the
Agreement, and the balance to be paid in ten quarterly installments of $21,250
starting on September 30, 1999 with a final payment of $42,500 on or before
March 31, 2002. The Company recorded license rights of $300,000 and amortized
the rights over a period of three years.
On November 21, 2000, the Company entered into an amendment of the Original
Agreement with Warner. Per the amendment, the term of the agreement was extended
to June 30, 2003 with the guaranteed consideration being increased to $400,000.
The Original Agreement, as amended, was extended to October 29, 2003, at which
time it expired. As of December 31, 2003, the outstanding obligation under this
agreement was $147,116.
The Company decided not to seek another license from Warner Bros. for China
beyond the October 2003 expiration based upon the lack of sales in the Company's
China markets and what the Company perceived to be the licensor's continuing
overall lack of brand support in China. The Company and Warner Bros. dispute the
contractual necessity of the payment of the balance owed on the China license as
a result of the above circumstances. As of December 31, 2003, the Company
reserved $152,448 for this obligation, representing the $147,116 balance of
guaranteed royalties plus $5,332 for the legally allowed default penalty.
LICENSING AGREEMENT IN THE UNITED STATES
On July 26, 2000, the Company entered into a license agreement with Warner Bros.
and obtained rights to utilize Looney Tunes(TM) character images and names in
the U.S. in connection with specified categories of products sold by Bravo!. The
license agreement was originally effective from January 1, 2000 to December 31,
2002. In April 2002, the Company and Warner Bros. reached an agreement to extend
this license agreement until December 31, 2003. The Company recorded the gross
amount of $500,000 as licensing costs and an obligation for the licensing
agreement of $500,000 simultaneously.
F-28
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In May 2002, the Company entered into a licensing agreement with Warner to
utilize licensed property in connection with the 2002 Taz Atti-Tour events for
the period March 13, 2002 to December 31, 2002. The Company recorded a
non-refundable minimum guaranteed payment of $250,000. The guaranteed payment
was amortized over the term of the license agreement. The Company recorded
amortization expense of $250,000 for the year ended December 31, 2002. At
December 31, 2002, $83,333 was due for payment under the terms of the agreement,
which was paid on February 26, 2003.
The history of the Company with Warner Bros. licenses, as a function of sales of
the flavored milks, has not supported the guaranteed royalty structure required
by Warner Bros. for its licenses. As a result, the Company decided to exploit
its own Slammers(R) brand, which has been developed in 2003, and commenced
negotiations for licenses with Marvel Comics and Moon Pie. For these reasons,
the Company decided not to accept the offer of Warner Bros. to renew the U.S.
license.
LICENSING AGREEMENT IN MEXICO
In September 2001, the Company entered into a licensing agreement with Warner
for the right to utilize Looney Tunes(TM) character images and names, as defined
in the agreement, on its products sold in Mexico. The Company agreed to pay
royalties of 5% on net sales, defined as the gross invoice price billed to the
dairy producing, distributing and selling the licensed products, from June 1,
2001 through May 31, 2002; 7% on net sales from June 1, 2002 through May 31,
2003; and 10% on net sales from June 1, 2003 through May 31, 2004; with a
minimum total guaranteed consideration of $145,000.
The licensing agreement is effective through May 31, 2004. The Company recorded
license rights of $145,000 to be amortized over a period of three years.
Amortization expense for the year ended December 31, 2003 and 2003 was $48,333
for each year. As of December 31, 2003, no outstanding obligation remained under
this agreement. Based upon the Company's analysis of the cost of this license as
a function of sales of the flavored milks, the Mexico license will not by
renewed by the Company.
LICENSING AGREEMENT IN CANADA
In May 2002, the Company entered into a licensing agreement with Warner to
utilize Looney Tunes(TM) characters and names on milk products sold in specified
retail outlets throughout Canada, for the period March 1, 2002 to March 31,
2004. The Company recorded a license right of $32,720 upon execution of the
agreement. The guaranteed payment is amortized over the term of the license
agreement. The Company recorded amortization expense for the year ended December
31, 2002 and 2003 of $13,088 and $15,706, respectively. Based upon the Company's
analysis of the cost of this license as a function of sales of the flavored
milks, the Canada license will not by renewed by the Company.
NOTE 4 - DEFAULT OF NOTE PAYABLE TO INTERNATIONAL PAPER
In 1999, the Company issued a promissory note to assume existing debt owed by
its then Chinese joint venture subsidiary to a supplier, International Paper.
The face value of that unsecured note was $282,637 at an interest rate of 10.5%
per annum. The note originally required 23 monthly payments of $7,250 and a
balloon payment of $159,862 due on July 15, 2000. During 2000, the Company
negotiated an extension of this note to July 1, 2001. International Paper
imposed a charge of $57,000 to renegotiate the note, which amount represents
interest due through the extension date. The current balance due on this note is
$187,743 at December 31, 2003, all of which is delinquent. The Company has not
had any communication with International Paper during the last three years.
Although International Paper has not pursued collection of the note, it is
possible that they could do so in the future and, if they do, such collection
effort may have a significant adverse impact on the liquidity of the Company.
The Company has not accrued interest as of December 31, 2002 and December 31,
2003.
F-29
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 5 - NOTES PAYABLE TO INDIVIDUAL LENDERS
On November 6 and 7, 2001, respectively, the Company received the proceeds of
two loans aggregating $100,000 from two offshore lenders. The two promissory
notes, one for $34,000 and the other for $66,000, were payable on February 1,
2002 with interest at an annual rate of 8%. These loans are secured by a general
security interest in all the assets of the Company. These lenders have agreed to
extend the notes without default on a demand basis. Interest accrued and unpaid
as December 31, 2003 aggregated $17,380.
NOTE 6 - CAPITAL DEFICIT
2002
During 2002, the Company issued 70,000 shares of its Series H convertible
preferred stock, having a conversion price of $0.40 per share of common stock,
and warrants for 1,750,000 shares at $0.50 per share. The Series H convertible
preferred stock and warrants were priced at $10.00 per unit, and resulted in
proceeds of $700,000 in cash. In accordance with EITF 00-27, the Company
allocated $225,513 to the warrants, $474,487 to the underlying preferred stock
and recorded deemed dividends of $236,764 related to the beneficial conversion
features.
In connection with the above private placement of Series H Preferred stock, the
Company issued 100,000 shares of common stock as finder fees.
On June 17, 2002, the Company issued 30,000 shares of its Series I convertible
and 8% cumulative and redeemable preferred stock and warrants for 2,000,000
shares of common stock at $0.50 per share, exercisable three years from issue,
to two sophisticated and accredited investors, pursuant to Rule 506, Regulation
D and Section 4(2) of the Securities Act of 1933. The conversion of the
preferred into common stock shall be at a per common share conversion price of
either $0.40 or 75% of the average of the three lowest closing bid prices for
the thirty day period immediately preceding conversion, at the option of the
holder. The conversion price is subject to a maximum of $0.50 per share and a
minimum of $0.30 per share, which minimum conversion price shall govern for the
270 days immediately following the issue date of the Series I preferred shares.
The minimum conversion price shall be extended indefinitely upon the occurrence
of certain defined events, including the effectiveness of a registration
statement for the resale of the common stock underlying the preferred and a
trading price of the Company's common stock at $0.50 or higher for fifteen
consecutive days. The Series I convertible preferred stock and warrants were
priced at $10.00 per unit, and resulted in gross cash proceeds of $300,000, less
expenses of $12,012. In accordance with EITF 00-27, the Company allocated
$215,796 to the 2 million warrants and $72,192 to the underlying preferred stock
and recorded deemed dividends of $294,793 arising from a beneficial conversion
feature.
F-30
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
On September 30, 2002, the Company issued 100,000 shares of non-voting Series J
Convertible and 8% cumulative and redeemable Preferred stock, having a stated
value of $10.00 per share, and common stock warrants to Mid-Am Capital, L.L.C.
("Mid-Am") for the aggregate purchase price of $1,000,000. Each preferred share
is convertible to 40 shares of the Company's common stock at a conversion price
of $0.25 per share, representing 4,000,000 shares of common stock underlying the
preferred stock. The issued warrants entitle the holder to purchase 25 shares of
common stock for each share of Series J Convertible Preferred stock issued at an
exercise price of $0.40 per common stock share, representing 2,500,000 shares of
common stock underlying the warrants. The warrants are exercisable for a
five-year period. This private offering was made to Mid-Am, an accredited
investor, pursuant to Rule 506 of Regulation D and Section 4(2) of the
Securities Act of 1933. In accordance with EITF 00-27, the Company allocated
$145,721 to the warrants, $854,279 to preferred stock and recorded deemed
dividends of $305,721 arising from a beneficial conversion feature. The value of
the warrants was determined using the Black Scholes Option Pricing Model with
the following inputs: Expected Volatility of 34.11%, Risk Free Rate of Return of
4.24%, No Dividends and an Expected Life of 3.75 years.
During 2002, the Company issued a total of 5,081,830 shares of common stock upon
the conversion of 87,500 shares of Series D preferred stock.
During 2002, the Company issued a total of 2,320,224 shares of common stock upon
the conversion of 44,484 shares of Series F preferred stock.
During 2002, the Company issued a total of 1,550,680 shares of common stock upon
the conversion of 23,127 shares of Series G preferred stock.
In connection with the aforementioned conversion of preferred stock, a total of
$187,586 of accrued dividends payable was also converted into the Company's
common stock, of which $146,670 related to Series D and $40,916 related to
Series G.
On June 10, 2002, the Company issued 1,000,000 shares of common stock in
exchange for cash of $330,000 due to exercise of the options.
On October 17, 2002, the Company issued a total of 999,112 shares of common
stock at the market price of $0.28 per share in lieu of cash payment of $225,151
and recorded non-cash expense of $54,600.
2003
On January 2, 2003, the Company issued 100,000 shares of common stock to an
employee. This common stock will be registered under a Form S-8 registration
statement. In January 2003, the Company recorded $28,000 of compensation expense
based upon a signing bonus for this grant. In addition, the Company granted
options for 100,000 shares of common stock to the employee pursuant to an
employment contract. These options vested immediately, expire on December 30,
2007 and have an exercise price of $0.40 per share. The Company also granted
options for 200,000 shares of common stock at an exercise price of $0.40 per
share and vest as follows: options for 100,000 shares on each of December 31,
2003 and 2004, and 100,000 expire on each of December 30, 2008 and 2009,
respectively.
On February 4, 2003, the Company issued 30,000 shares of common stock to Keshet,
LP, upon the conversion of 480 shares of Series G Convertible Preferred stock,
at a conversion price of $0.196. The conversion included accrued and unpaid
dividends on the preferred converted.
F-31
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
On February 21, 2002, the Company issued 50,000 shares of non-voting Series J 8%
Convertible Preferred stock, having a stated value of $10.00 per Preferred J
share, and common stock warrants to Mid-Am Capital, L.L.C. ("Mid-Am") for the
aggregate purchase price of $500,000. Each preferred share is convertible to 40
shares of the Company's common stock at a per common share conversion price of
$0.25, representing 2,000,000 shares of common stock underlying the preferred.
The issued warrants entitle the holder to purchase 33.33 shares of common stock
for each share of Series J Convertible Preferred stock issued at an exercise
price of $0.30 per common stock share, representing 1,666,667 shares of common
stock underlying the warrants. The warrants are exercisable for a five-year
period. The February 21, 2003 closing market trading price was $0.23 per share.
This private offering was made to Mid-Am, an accredited investor, pursuant to
Rule 506 of Regulation D and Section 4(2) of the Securities Act of 1933. In
accordance with EITF 00-27, the Company recorded a deemed dividend of $274,720
related to a beneficial conversion feature.
On April 14, 2003, the Company issued 50,000 shares of common stock to Keshet,
LP, upon the conversion of 596 shares of Series G Convertible Preferred, at a
conversion price of $0.148. The conversion included accrued and unpaid dividends
on the preferred converted.
On April 22, 2003, the Company issued 50,000 shares of common stock to The
Keshet Fund, LP, upon the conversion of 595 shares of Series G Convertible
Preferred, at a conversion price of $0.148. The conversion included accrued and
unpaid dividends on the preferred converted.
On May 22, 2003, the Company issued 100,000 shares of common stock to Keshet,
LP, upon the conversion of 607 shares of Series G Convertible Preferred, at a
conversion price of $0.076. The conversion included accrued and unpaid dividends
on the preferred converted.
On May 22, 2003, the Company issued 100,000 shares of common stock to The Keshet
Fund, LP, upon the conversion of 607 shares of Series G Convertible Preferred,
at a conversion price of $0. 076. The conversion included accrued and unpaid
dividends on the preferred converted.
On May 29, 2003, the Company issued 50,000 shares of non-voting Series J 8%
Convertible Preferred stock, having a stated value of $10.00 per Preferred J
share, and common stock warrants to Mid-Am Capital, L.L.C. for the aggregate
purchase price of $500,000. Each preferred share is convertible to 50 shares of
the Company's common stock at a conversion price of $0.20, representing
2,500,000 shares of common stock underlying the preferred. The issued warrants
entitle the holder to purchase 40 shares of common stock for each share of
Series J Convertible Preferred stock issued at an exercise price of $0.25 per
common stock share, representing 2,000,000 shares of common stock underlying the
warrants. The warrants are exercisable for a five-year period. The May 22, 2003
closing market trading price was $0.12 per share. In addition, the following
adjustments were made to prior issued warrants for the purpose of facilitating
future fund raising by the Company arising out of the exercise of the warrants
by Holder. The purchase price, as defined in the Warrants No. 1 and 2, has been
reduced to $0.25, subject to further adjustment as described in the warrants.
The warrant stock provided for in Warrant No.1 has been increased by 1,500,000
shares. The warrant stock provided for in Warrant No. 2 has been increased by
333,333 shares. The expiration date, as defined in the respective warrants,
remains as stated. The trading price call option trigger set forth in Section 9
(b) of the warrants has been reduced from $1.75 to $0.75 per share. This private
offering was made to Mid-Am, an accredited investor, pursuant to Rule 506 of
Regulation D and Section 4(2) of the Securities Act of 1933. The value of the
warrants, $92,491, was determined using the Black-Scholes model.
On August 12, 2003, the Company issued 1,200,000 shares of common stock based
upon Series G notices of conversion received in June and July 2003. The issuance
of common stock was delayed in order to determine the accuracy of the conversion
variables contained in the respective notices of conversion, as follows:
The Company issued 200,000 shares of common stock to Keshet, LP, upon the
conversion of 1,209 shares of Series G Convertible Preferred, at a conversion
price of $0.076. The conversion included accrued and unpaid dividends on the
preferred converted.
F-32
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The Company issued 200,000 shares of common stock to The Keshet Fund, LP, upon
the conversion of 1,209 shares of Series G Convertible Preferred, at a
conversion price of $0.076. The conversion included accrued and unpaid dividends
on the preferred converted.
The Company issued 150,000 shares of common stock to The Keshet Fund, LP, upon
the conversion of 773 shares of Series G Convertible Preferred, at a conversion
price of $0.0653. The conversion included accrued and unpaid dividends on the
preferred converted.
The Company issued 250,000 shares of common stock to Keshet, LP, upon the
conversion of 1,289 shares of Series G Convertible Preferred, at a conversion
price of $0.0653. The conversion included accrued and unpaid dividends on the
preferred converted.
The Company issued 200,000 shares of common stock to Talbiya B. Investments,
Ltd., upon the conversion of 1,031 shares of Series G Convertible Preferred, at
a conversion price of $0.0653. The conversion included accrued and unpaid
dividends on the preferred converted.
The Company issued 200,000 shares of common stock to Nesher. Ltd., upon the
conversion of 1,031 shares of Series G Convertible Preferred, at a conversion
price of $0.0653. The conversion included accrued and unpaid dividends on the
preferred converted.
On September 15, 2003, the Company issued 213,750 shares of common stock to
Michael Willms, upon the conversion of 7,500 shares of Series H Convertible
Preferred, at the fixed conversion price of $0.40. The conversion included
accrued and unpaid dividends on the preferred converted.
On September 29, 2003, the Company issued 70,938 shares of common stock to The
Dennis H. Willms Irrevocable Trust, Michael Willms, Trustee, upon the conversion
of 2,500 shares of Series H Convertible Preferred, at the fixed conversion price
of $0.40. The conversion included accrued and unpaid dividends on the preferred
converted.
On November 21, 2003, the Company entered into a Subscription Agreement with
Gamma Opportunity Capital Partners, LP for the sale of a convertible note in the
amount of $200,000 and warrants to purchase 5,000,000 shares of common stock, at
$1.00 per share. The convertible note is convertible into shares of common stock
of the Company at the lesser of $0.05 or 75% of the average of the three lowest
closing bid prices for the thirty trading days prior to but not including the
conversion date. During the 180 days following the issuance of the convertible
note, the conversion price shall not be less than $.03 per share if no event of
default exists. This 180 day period shall be extended indefinitely if no event
of default exists, the closing trading price for any 15 day consecutive trading
period is $0.20 or higher, the daily trading volume for the 15 days is at least
300,000 and a registration statement registering the convertible note is
effective. In connection with this transaction, the Company issued 400,000
shares of its common stock and a warrant to purchase 2,000,000 shares of common
stock at $.05 per share.
F-33
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
On November 21, 2003, the Company also entered into a Subscription Agreement
with Mid-Am Capital, LLC for the sale of a convertible note in the amount of
$200,000 and warrants to purchase 5,000,000 shares of common stock, at $1.00 per
share. The convertible note is convertible into shares of common stock of the
Company at the lesser of $0.05 or 75% of the average of the three lowest closing
bid prices for the thirty trading days prior to but not including the conversion
date. During the 180 days following the issuance of the convertible note, the
conversion price shall not be less that $.03 per share if no event of default
exists. This 180 day period shall be extended indefinitely if no event of
default exists, the closing trading price for any 15 day consecutive trading
period is $0.20 or higher, the daily trading volume for the 15 days is at least
300,000 and a registration statement registering the convertible note is
effective.
NOTE 7 - STOCK WARRANTS AND OPTIONS
2002
In March 2002, the Company issued to a lender, warrants to purchase 25,000
shares of common stock with an exercise price of $0.40 per share. The warrants
are immediately exercisable and have an expiration date of February 28, 2007.
Based on a Black-Scholes option pricing model, the Company recorded interest
expense of $4,051. The value of the warrants was determined using the Black
Scholes Option Pricing Model with the following inputs: Expected Volatility of
44%, Risk Free Rate of Return of 4.24%, No Dividends and an Expected Life of
3.75 years.
In May 2002, the Company issued stock options to purchase 1,710,000 shares of
common stock, in the aggregate, as compensation to three consultants. These
options are exercisable for a one-year period. Of the 1,710,000 options,
1,150,000 options have an exercise price of $0.33 per share and 560,000 options
have an exercise price of $0.50 per share. Based on a Black-Scholes option
pricing model, the Company recorded a non-cash expense of $124,859. In June
2002, 1 million options with an exercise price of $0.33 per share were
exercised. The value of the warrants was determined using the Black Scholes
Option Pricing Model with the following inputs: Expected Volatility of 64%, Risk
Free Rate of Return of 4.24%, No Dividends and an Expected Life of 1 year.
In April 2002 the Company extended options for 1,383,705 shares of common stock
issued on April 29 and April 30, 1997 to Tamarind Management, Ltd. (an affiliate
of Mr. Paul Downes, a founder of the Company) and options for 700,000 shares of
common stock issued on April 1997 to Mr. Dale Reese (a founder of the Company).
These extended options are exercisable upon the following conditions: The option
expiration dates are extended for a two year period, commencing upon the
effective date of a registration statement for the resale of the common stock
underlying the options; the options will not be exercised during a one year
lockup period commencing on the 1st day after the Company's common stock trades
during a 90 day period at a moving average of at least $1.00; the Company can
call the options commencing on the 1st day after its common stock trades during
a 90 day period at a moving average of at least $2.00.
In June 2002, the Company agreed to extend the expiration dates of warrants,
aggregating 6,089,777 shares of common stock, issued in connection with the
Company's Series D and F preferred stock until June 2005 and to reduce the
exercise price of certain of those warrants to $1.00. In consideration for this
warrant modification, the holders of two promissory notes executed by the
Company aggregating $100,000, agreed to extend the maturity dates of the notes
to December 31, 2002. In addition, the holders of the Company's Series D and F
preferred stock agreed to waive all potential penalties associated with the
Series D and F preferred stock, including the abandonment of a certain SB-2
registration statement filed in connection with the resale of the common stock
underlying the Series D and F preferred stock. As a result of extending the life
and reducing the exercise prices of these warrants, the Company remeasured the
value of the warrants and recorded $391,345 as non-cash expense.
F-34
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In October 2002, the Company issued options to purchase 310,714 shares of common
stock to consultants and third party professional service providers pursuant to
written agreements with the Company. Of the options issued, 75,000 options have
an exercise price of $1.00 per share and the remaining 235,714 options have an
exercise price of $0.35 per share. The Company recorded stock compensation of
$36,753. The value of the warrants was determined using the Black Scholes Option
Pricing Model with the following inputs: Expected Volatility of 70%, Risk Free
Rate of Return of 3.8%, No Dividends and an Expected Life of 3.75 years.
2003
On January 2, 2003, the Company granted options for 100,000 shares of common
stock to an employee pursuant to an employment contract. These options vested
immediately, expire on December 30, 2007 and have an exercise price of $0.40 per
share. The Company also granted options for 200,000 shares of common stock at an
exercise price of $0.40 per share and vest as follows: options for 100,000
shares on each of December 31, 2003 and 2004, and 100,000 expire on each of
December 30, 2008 and 2009, respectively.
On February 21, 2003, the Company issued a warrant for 1,666,667 shares of
common stock to Mid-Am, in connection with the issuance of 50,000 shares of
non-voting Series J 8% Convertible Preferred stock, having a stated value of
$10.00 per Preferred J share, for the aggregate purchase price of $500,000. The
warrants have an exercise price of $0.30 per common stock share, and are
exercisable for a five-year period. The February 21, 2003 closing market trading
price was $0.23 per share. In accordance with EITF 00-27, the Company recorded a
deemed dividend of $274,720 related to a beneficial conversion feature.
On May 29, 2003, the Company issued a warrant for 2,000,000 shares of common
stock to Mid-Am, in connection with the issuance of 50,000 shares of non-voting
Series J 8% Convertible Preferred stock, having a stated value of $10.00 per
Preferred J share, for the aggregate purchase price of $500,000. The warrants
entitle the holder to purchase 40 shares of common stock for each share of
Series J Convertible Preferred stock issued at an exercise price of $0.25 per
common stock share, and are exercisable for a five-year period. The May 22, 2003
closing market trading price was $0.12 per share. In addition, the following
adjustments were made to prior issued warrants for the purpose of facilitating
future fund raising by the Company arising out of the exercise of the warrants
by Holder. The purchase price, as defined in the Warrants No. 1 (issued
September 2002) and 2 (issued February 2003), was reduced to $0.25, subject to
further adjustment as described in the warrants. The warrant stock provided for
in Warrant No.1 was increased by 1,500,000 shares. The warrant stock provided
for in Warrant No. 2 was increased by 333,333 shares. The expiration date, as
defined in the respective warrants, remains as stated. The trading price call
option trigger set forth in Section 9 (b) of all of the warrants has been
reduced from $1.75 to $0.75 per share. The value of the warrants, $92,491, was
determined using the Black-Scholes model.
On November 21, 2003, the Company issued two "A" warrants for the aggregate
amount of 2,000,000 shares of common stock, and two "B" warrants for the
aggregate amount of 10,000,000 shares of common stock to Mid-Am Capital, L.L.C.
and Gamma Opportunity Capital Partners, LP, in connection with the issuance of
two convertible notes in the aggregate face amount of $400,000. The "A" warrants
have an exercise price of $0.05 per share and the "B" warrants have an exercise
price of $1.00 per share. In connection with this transaction, the Company
issued a warrant to purchase 2,000,000 shares of common stock at $0.05 per
share, as a finder's fee. All warrants issued in connection with this
transaction are exercisable for five years.
F-35
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The assumptions used in the Black Scholes option pricing model in 2002 and 2003
were as follows:
December 31,
----------------------------------
2002 2003
-------------- --------------
Discount rate - bond yield rate 3.80 - 4.13% 2.35 - 4.9%
Volatility 34 - 70% 69 - 88%
Expected life 1 - 3.75 years 2.25 - 3.75 years
Expected dividend yield -- --
A summary of the status of the Company's stock options and warrants as of
December 31, 2002 and 2003 with changes during the years then ended are
presented below:
Weighted
Average
Exercise
Shares Price
----------- -----------
Total warrants and options outstanding at December 31, 2001 15,154,917 $ 0.74
Warrants and options granted 8,297,714 0.28
Warrants and options exercised (1,000,000) (0.33)
Warrants and options expired (1,294,828) (1.15)
----------- -----------
Total warrants and options outstanding at December 31, 2002 21,157,803 0.70
Warrants and options granted 18,668,337 0.13
Warrants and options exercised --
Warrants and options expired (214,777) (1.03)
----------- -----------
Total warrants and options outstanding at December 31, 2003 39,611,363 $ 0.28
=========== ===========
The following table summarizes information about stock options and warrants
outstanding at December 31, 2003:
Warrants/Options Outstanding Options/Warrants Exercisable
-------------------------------------- ----------------------------
Weighted
Average Weighted Weighted
Remaining Average Average
Number Contractual Exercise Number Exercise
Exercise Price Outstanding Life (Years) Price Exercisable Price
-------------- ----------- ------------ -------- -------------- ---------
$0 to $0.75 37,054,658 2.9 $ 0.23 37,054,658 $ 0.23
$0.75 to $2.00 2,523,705 1.3 1.04 2,523,705 1.04
$2.00 to $3.00 33,000 0.7 2.75 33,000 2.75
----------- ------------ -------- -------------- ---------
39,611,363 2.42 $ 0.29 39,611,363 $ 0.28
=========== ============ ======== ============== =========
F-36
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 8 - INCOME TAXES
The Company is subject to Federal income taxes. As the Company has experienced
operating losses for the years of 2002 and 2003, no income tax has been provided
for.
The Company has gross deferred tax assets of approximately $5.4 million and $6.8
million at December 31, 2002 and 2003, respectively, relating principally to tax
effects of net operating loss carryforwards. In assessing the recoverability of
deferred tax assets, management considers whether it is more likely than not
that the assets will be realized. The ultimate realization of deferred tax
assets is dependent upon the generation of future taxable income during the
periods in which those temporary differences become deductible. Management
considers projected future taxable income and tax planning strategies in making
this assessment. Based upon the level of historical taxable loss and projections
for future taxable income over the periods in which the deferred tax items are
recognizable for tax reporting purposes, it is more likely than not that the
Company will not realize the benefits of these differences at December 31, 2002
and 2003. As such, management has recorded a valuation allowance for the full
amount of deferred tax assets at December 31, 2002 and 2003.
At December 31, 2003, the Company has available net operating losses of
approximately $17.7 million for federal income tax purposes, to offset future
taxable income, if any, which will expire at various dates through the year 2022
for federal income tax purposes. The utilization of net operating losses,
however, may be subject to certain limitations as prescribed by Section 382 of
the Internal Revenue Code.
NOTE 9 - BUSINESS SEGMENT AND GEOGRAPHIC INFORMATION
The Company operates principally in one industry segment. The following sales
information was based on customer location rather than subsidiary location.
The allocation of the cost of equipment and the current year investment in new
equipment and depreciation expense have been made on the basis of the primary
purpose for which the equipment was acquired. The following furniture and
equipment information was based on where the furniture and equipment was used.
Geographic Area Information:
United Total
2003 States Canada Mexico China Company
----------- ----------- ----------- ----------- -----------
Revenue - unit sales $ 356,985 $ -- $ -- $ -- $ 356,985
Revenue - net kit sales 2,737 -- -- -- 2,737
Revenue - gross kit sales 629,999 43,745 145,362 21,314 840,420
----------- ----------- ----------- ----------- -----------
Total revenue 989,721 43,745 145,362 21,314 1,200,142
Cost of goods sold (127,647) (10,403) (45,247) (9,201) (192,498)
----------- ----------- ----------- ----------- -----------
Gross margin $ 862,074 $ 33,342 $ 100,115 $ 12,113 $ 1,007,644
----------- ----------- ----------- ----------- -----------
Furniture and equipment, net $ 62,407 $ -- $ -- $ 6,216 $ 68,623
=========== =========== =========== =========== ===========
F-37
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
United Total
2002 States Canada Mexico China Company
----------- ----------- ----------- ----------- -----------
Revenue -unit sales $ 232,595 $ -- $ -- $ -- $ 232,595
Revenue -net kit sales 433,118 -- -- -- 433,118
Revenue -gross kit sales 849,404 112,700 90,025 55,128 1,107,257
----------- ----------- ----------- ----------- -----------
Total revenue 1,515,117 112,700 90,025 55,128 1,772,970
Cost of goods sold (184,022) (23,511) (18,780) (53,042) (279,355)
----------- ----------- ----------- ----------- -----------
Gross margin $ 1,331,095 $ 89,189 $ 71,245 $ 2,086 $ 1,493,615
----------- ----------- ----------- ----------- -----------
Furniture and equipment, net $ 63,405 $ -- $ -- $ 26,197 $ 89,602
----------- ----------- ----------- ----------- -----------
NOTE 10 - COMMITMENTS AND CONTINGENCIES
COMMITMENTS
The Company leases office space at its corporate office in Florida under an
original operating lease expiring May 31, 2004. The Company has renewed the
operating lease for an additional five year period at a 25% reduction to the
cost of the original lease.
Future minimum rental payments required under the operating lease as of December
31, 2003 are as follows:
Years ending December 31, Amount
------------------------- -------
2004 Partial old rate (5 months) $53,307
2005 $37,275
2006 $37,275
2007 $37,275
2008 $37,275
2009 Partial year $15,531
Rental expense for the years ended December 31, 2002 and 2003 was $72,550 and
$75,270, respectively.
NOTE 11 - SUBSEQUENT EVENTS
On February 12, 2004, the Company held a special meeting of shareholders at
which the shareholders approved an increase of the Company's authorized common
stock from 50,000,000 shares to 300,000,000 shares.
On February 17, 2004, the Company converted 875 shares of Series G Convertible
Preferred Stock into 215,164 shares of common stock pursuant to a January 12,
2004 notice of conversion from Nesher, LP, at a conversion price of $0.0407. The
conversion included accrued and unpaid dividends on the converted preferred. The
Company and the holder delayed processing this notice in light of the Company's
special meeting of shareholders held February 12, 2004. The shares of common
stock issued pursuant to this conversion were retired and cancelled on March 5,
2004 and issued to third parties on that date in accordance with the
instructions of Nesher, LP. On February 17, 2004, the Company converted 1,400
shares of Series G Convertible Preferred Stock into 343,980 shares of common
stock pursuant to a January 12, 2004 notice of conversion from Talbiya
Investments, Ltd., at a conversion price of $0. 0407. The conversion included
accrued and unpaid dividends on the converted preferred. The Company and the
holder delayed processing this notice in light of the Company's special meeting
of shareholders held February 12, 2004. The shares of common stock issued
pursuant to this conversion were retired and cancelled on March 5, 2004 and
issued to third parties on that date in accordance with the instructions of
Talbiya Investments, Ltd.
F-38
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
On February 17, 2004, the Company converted 700 shares of Series G Convertible
Preferred Stock into 172,162 shares of common stock pursuant to a January 12,
2004 notice of conversion from The Keshet Fund, LP, at a conversion price of $0.
0407. The conversion included accrued and unpaid dividends on the converted
preferred. The Company and the holder delayed processing this notice in light of
the Company's special meeting of shareholders held February 12, 2004. The shares
of common stock issued pursuant to this conversion were retired and cancelled on
March 5, 2004 and issued to third parties on that date in accordance with the
instructions of The Keshet Fund, LP.
On February 17, 2004, the Company converted 2,025 shares of Series G Convertible
Preferred Stock into 497,951 shares of common stock pursuant to a January 12,
2004 notice of conversion from Keshet LP, at a conversion price of $0. 0407. The
conversion included accrued and unpaid dividends on the converted preferred. The
Company and the holder delayed processing this notice in light of the Company's
special meeting of shareholders held February 12, 2004. The shares of common
stock issued pursuant to this conversion were retired and cancelled on March 5,
2004 and issued to third parties on that date in accordance with the
instructions of Keshet, LP.
On March 1,2004, the Company issued 80,000 shares of non-voting Series K 8%
Convertible Preferred stock, to Mid-Am Capital, LLC, having a stated value of
$10.00 per Preferred K share, for the aggregate purchase price of $800,000. Each
preferred share is convertible to 100 shares of the Company's common stock at a
conversion price of $0.10, representing 8,000,000 shares of common stock
underlying the preferred. In addition, the following adjustments were made to
prior issued warrants for the purpose of facilitating future fund raising by the
Company arising out of the exercise of the warrants by Holder. The purchase
price, as defined in the Warrant No. 2003-B-002, has been reduced to $0.10,
subject to further adjustment as described in the warrant. The expiration date,
as defined in the warrant, remains as stated. This private offering was made to
Mid-Am, an accredited investor, pursuant to Rule 506 of Regulation D and Section
4(2) of the Securities Act of 1933.
On March 9, 2004, the Company converted 5,000 shares of Series F Convertible
Preferred Stock into 1,315,789 shares of common stock pursuant to a January 8,
2004 notice of conversion from Esquire Trade & Finance Inc., at a conversion
price of $0.038. The conversion did not include accrued and unpaid dividends on
the converted preferred. The Company and the holder delayed processing this
notice in light of the Company's special meeting of shareholders held February
12, 2004. The shares of common stock issued pursuant to this conversion were
issued to third parties on that date in accordance with the instructions of
Esquire Trade & Finance Inc.
On April 1 2004, the Company converted 5,000 shares of Series F Convertible
Preferred Stock into 1,315,789 shares of common stock pursuant to a January 8,
2004 notice of conversion from Austinvest Anstalt Balzers, at a conversion price
of $0.038. The conversion did not include accrued and unpaid dividends on the
converted preferred. The Company and the holder delayed processing this notice
in light of the Company's special meeting of shareholders held February 12,
2004. The shares of common stock issued pursuant to this conversion were issued
to third parties on that date in accordance with the instructions of Austinvest
Anstalt Balzers.
F-39
BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
On April 2, 2004, the Company and Mid-Am Capital, LLC entered into Supplement
No.1 to the Series K Convertible Preferred Subscription Agreement, by which the
Company sold an additional 15,000 shares of its Series K Convertible Preferred
Stock utilizing the proceeds from a certain promissory note issued by the
Company to Mid-Am in the face amount of $150,000. With the consummation of this
sale, the $150,000 promissory note was deemed paid in full by the Company
F-40
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
ITEM 24. INDEMNIFICATION OF DIRECTORS AND OFFICERS.
Our Articles of Incorporation, as amended, provide to the fullest extent
permitted by Delaware law, our directors or officers shall not be personally
liable to us or our shareholders for damages for breach of such director's or
officer's fiduciary duty. The effect of this provision of our Articles of
Incorporation, as amended, is to eliminate our right and our shareholders
(through shareholders' derivative suits on behalf of our company) to recover
damages against a director or officer for breach of the fiduciary duty of care
as a director or officer (including breaches resulting from negligent or grossly
negligent behavior), except under certain situations defined by statute. We
believe that the indemnification provisions in its Articles of Incorporation, as
amended, are necessary to attract and retain qualified persons as directors and
officers.
Insofar as indemnification for liabilities arising under the Securities
Act of 1933 may be permitted to directors, officers and controlling persons of
the registrant pursuant to the foregoing provisions, or otherwise, the
registrant has been advised that in the opinion of the Securities and Exchange
Commission such indemnification is against public policy as expressed in the
Securities Act and is, therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment by the
registrant of expenses incurred or paid by a director, officer or controlling
person of the registrant in the successful defense of any action, suit or
proceeding) is asserted by such director, officer or controlling person in
connection with the securities being registered, the registrant will, unless in
the opinion of its counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the Securities
Act and will be governed by the final adjudication of such issue.
ITEM 25. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION.
The following table sets forth an itemization of all estimated expenses,
all of which we will pay, in connection with the issuance and distribution of
the securities being registered:
NATURE OF EXPENSE AMOUNT
SEC Registration fee $ 3,726.60
Accounting fees and expenses 10,000.00*
Legal fees and expenses 35,000.00*
Miscellaneous 5,000.00
-----------
TOTAL $53,726.60*
===========
* Estimated.
1
ITEM 26. RECENT SALES OF UNREGISTERED SECURITIES.
On January 2, 2001, an employment agreement with a new President and Chief
Operating Officer became effective pursuant to which the Company granted 100,000
shares of its common stock and options to purchase an additional 400,000 shares
of common stock at a per share price of $0.75.
On March 6, 2001, a sophisticated and accredited investor deposited $250,000
with the Company as consideration for 25,000 shares of Series H convertible
preferred stock to be issued. Through the period ended June 30, 2001 the Company
received an additional $550,000. The Series H convertible preferred stock is
priced at $10.00 per unit. The Series H convertible preferred stock has a stated
value of $10.00 per share and a conversion feature of $0.50 per share. The
Series H convertible preferred stock will be issued pursuant to an exemption to
registration provided by Regulation D, Rule 506 and Section 4(2) of the 1933
Act. The gross proceeds of $800,000 were part of a total offering of Series H
convertible preferred stock having aggregate gross proceeds of $1,280,000. As of
June 30, 2001 the Series H Preferred Stock had not been issued to the investor.
On August 1, 2001, the Company issued 228,000 shares of common stock to
Austinvest Anstalt Balzers, upon the conversion of 4,000 shares of Series D
Convertible Preferred, at a conversion price of $0.20. The conversion included
accrued and unpaid dividends on the preferred converted. The preferred and the
underlying common were issued under Rule 506 of Regulation D and Section 4(2) of
the Securities Act of 1933. The Company relied upon the accredited status of the
purchasers, the information contained in completed subscriber questionnaires
concerning the business and investing history and experience of each purchaser
and their representations to the company as to investment intent.
On August 14, 2001, the Company granted to an employee, 232,000 options to
purchase common stock of the Company at the price of $0.35 per share. These
options are for five years and are exercisable immediately. These options were
issued as compensation for services rendered in the development of the business
of Company's U.S. subsidiary.
On August 14, 2001, the Company granted to 4 employees, a total of 110,000
options to purchase common stock of the Company at the market price on that date
($0.36 per share). These options are for five years and are exercisable
immediately. These options were issued as incentive options for future services.
On August 14, 2001, the Company voted to issue to the Board of Directors 25,000
options each, for a total of 250,000 options, to purchase common stock of the
Company at the exercise price of $0.60 per share. These options are for five
years and are exercisable immediately. These options were issued as incentive
options for future services.
On September 30, 2001, 4000 Series D Convertible Preferred Shares and 3,265
Series G Convertible Preferred Shares were converted to 383,137 shares of Common
Stock. These shares were issued to two accredited and sophisticated investors
pursuant to an exemption from registration provided by Regulation D, Rule 506
and Section 4(2) of the Securities Act of 1933.
On October 30, 2001, the Company issued 25,000 shares of common stock to The
Keshet Fund LP, upon the conversion of 665 shares of Series G Convertible
Preferred, at a conversion price of $0.2907. The conversion included accrued and
unpaid dividends on the preferred converted. The preferred and the underlying
common were issued under Rule 506 of Regulation D and Section 4(2) of the
Securities Act of 1933. The Company relied upon the accredited status of the
purchasers, the information contained in completed subscriber questionnaires
concerning the business and investing history and experience of each purchaser
and their representations to the company as to investment intent.
On October 30, 2001, the Company issued 107,347 shares of common stock to
Austinvest Anstalt Balzers, upon the conversion of 3,000 shares of Series D
Convertible Preferred, at a conversion price of $0.3226. The conversion included
accrued and unpaid dividends on the preferred converted. The preferred and the
underlying common were issued under Rule 506 of Regulation D and Section 4(2) of
the Securities Act of 1933. The Company relied upon the accredited status of the
purchasers, the information contained in completed subscriber questionnaires
concerning the business and investing history and experience of each purchaser
and their representations to the company as to investment intent.
2
On October 30, 2001, the Company issued 55,139 shares of common stock to AMRO
International, S.A., upon the conversion of 1,500 shares of Series D Convertible
Preferred, at a conversion price of $0.3146. The conversion included accrued and
unpaid dividends on the preferred converted. The preferred and the underlying
common were issued under Rule 506 of Regulation D and Section 4(2) of the
Securities Act of 1933. The Company relied upon the accredited status of the
purchasers, the information contained in completed subscriber questionnaires
concerning the business and investing history and experience of each purchaser
and their representations to the company as to investment intent.
On October 30, 2001, the Company issued 107,347 shares of common stock to
Esquire Trade & Finance, Inc., upon the conversion of 3,000 shares of Series D
Convertible Preferred, at a conversion price of $0.3226. The conversion included
accrued and unpaid dividends on the preferred converted. The preferred and the
underlying common were issued under Rule 506 of Regulation D and Section 4(2) of
the Securities Act of 1933. The Company relied upon the accredited status of the
purchasers, the information contained in completed subscriber questionnaires
concerning the business and investing history and experience of each purchaser
and their representations to the company as to investment intent.
On November 16, 2001, the Company issued 20,000 shares of common stock to Keshet
LP, upon the conversion of 547 shares of Series G Convertible Preferred, at a
conversion price of $0.2987. The conversion included accrued and unpaid
dividends on the preferred converted. The preferred and the underlying common
were issued under Rule 506 of Regulation D and Section 4(2) of the Securities
Act of 1933. The Company relied upon the accredited status of the purchasers,
the information contained in completed subscriber questionnaires concerning the
business and investing history and experience of each purchaser and their
representations to the company as to investment intent.
On November 16, 2001, the Company issued 45,898 shares of common stock to The
Keshet Fund LP, upon the conversion of 1,175 shares of Series G Convertible
Preferred, at a conversion price of $0.2806. The conversion included accrued and
unpaid dividends on the preferred converted. The preferred and the underlying
common were issued under Rule 506 of Regulation D and Section 4(2) of the
Securities Act of 1933. The Company relied upon the accredited status of the
purchasers, the information contained in completed subscriber questionnaires
concerning the business and investing history and experience of each purchaser
and their representations to the company as to investment intent.
On November 20, 2001, the Company issued 10,000 shares of common stock to The
Keshet Fund LP, upon the conversion of 255 shares of Series G Convertible
Preferred, at a conversion price of $0.2800. The conversion included accrued and
unpaid dividends on the preferred converted. The preferred and the underlying
common were issued under Rule 506 of Regulation D and Section 4(2) of the
Securities Act of 1933. The Company relied upon the accredited status of the
purchasers, the information contained in completed subscriber questionnaires
concerning the business and investing history and experience of each purchaser
and their representations to the company as to investment intent.
On November 27, 2001, the Company issued 10,000 shares of common stock to The
Keshet Fund LP, upon the conversion of 255 shares of Series G Convertible
Preferred, at a conversion price of $0.2800. The conversion included accrued and
unpaid dividends on the preferred converted. The preferred and the underlying
common were issued under Rule 506 of Regulation D and Section 4(2) of the
Securities Act of 1933. The Company relied upon the accredited status of the
purchasers, the information contained in completed subscriber questionnaires
concerning the business and investing history and experience of each purchaser
and their representations to the company as to investment intent.
On November 29, 2001, the Company issued 10,000 shares of common stock to The
Keshet Fund LP, upon the conversion of 249 shares of Series G Convertible
Preferred, at a conversion price of $0.2740. The conversion included accrued and
unpaid dividends on the preferred converted. The preferred and the underlying
common were issued under Rule 506 of Regulation D and Section 4(2) of the
Securities Act of 1933. The Company relied upon the accredited status of the
purchasers, the information contained in completed subscriber questionnaires
concerning the business and investing history and experience of each purchaser
and their representations to the company as to investment intent.
3
On December 5, 2001, the Company issued 126,863 shares of common stock to
Austinvest Anstalt Balzers, upon the conversion of 3,000 shares of Series D
Convertible Preferred, at a conversion price of $0.2747. The conversion included
accrued and unpaid dividends on the preferred converted. The preferred and the
underlying common were issued under Rule 506 of Regulation D and Section 4(2) of
the Securities Act of 1933. The Company relied upon the accredited status of the
purchasers, the information contained in completed subscriber questionnaires
concerning the business and investing history and experience of each purchaser
and their representations to the company as to investment intent.
On December 5, 2001, the Company issued 126,863 shares of common stock to
Esquire Trade & Finance, Inc., upon the conversion of 3,000 shares of Series D
Convertible Preferred, at a conversion price of $0.2747. The conversion included
accrued and unpaid dividends on the preferred converted. The preferred and the
underlying common were issued under Rule 506 of Regulation D and Section 4(2) of
the Securities Act of 1933. The Company relied upon the accredited status of the
purchasers, the information contained in completed subscriber questionnaires
concerning the business and investing history and experience of each purchaser
and their representations to the company as to investment intent.
On December 5, 2001, the Company issued 105,500 shares of its Series H
convertible preferred stock and warrants for 2,637,500 shares at $0.50 per share
to five sophisticated and accredited investors. The Series H convertible
preferred stock and warrants were priced at $10.00 per unit, and resulted in
proceeds of $1,055,000 in cash, with legal and issuance expenses of $5,000. The
Series H preferred and the common stock underlying the preferred and the
warrants were issued under Rule 506 of Regulation D and Section 4(2) of the
Securities Act of 1933. The Company relied upon the accredited status of the
purchasers, the information contained in completed subscriber questionnaires
concerning the business and investing history and experience of each purchaser
and their representations to the company as to their individual investment
intent. All of the purchasers are known to a director of the Company, who is the
primary investor in the Series H offering. The Company's directors have approved
a total Series H offering in the amount of $2,350,000, representing 235,000
shares of the Series H preferred. Each share of Series H convertible preferred
stock (1) has a stated value of $10.00 per share; (2) accrues dividends at 7%
simple interest per annum, payable in cash or, at the option of the holder,
added to the stated value of the preferred for conversion computation purposes;
(3) has no voting rights; (4) has a conversion price of $0.40 per share of
common stock, subject to a contractually limited maximum conversion into no
greater than 9.99% of the Company's issued and outstanding common stock at
conversion; (5) is redeemable at the option of the Company after two years from
issuance at 135% of the stated value, plus accrued dividends; and (6) has a
mandatory conversion feature exercisable by the Company five years from issue at
the stated conversion price, subject to a minimum daily trading volume of
100,000 shares during a lookback period and closing bid prices not less that
300% of the conversion price. Each Series H unit consists of one share of Series
H convertible preferred stock plus warrants for 25 shares of common stock having
an exercise price of $0.50 per share and an expiration date of December 4, 2006.
On December 11, 2001, the Company issued 10,000 shares of common stock to The
Keshet Fund LP, upon the conversion of 254 shares of Series G Convertible
Preferred, at a conversion price of $0.2704. The conversion included accrued and
unpaid dividends on the preferred converted. The preferred and the underlying
common were issued under Rule 506 of Regulation D and Section 4(2) of the
Securities Act of 1933. The Company relied upon the accredited status of the
purchasers, the information contained in completed subscriber questionnaires
concerning the business and investing history and experience of each purchaser
and their representations to the company as to investment intent.
On January 2, 2002, we issued options for 3,714 shares of common stock having an
exercise price of $0.35 and exercisable for five years, pursuant to an
employment agreement.
On January 18, 2002, we issued 238,334 shares of common stock to Austinvest
Anstalt Balzers, upon the conversion of 5,000 shares of Series D Convertible
Preferred, at a conversion price of $0.2453. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $8,463.34.
On January 18, 2002, we issued 238,334 shares of common stock to Esquire Trade &
Finance, Inc., upon the conversion of 5,000 shares of Series D Convertible
Preferred, at a conversion price of $0.2453. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $8,463.34.
4
On January 28, 2002, we issued 40,000 shares of common stock to The Keshet Fund
LP, upon the conversion of 883 shares of Series G Convertible Preferred, at a
conversion price of $0.2453. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $984.83.
On January 28, 2002, we issued 136,038 shares of common stock to Amro
International, S.A., upon the conversion of 2,840 shares of Series D Convertible
Preferred, at a conversion price of $0.2453. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $4,970.00.
On January 30, 2002, we issued 15,000 shares of its Series H convertible
preferred stock, having a conversion price of $0.40 per share of common stock,
and warrants for 375,000 shares at $0.50 per share. The Series H convertible
preferred stock and warrants were priced at $10.00 per unit, and resulted in
proceeds of $150,000 in cash.
On February 4, 2002, we issued 206,700 shares of common stock to Austinvest
Anstalt Balzers, upon the conversion of 4,375 shares of Series D Convertible
Preferred, at a conversion price of $0.2480. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $7,511.60.
On February 4, 2002, we issued 206,700 shares of common stock to Esquire Trade &
Finance, Inc., upon the conversion of 4,375 shares of Series D Convertible
Preferred, at a conversion price of $0.2480. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $7,511.60.
On February 5, 2002, we issued 20,000 shares of common stock to The Keshet Fund
LP, upon the conversion of 492 shares of Series G Convertible Preferred, at a
conversion price of $0.2453. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $496.03.
On February 15, 2002, we issued 5,000 shares of its Series H convertible
preferred stock, having a conversion price of $0.40 per share of common stock,
and warrants for 125,000 shares at $0.50 per share to a sophisticated and
accredited investor. The Series H convertible preferred stock and warrants were
priced at $10.00 per unit, and resulted in proceeds of $50,000 in cash.
On February 20, 2002, we issued 35,000 shares of common stock to The Keshet Fund
LP, upon the conversion of 832 shares of Series G Convertible Preferred, at a
conversion price of $0.2949. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $952.05.
On February 29, 2002, we issued 279,795 shares of common stock to Amro
International, S.A, upon the conversion of 7,160 shares of Series D Convertible
Preferred, at a conversion price of $0.3013. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $12,711.00.
On March 1, 2002, we issued 20,000 shares of common stock to The Keshet Fund LP,
upon the conversion of 536 shares of Series G Convertible Preferred, at a
conversion price of $0.2993. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $630.20.
On March 1, 2002, we issued warrants for 25,000 shares of common stock, having
an exercise price of $0.40 per share. The warrants are immediately exercisable
and have an expiration date of February 28, 2007. These warrants were issued to
the lender in connection with a December 27, 2001 loan of $250,000 to us.
On March 15, 2002, we issued 20,000 shares of common stock to The Keshet Fund
LP, upon the conversion of 532 shares of Series G Convertible Preferred, at a
conversion price of $0.2973. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $633.70.
On March 18, 2002, we issued 50,000 shares of its Series H convertible preferred
stock, having a conversion price of $0.40 per share of common stock, and
warrants for 1,250,000 shares at $0.50 per share to a sophisticated and
accredited investor. The Series H convertible preferred stock and warrants were
priced at $10.00 per unit, and resulted in proceeds of $500,000 in cash.
5
On April 19, 2002, we issued 10,000 shares of common stock to The Keshet Fund
LP, upon the conversion of 252 shares of Series G Convertible Preferred, at a
conversion price of $0.2840. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $320.80.
On April 19, 2002, we issued 10,000 shares of common stock to The Keshet Fund
LP, upon the conversion of 234 shares of Series G Convertible Preferred, at a
conversion price of $0.2640. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $299.40.
On April 24, 2002 our Board of Directors voted to extend options for 1,383,705
shares of common stock issued on April 29 and December 15, 1997 to Tamarind
Management, Ltd. (an affiliate of Mr. Paul Downes, a founder of the Company) and
options for 700,000 shares of common stock issued on December 15, 1997 to Mr.
Dale Reese (a founder of the Company), for services rendered to us. These
extended options, which had original expiration dates of April 29 and December
15, 2002, respectively, retain an exercise price of $1.00 and are exercisable
upon the following conditions: The expiration dates for these options are
extended for a two year period, commencing upon the effective date of a
registration statement for the resale of the common stock underlying the
options; the options will not be exercised during a one year lockup period
commencing on the 1st day after our common stock trades during a 90 day period
at a moving average of at least $1.00; we have the option to call the options
commencing on the 1st day after our common stock trades during a 90 day period
at a moving average of at least $2.00.
On May 3, 2002, we issued 52,730 shares of common stock to Amro International,
S.A, upon the conversion of 1,000 shares of Series D Convertible Preferred, at a
conversion price of $0.22. The conversion included accrued and unpaid dividends
on the preferred converted in the amount of $1,811.51.
On May 7, 2002, we issued 10,000 shares of common stock to The Keshet Fund LP,
upon the conversion of 215 shares of Series G Convertible Preferred, at a
conversion price of $0.2427. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $277.44.
On May 13, 2002, we issued 10,000 shares of common stock to The Keshet Fund LP,
upon the conversion of 158 shares of Series G Convertible Preferred, at a
conversion price of $0.1787. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $207.77.
On May 13, 2002, we issued 10,000 shares of common stock to The Keshet Fund LP,
upon the conversion of 158 shares of Series G Convertible Preferred, at a
conversion price of $0.1787. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $207.77.
On May 13, 2002, we issued 20,000 shares of common stock to Keshet LP, upon the
conversion of 316 shares of Series G Convertible Preferred, at a conversion
price of $0.1787. The conversion included accrued and unpaid dividends on the
preferred converted in the amount of $416.07.
On May 13, 2002, we issued 15,000 shares of common stock to Keshet LP, upon the
conversion of 237 shares of Series G Convertible Preferred, at a conversion
price of $0.1787. The conversion included accrued and unpaid dividends on the
preferred converted in the amount of $312.45.
On May 17, 2002, we issued 131,239 shares of common stock to Amro International,
S.A, upon the conversion of 2,000 shares of Series D Convertible Preferred, at a
conversion price of $0.18. The conversion included accrued and unpaid dividends
on the preferred converted in the amount of $3,623.00.
On May 17, 2002, we issued 278,498 shares of common stock to Amro International,
S.A, upon the conversion of 4,000 shares of Series D Convertible Preferred, at a
conversion price of $0.17. The conversion included accrued and unpaid dividends
on the preferred converted in the amount of $7,344.00.
6
On May 20, 2002, we issued 10,000 shares of common stock to Keshet LP, upon the
conversion of 158 shares of Series G Convertible Preferred, at a conversion
price of $0.1787. The conversion included accrued and unpaid dividends on the
preferred converted in the amount of $209.37.
On May 20, 2002, we issued 10,000 shares of common stock to Keshet LP, upon the
conversion of 131 shares of Series G Convertible Preferred, at a conversion
price of $0.1680. The conversion included accrued and unpaid dividends on the
preferred converted in the amount of $372.82.
On May 23, 2002, we issued 63,454 shares of common stock to Austinvest Anstalt
Balzers, upon the conversion of 1,000 shares of Series D Convertible Preferred,
at a conversion price of $0.1787. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $7,494.00.
On May 23, 2002, we issued 63,454 shares of common stock to Esquire Trade &
Finance, Inc., upon the conversion of 1,000 shares of Series D Convertible
Preferred, at a conversion price of $0.1787. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $7,494.00.
On May 24, 2002, we issued 15,000 shares of common stock to Keshet LP, upon the
conversion of 237 shares of Series G Convertible Preferred, at a conversion
price of $0.1787. The conversion included accrued and unpaid dividends on the
preferred converted in the amount of $312.85.
On May 24, 2002, we issued 15,000 shares of common stock to The Keshet Fund LP,
upon the conversion of 157 shares of Series G Convertible Preferred, at a
conversion price of $0.1680. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $449.88.
On May 29, 2002, we issued 652,178 shares of common stock to Amro International,
S.A, upon the conversion of 9,642 shares of Series D Convertible Preferred, at a
conversion price of $0.168. The conversion included accrued and unpaid dividends
on the preferred converted in the amount of $13,146.
On May 29, 2002, we issued 652,178 shares of common stock to Esquire Trade &
Finance, Inc., upon the conversion of 9,642 shares of Series D Convertible
Preferred, at a conversion price of $0.168. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $13,146.
On May 30, 2002, we issued 652,178 shares of common stock to Austinvest Anstalt
Balzers, upon the conversion of 9,642 shares of Series D Convertible Preferred,
at a conversion price of $0.168. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $13,146.
On June 13, 2002, we issued 10,000 shares of common stock to The Keshet Fund LP,
upon the conversion of 126 shares of Series G Convertible Preferred, at a
conversion price of $0.1627. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $366.70.
On June 13, 2002, we issued 10,000 shares of common stock to The Keshet Fund LP,
upon the conversion of 130 shares of Series G Convertible Preferred, at a
conversion price of $0.1680. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $381.12.
On June 17, 2002, we received sufficient consents to file an amended certificate
of incorporation, which increased our authorized common stock from 20,000,000 to
50,000,000 shares.
On June 17, 2002, we issued 30,000 shares of its Series I 8% convertible
preferred stock and warrants for 2,000,000 shares at $0.50 per share,
exercisable within three years from issue, to two sophisticated and accredited
investors, pursuant to Rule 506, Regulation D and Section 4(2) of the Securities
Act of 1933. The conversion of the preferred into common stock shall be at a per
common share conversion price of 75% of the average of the three lowest closing
bid prices for the thirty day period immediately preceding conversion. The
conversion price is subject to a maximum of $0.50 per share and a minimum of
$0.30 per share, which minimum conversion price shall govern for the 270 days
immediately following the issue date of the Series I preferred shares. The
minimum conversion price shall be extended indefinitely upon the occurrence of
certain defined events, including the effectiveness of a registration statement
for the resale of the common stock underlying the preferred and a trading price
of our common stock at $0.50 or higher for fifteen consecutive days. We have the
ability to compel the exercise of the warrants in tranches of not more than
500,000 warrants each, if the trading price of our common stock equals or
exceeds $1.00 for thirty consecutive trading days and a registration statement
for the underlying common is effective. The Series I convertible preferred stock
and warrants were priced at $10.00 per unit, and resulted in gross cash proceeds
of $300,000, less expenses of $12,000.
7
On June 18, 2002, we agreed to extend the expiration dates of warrants issued in
connection with our Series D and F preferred until June 17, 2005 and to reduce
the exercise price of certain of those warrants to $1.00. In consideration for
this warrant modification, the holders of two promissory notes executed by us
aggregating $100,000, dated November 6 and 7, 2001, respectively, agreed to
extend the maturity dates of the notes to December 31, 2002. In addition, the
holders of our Series D and F preferred stock agreed to waive all potential
penalties associated with the Series D and F preferred, including the
abandonment of a certain SB-2 registration statement filed in connection with
the resale of the common stock underlying the Series D and F preferred. Below is
a table containing the warrant modifications.
WARRANT COMMON UNMODIFIED
ISSUE SHARES UPON PURCHASE
WARRANTHOLDER (Series) DATE EXERCISE PRICE
---------------------- -------- ------- ----------- ----------
Austinvest Anstalt Balzers (D) 3-9-99 16,250 $2.96
Austinvest Anstalt Balzers (D) 4-23-99 8,125 $2.96
Austinvest Anstalt Balzers (D) 2-1-00 422,500 $0.625*
Austinvest Anstalt Balzers (F) 4-7-00 1,000,000 $1.00
Austinvest Anstalt Balzers (F) 10-13-00 38,259 $0.9825*
Esquire Trade & Finance, Inc. (D) 3-9-99 16,250 $2.96
Esquire Trade & Finance, Inc. (D) 4-23-99 8,125 $2.96
Esquire Trade & Finance, Inc. (D) 2-1-00 422,500 $0.625*
Esquire Trade & Finance, Inc. (F) 4-7-00 1,000,000 $1.00
Esquire Trade & Finance, Inc. (F) 10-13-00 38,259 $0.9625*
Libra Finance, S.A . (F) 4-7-00 1,600,000 $0.84*
Amro International, S.A. (D) 2-1-00 455,000 $0.625*
Amro International, S.A. (F) 4-7-00 1,000,000 $1.00
Amro International, S.A. (F) 10-13-00 38,259 $0.9625*
Amro International, S.A. (D) 3-9-99 17,500 $2.96
Amro International, S.A. (D) 4-23-99 8,750 $2.96
* Exercise price not adjusted
On June 19, 2002, we issued 33,333 shares of restricted common stock to
Tradersbloom Limited, as a finder fee in connection with the issuance of our
Series I preferred stock. Tradersbloom Limited is a sophisticated and accredited
investor.
On June 19, 2002, we issued 66,667 shares of restricted common stock to Libra
Finance, S.A., as a finder fee in connection with the issuance of our Series I
preferred stock. Libra Finance, S.A. is a sophisticated and accredited investor.
On June 21, 2002, we issued 10,000 shares of common stock to The Keshet Fund LP,
upon the conversion of 135 shares of Series G Convertible Preferred, at a
conversion price of $0.1760. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $402.29.
On July 1, 2002, the Company issued 500,000 shares of common stock to Esquire
Trade & Finance, Inc., upon the conversion of 8,250 shares of Series D
Convertible Preferred, at a conversion price of $0.165. The conversion did not
include accrued and unpaid dividends on the preferred converted.
On July 1, 2002, the Company issued 500,000 shares of common stock to Austinvest
Anstalt Balzers, upon the conversion of 8,250 shares of Series D Convertible
Preferred, at a conversion price of $0.165. The conversion did not include
accrued and unpaid dividends on the preferred converted.
8
On July 23, 2002, the Company issued 475,000 shares of common stock to The
Keshet Fund LP, upon the conversion of 6,172 shares of Series G Convertible
Preferred, at a conversion price of $0.1680. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $18,083.72.
On July 23, 2002, the Company issued 475,000 shares of common stock to Keshet
LP, upon the conversion of 6,172 shares of Series G Convertible Preferred, at a
conversion price of $0.1680. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $18,083.72.
On September 26, 2002, the Company issued 154,171 shares of common stock to Amro
International, SA, upon the conversion of 2,500 shares of Series D Convertible
Preferred, at a conversion price of $0.187. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $3,830.
On September 26, 2002, the Company issued 396,053 shares of common stock to Amro
International, SA, upon the conversion of 7,108 shares of Series D Convertible
Preferred, at a conversion price of $0.208. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $11,299.
On September 30, 2002, the Company issued 100,000 shares of non-voting Series J
Convertible Preferred stock, having a stated value of $10.00 per Preferred J
share, and common stock warrants to Mid-Am Capital, L.L.C. ("Mid-Am") for the
aggregate purchase price of $1,000,000. Each preferred share is convertible to
40 shares of the Company's common stock of at a per common share conversion
price of $0.25, representing 4,000,000 shares of common stock underlying the
preferred. The issued warrants entitle the holder to purchase 25 shares of
common stock for each share of Series J Convertible Preferred stock issued at an
exercise price of $0.40 per common stock share, representing 2,500,000 shares of
common stock underlying the warrants. The warrants are exercisable for a
five-year period . The blended per share price for the common stock underlying
the preferred and the warrants is $0.307; the September 30, 2002 closing market
trading price was $0.29 per share. This private offering was made to Mid-Am, an
accredited investor, pursuant to Rule 506 of Regulation D and Section 4(2) of
the Securities Act of 1933.
The common stock issued by the Company in the fourth quarter 2002 resulted from
conversions by the holders of Series F and G convertible preferred stock. The
common stock and the preferred converted were issued to sophisticated and
accredited investors, who had appropriate access to information concerning the
Company's operations and financial condition in a rule 506 private offering.
Holders of the Series F and G preferred can convert such equity into common
shares at 75% of the average of the three lowest bid trading prices of the
Company's common shares measured during a 20 day lookback period.
On November 8, 2002, the Company issued 160,112 shares of common stock to
Austinvest Anstalt Balzers, upon the conversion of 2,642 shares of Series F
Convertible Preferred, at a conversion price of $0.165. The Series F preferred
does not include dividends.
On November 8, 2002, the Company issued 160,112 shares of common stock to
Esquire Trade & Finance, Inc., upon the conversion of 2,642 shares of Series F
Convertible Preferred, at a conversion price of $0.165. The Series F preferred
does not include dividends.
On November 18, 2002, the Company issued 26,000 shares of common stock to
Nesher, Ltd., upon the conversion of 377 shares of Series G Convertible
Preferred, at a conversion price of $0.1963. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $1,333.92.
On November 18, 2002, the Company issued 11,240 shares of common stock to
Talbiya B. Investments, Ltd., upon the conversion of 163 shares of Series G
Convertible Preferred, at a conversion price of $0.1963. The conversion included
accrued and unpaid dividends on the preferred converted in the amount of
$577.16.
9
On November 18, 2002, the Company issued 10,000 shares of common stock to
Nesher, Ltd., upon the conversion of 145 shares of Series G Convertible
Preferred, at a conversion price of $0.1963. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $515.68.
On November 18, 2002, the Company issued 6,000 shares of common stock to Talbiya
B. Investments, Ltd., upon the conversion of 87 shares of Series G Convertible
Preferred, at a conversion price of $0.1963. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $309.67.
On November 18, 2002, the Company issued 8,000 shares of common stock to The
Keshet Fund LP, upon the conversion of 116 shares of Series G Convertible
Preferred, at a conversion price of $0.1963. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $413.25.
On November 18, 2002, the Company issued 14,440 shares of common stock to
Keshet, LP, upon the conversion of 208 shares of Series G Convertible Preferred,
at a conversion price of $0.1960. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $747.92.
On November 18, 2002, the Company issued 6,000 shares of common stock to Keshet,
LP, upon the conversion of 93 shares of Series G Convertible Preferred, at a
conversion price of $0.2093. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $332.70.
On November 20, 2002, the Company issued 2,000,000 shares of common stock to
Amro International, SA, upon the conversion of 39,200 shares of Series F
Convertible Preferred, at a conversion price of $0.1960. The Series F preferred
does not include dividends.
On November 27, 2002, the Company issued 16,000 shares of common stock to
Keshet, LP, upon the conversion of 257 shares of Series G Convertible Preferred,
at a conversion price of $0.2093. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $931.69.
On November 27, 2002, the Company issued 15,000 shares of common stock to
Keshet, LP, upon the conversion of 273 shares of Series G Convertible Preferred,
at a conversion price of $0.2480. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $994.59.
On December 24, 2002, the Company issued 8,000 shares of common stock to The
Keshet Fund LP, upon the conversion of 144 shares of Series G Convertible
Preferred, at a conversion price of $0.2467. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $534.17.
On December 24, 2002, the Company issued 45,000 shares of common stock to
Nesher, LP, upon the conversion of 750 shares of Series G Convertible Preferred,
at a conversion price of $0.2293. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $2,815.26.
On December 24, 2002, the Company issued 90,000 shares of common stock to
Keshet, LP, upon the conversion of 1,501 shares of Series G Convertible
Preferred, at a conversion price of $0.2293. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $5,630.52.
On December 24, 2002, the Company issued 45,000 shares of common stock to
Talbiya B. Investments, Ltd, upon the conversion of 750 shares of Series G
Convertible Preferred, at a conversion price of $0.2293. The conversion included
accrued and unpaid dividends on the preferred converted in the amount of
$2,815.26.
On January 2, 2003 the Company granted options for 100,000 shares of common
stock to Mr. Toulan pursuant to an employment contract. These options vested
immediately, expire on December 30, 2007 and have an exercise price of $0.40 per
share.
On January 2, 2003 the Company granted options for 100,000 shares of common
stock to Mr. Toulan pursuant to an employment contract. These options vest on
December 31, 2003, expire on December 30, 2008 and have an exercise price of
$0.40 per share.
10
On January 2, 2003 the Company granted options for 100,000 shares of common
stock to Mr. Toulan pursuant to an employment contract. These options vest on
December 31, 2004, expire on December 30, 2009 and have an exercise price of
$0.40 per share.
On February 4, 2003, the Company issued 30,000 shares of common stock to Keshet,
LP, upon the conversion of 480 shares of Series G Convertible Preferred, at a
conversion price of $0.1960. The conversion included accrued and unpaid
dividends on the preferred converted.
On February 21, 2003, the Company issued 50,000 shares of non-voting Series J 8%
Convertible Preferred stock, having a stated value of $10.00 per Preferred J
share, and common stock warrants to Mid-Am Capital, L.L.C. ("Mid-Am") for the
aggregate purchase price of $500,000. Each preferred share is convertible to 40
shares of the Company's common stock of at a per common share conversion price
of $0.25, representing 2,000,000 shares of common stock underlying the
preferred. The issued warrants entitle the holder to purchase 33.33 shares of
common stock for each share of Series J Convertible Preferred stock issued at an
exercise price of $0.30 per common stock share, representing 1,666,667 shares of
common stock underlying the warrants. The warrants are exercisable for a
five-year period. The February 21, 2003 closing market trading price was $0.23
per share. This private offering was made to Mid-Am, an accredited investor,
pursuant to Rule 506 of Regulation D and Section 4(2) of the Securities Act of
1933.
On April 14, 2003, the Company issued 50,000 shares of common stock to Keshet,
LP, upon the conversion of 596 shares of Series G Convertible Preferred, at a
conversion price of $0.148. The conversion included accrued and unpaid dividends
on the preferred converted.
On April 22, 2003, the Company issued 50,000 shares of common stock to The
Keshet Fund, LP, upon the conversion of 595 shares of Series G Convertible
Preferred, at a conversion price of $0.148. The conversion included accrued and
unpaid dividends on the preferred converted.
On May 22, 2003, the Company issued 100,000 shares of common stock to Keshet,
LP, upon the conversion of 607 shares of Series G Convertible Preferred, at a
conversion price of $0.076. The conversion included accrued and unpaid dividends
on the preferred converted.
On May 22, 2003, the Company issued 100,000 shares of common stock to The Keshet
Fund, LP, upon the conversion of 607 shares of Series G Convertible Preferred,
at a conversion price of $0.076. The conversion included accrued and unpaid
dividends on the preferred converted.
On May 29, 2003, the Company issued 50,000 shares of non-voting Series J 8%
Convertible Preferred stock, having a stated value of $10.00 per Preferred J
share, and common stock warrants to Mid-Am Capital, L.L.C. ("Mid-Am") for the
aggregate purchase price of $500,000. Each preferred share is convertible to 50
shares of the Company's common stock of at a per common share conversion price
of $0.20, representing 2,500,000 shares of common stock underlying the
preferred. The issued warrants entitle the holder to purchase 40 shares of
common stock for each share of Series J Convertible Preferred stock issued at an
exercise price of $0.25 per common stock share, representing 2,000,000 shares of
common stock underlying the warrants. The warrants are exercisable for a
five-year period. The May 22, 2003 closing market trading price was $0.22 per
share. In addition, the following adjustments were made to prior issued Warrants
for the purpose of facilitating future fund raising by the Company arising out
of the exercise of the Warrants by Holder. The Purchase Price, as defined in the
Warrants No. 1 and 2, has been reduced to $0.25, subject to further adjustment
as described in the Warrants. The Warrant Stock provided for in Warrant No.1 has
been increased by 1,500,000 shares. The Warrant Stock provided for in Warrant
No. 2 has been increased by 333,333 shares. The Expiration Date, as defined in
the respective Warrants, remains as stated. The aforementioned adjustments
resulted in a total of 6,000,000 shares of common stock underlying Warrant No. 1
and Warrant No. 2. Those warrants were valued using the Black-Scholes model as
of May 22, 2003. No adjustments resulted from that valuation. The trading price
Call Option trigger set forth in Section 9 (b) of the Warrants has been reduced
from $1.75 to $0.75 per share. This private offering was made to Mid-Am, an
accredited investor, pursuant to Rule 506 of Regulation D and Section 4(2) of
the Securities Act of 1933.
On August 12, 2003, the Company issued 1,200,000 shares of common stock upon the
conversion of 6,542 shares of Series G Convertible Preferred. The conversions
were based upon notices of conversion received in June and July 2003, and was
delayed in order to determine the accuracy of the conversion variables contained
in the respective notices of conversion. The conversion-based issuances of
common were as follows:
11
o The Company issued 200,000 shares of common stock to Keshet, LP,
upon the conversion of 1,209 shares of Series G Convertible
Preferred, at a conversion price of $0.076. The conversion included
accrued and unpaid dividends on the preferred converted.
o The Company issued 200,000 shares of common stock to The Keshet
Fund, LP, upon the conversion of 1,209 shares of Series G
Convertible Preferred, at a conversion price of $0.076. The
conversion included accrued and unpaid dividends on the preferred
converted.
o The Company issued 150,000 shares of common stock to The Keshet
Fund, LP, upon the conversion of 773 shares of Series G Convertible
Preferred, at a conversion price of $0.0653. The conversion included
accrued and unpaid dividends on the preferred converted.
o The Company issued 250,000 shares of common stock to Keshet, LP,
upon the conversion of 1,289 shares of Series G Convertible
Preferred, at a conversion price of $0.0653. The conversion included
accrued and unpaid dividends on the preferred converted.
o The Company issued 200,000 shares of common stock to Talbiya B.
Investments, Ltd., upon the conversion of 1,031 shares of Series G
Convertible Preferred, at a conversion price of $0.0653. The
conversion included accrued and unpaid dividends on the preferred
converted.
o The Company issued 200,000 shares of common stock to Nesher. Ltd.,
upon the conversion of 1,031 shares of Series G Convertible
Preferred, at a conversion price of $0.0653. The conversion included
accrued and unpaid dividends on the preferred converted.
On September 15, 2003, the Company issued 213,750 shares of common stock to
Michael Willms, upon the conversion of 7,500 shares of Series H Convertible
Preferred, at the fixed conversion price of $0.40. The conversion included
accrued and unpaid dividends on the preferred converted.
On September 29, 2003, the Company issued 70,938 shares of common stock to The
Dennis H. Willms Irrevocable Trust, Michael Willms, Trustee, upon the conversion
of 2,500 shares of Series H Convertible Preferred, at the fixed conversion price
of $0.40. The conversion included accrued and unpaid dividends on the preferred
converted.
To obtain funding for our ongoing operations, we entered into a Subscription
Agreement with two accredited investors in November 2003 for the sale of (i)
$400,000 in convertible debentures, (ii) class A warrants to buy 2,000,000
shares of our common stock and (iii) class B warrants to buy 10,000,000 shares
of common stock. In connection with this financing, we paid a finders fee to an
accredited investor, which included (i) 400,000 shares of common stock, (ii)
class A warrant to purchase 2,000,000 shares of common stock and (iii) 10% of
the proceeds received by us in connection with the exercise of the class B
warrants, which is payable in shares of common stock at the rate of one share of
common stock for every ten shares of common stock actually issued upon exercise
of the class B warrants.
In April 2004, we entered into a Subscription Agreement with two
accredited investors for the sale of (i) $500,000 in convertible debentures and
(ii) warrants to buy 3,000,000 shares of our common stock. In connection with
this financing, we paid a fee in the amount of $50,000 in the form of a
convertible debentures.
The debentures issued in connection with the April 2004 financing bear interest
at 10%. The principal on the notes is due in equal monthly installments
commencing on November 1, 2004 until October 1, 2005. On October 1, 2005, all
principal and interest shall become due. In the event that our common stock has
a closing price in excess of $.20 for the five days preceding the monthly
payment, then, within our discretion, the monthly payment may be deferred. and
the notes are convertible into our common stock at $0.10 per share.
12
Marvel License
On February 1, 2004, we entered into a license agreement with Marvel
Enterprises, Inc. In consideration for the use of proprietary information, we
issued Marvel 750,000 shares of our common stock and a common stock purchase
warrant to purchase 750,000 shares of our common stock. The warrants have an
exercise price of $.10 per share for the first year and, upon the occurrence of
certain conditions tied to the royalty performance under the license, can be
extended for an additional year with an exercise price of $.14 per share.
June 2004
In June 2004, we entered into a Subscription Agreement with Longview Fund,
LP, Alpha Capital Aktiengesellschaft, Whalehaven Funds Limited, Stonestreet
Limited Partnership and Mid-Am Capital L.L.C for the issuance of convertible 10%
notes in the aggregate amount of $1,300,000 and five-year "A" warrants for the
purchase of, in the aggregate, 5,200,000 shares of common stock, at $0.25 per
share, and five-year "B" warrants for the purchase of, in the aggregate,
13,000,000 shares of common stock, at $2.00 per share. In connection with the
October 2004 financing, we subsequently amended the exercise price to $.15 for
the "A" warrants issued to Longview Fund, LP, Alpha Capital Aktiengesellschaft,
Whalehaven Funds Limited and Stonestreet Limited Partnership. The notes are
convertible into shares of common stock of the Company at $0.15 per common
share. The notes are payable in twelve equal monthly installments, commencing
January 1, 2005. The installment payments consist of principal and a "premium"
of 20% of the principal paid per installment. We have the option to defer such
payment until the note's maturity date on December 1, 2005, if our common stock
trades above $0.20 for the five trading days prior to the due date of an
installment payment. In connection with this transaction, we issued additional
notes in the aggregate amount of $40,000 to Gem Funding, LLC, Bi-Coastal
Consulting Corp., Stonestreet Limited Partnership and Libra Finance, S.A upon
identical terms as the principal notes, as a finder's fee, and paid $12,500 in
legal fees. The common stock underlying all notes and warrants carry
registration rights.
The selling stockholders have contractually agreed to restrict their
ability to convert or exercise their warrants and receive shares of our common
stock such that the number of shares of common stock held by them and their
affiliates after such conversion or exercise does not exceed 9.99% of the then
issued and outstanding shares of common stock. See the "Selling Stockholders"
and "Risk Factors" sections for a complete description of the convertible
debentures.
This prospectus relates to the resale of the shares of common stock and
the common stock underlying these convertible debentures and warrants.
October 2004
On October 29, 2004, we entered into Subscription Agreements with Longview
Fund, LP, Alpha Capital Aktiengesellschaft, Whalehaven Funds Limited and
Stonestreet Limited Partnership for the issuance of convertible 10% notes in the
aggregate amount of $550,000 and five-year "C" warrants for the purchase of, in
the aggregate, 2,200,000 shares of common stock, at $0.15 per share, and the
repricing of five-year "A" warrants, issued June 30, 2004 for the purchase of,
in the aggregate, 3,200,000 shares of common stock, from $0.25 to $0.15 per
share. The notes are convertible into shares of common stock at $0.10 per common
share. The notes are payable in twelve equal monthly installments, commencing
May 1, 2005. The installment payments consist of principal and a "premium" of
20% of the principal paid per installment. We have the option to defer such
payment until the note's maturity date on April 30, 2006, if our common stock
trades above $0.15 for the five trading days prior to the due date of an
installment payment and the underlying common stock is registered. In connection
with this transaction, we issued additional notes, without attached warrants, in
the aggregate amount of $27,500 to Gem Funding, LLC, Bi-Coastal Consulting
Corp., Stonestreet Limited Partnership and Libra Finance, S.A upon identical
terms as the principal notes, as a finder's fee, and paid $12,500 in legal fees.
The common stock underlying all notes and warrants carry registration rights.
The selling stockholders have contractually agreed to restrict their
ability to convert or exercise their warrants and receive shares of our common
stock such that the number of shares of common stock held by them and their
affiliates after such conversion or exercise does not exceed 9.99% of the then
issued and outstanding shares of common stock. See the "Selling Stockholders"
and "Risk Factors" sections for a complete description of the convertible
debentures.
13
December 2004
In December 2004, we entered into Subscription Agreements with Momona
Capital Corp. and Ellis International Ltd. for the issuance of convertible 10%
notes in the aggregate amount of $400,000 and five-year "C" warrants for the
purchase of, in the aggregate, 800,000 shares of common stock, at $0.15 per
share The notes are convertible into shares of common stock at $0.10 per common
share. The notes are payable in twelve equal monthly installments, commencing
May 1, 2005. The installment payments consist of principal and a "premium" of
20% of the principal paid per installment. We have the option to defer such
payment until the note's maturity date on April 30, 2006, if our common stock
trades above $0.15 for the five trading days prior to the due date of an
installment payment and the underlying common stock is registered. In connection
with this transaction, we issued additional notes, without attached warrants, in
the aggregate amount of $10,000 to Momona Capital Corp. and Ellis International
Ltd. upon identical terms as the principal notes, as a finder's fee. The common
stock underlying all notes and warrants carry registration rights.
The selling stockholders have contractually agreed to restrict their
ability to convert or exercise their warrants and receive shares of our common
stock such that the number of shares of common stock held by them and their
affiliates after such conversion or exercise does not exceed 9.99% of the then
issued and outstanding shares of common stock. See the "Selling Stockholders"
and "Risk Factors" sections for a complete description of the convertible
debentures.
* All of the above offerings and sales were deemed to be exempt under rule
506 of Regulation D and Section 4(2) of the Securities Act of 1933, as amended.
No advertising or general solicitation was employed in offering the securities.
The offerings and sales were made to a limited number of persons, all of whom
were accredited investors, business associates of Bravo! Foods International
Corp. or executive officers of Bravo! Foods International Corp., and transfer
was restricted by Bravo! Foods International Corp. in accordance with the
requirements of the Securities Act of 1933. In addition to representations by
the above-referenced persons, we have made independent determinations that all
of the above-referenced persons were accredited or sophisticated investors, and
that they were capable of analyzing the merits and risks of their investment,
and that they understood the speculative nature of their investment.
Furthermore, all of the above-referenced persons were provided with access to
our Securities and Exchange Commission filings.
Except as expressly set forth above, the individuals and entities to whom
we issued securities as indicated in this section of the registration statement
are unaffiliated with the Company.
14
ITEM 27. EXHIBITS.
The following exhibits are included as part of this Form SB-2. References
to "the Company" in this Exhibit List mean Bravo! Foods International Corp., a
Delaware corporation.
Exhibit
No. Title of Document
--- -----------------
3.1 Articles of Incorporation (1)
3.2 Amended Articles (name change) (1)
3.3 Restated Bylaws China Peregrine Food Corporation (1)
4.1 Preferred, Series B Designation (1)
4.2 Preferred, Series F Designation (2)
4.3 Preferred, Series G Designation (3)
4.4 Preferred, Series H Designation (6)
4.5 Preferred, Series I Designation (7)
4.6 Preferred, Series J Designation (8)
4.7 Preferred, Series K Designation (10)
4.8 Subscription Agreement dated November 2003 entered with Gamma
Opportunity Capital Partners, LP (11)
4.9 Class A Common Stock Purchase Warrant issued to Gamma
Opportunity Capital Partners, LP (11)
4.10 Class B Common Stock Purchase Warrant issued to Gamma
Opportunity Capital Partners, LP (11)
4.11 Convertible Note issued to Gamma Opportunity Capital Partners,
LP dated November 2003 (11)
4.12 Class A Common Stock Purchase Warrant issued to Libra Finance,
S.A. (11)
4.13 Subscription Agreement dated November 2003 entered with MID-AM
CAPITAL, L.L.C. (11)
4.14 Class A Common Stock Purchase Warrant issued to MID-AM
CAPITAL, L.L.C. (11)
4.15 Class B Common Stock Purchase Warrant issued to MID-AM
CAPITAL, L.L.C. (11)
4.16 Convertible Note issued to MID-AM CAPITAL, L.L.C. dated
November 2003 (11)
4.17 Subscription Agreement dated April 2, 2004 entered with Alpha
Capital Aktiengesellschaft and Longview Fund LP (11)
4.18 Convertible Note issued to Alpha Capital Aktiengesellschaft
dated April 2004 (11)
4.19 Convertible Note issued to Longview Fund LP dated April 2004
(11)
15
4.20 Common Stock Purchase Warrant issued to Alpha Capital
Aktiengesellschaft dated April 2004 (11)
4.21 Common Stock Purchase Warrant issued to Longview Fund LP dated
April 2004 (11)
4.21 Subscription Agreement entered by and between the Company and
Mid-AM Capital LLC dated June 2004 (filed herewith)
4.22 Convertible Note issued to Mid-AM Capital LLC dated June 2004
(filed herewith)
4.23 Common Stock Purchase Warrant A issued to Mid-AM Capital LLC
dated June 2004 (filed herewith)
4.24 Common Stock Purchase Warrant B issued to Mid-AM Capital LLC
dated June 2004(filed herewith)
4.25 Subscription Agreement entered by and between the Company and
Alpha Capital, Longview Fund LP, Stonestreet Limited
Partnership, Whalehaven Funds Limited and Gamma Opportunity
Capital Partners LP dated June 2004 (filed herewith)
4.26 Form of Common Stock Purchase A issued to Alpha Capital,
Longview Fund LP, Stonestreet Limited Partnership, Whalehaven
Funds Limited and Gamma Opportunity Capital Partners LP dated
June 2004 (filed herewith)
4.27 Form of Common Stock Purchase B issued to Alpha Capital,
Longview Fund LP, Stonestreet Limited Partnership, Whalehaven
Funds Limited and Gamma Opportunity Capital Partners LP dated
June 2004 (filed herewith)
4.28 Form of Convertible Note issued to Alpha Capital, Longview
Fund LP, Stonestreet Limited Partnership, Whalehaven Funds
Limited and Gamma Opportunity Capital Partners LP dated June
2004 (filed herewith)
4.29 Subscription Agreement entered by and between the Company and
Alpha Capital, Longview Fund LP, Stonestreet Limited
Partnership and Whalehaven Funds Limited dated October 2004
(filed herewith)
4.30 Form of Common Stock Purchase C issued to Alpha Capital,
Longview Fund LP, Stonestreet Limited Partnership and
Whalehaven Funds Limited dated October 2004 (filed herewith)
4.31 Form of Convertible Note issued to Alpha Capital, Longview
Fund LP, Stonestreet Limited Partnership, Whalehaven Funds
Limited and Gamma Opportunity Capital Partners LP dated
October 2004 (filed herewith)
4.32 Subscription Agreement entered by and between the Company and
Momona Capital Corp. and Ellis International Ltd. dated
December 2004 (filed herewith)
4.33 Form of Common Stock Purchase C issued to Momona Capital Corp.
and Ellis International Ltd. dated December 2004 (filed
herewith)
4.34 Form of Convertible Note issued to Momona Capital Corp. and
Ellis International Ltd. dated December 2004 (filed herewith)
5.1 Sichenzia Ross Friedman Ference LLP Opinion and Consent (filed
herewith)
16
10.1 Warner Bros China License Agreement (5)
10.2 Warner Bros China License Agreement (modified) (5)
10.3 Warner Bros. U.S. License Agreement (5)
10.4 Warner Bros. Mexico License Agreement (6)
10.5 Warner Bros. Cananda License Agreement (6)
10.6 MoonPie License Agreement (10)
10.7 Marvel License Agreement (10)
10.8 SADAFCO Production Agreement (10)
10.9 Real Estate Lease Amendment Extending Term (10)
21.1 Subsidiaries Certificate of Incorporation Bravo!
Foods, Inc. (6)
21.2 Subsidiaries Articles of Association (6)
China Premium Food Corporation (Shanghai)
Co., Inc.
23.1 Consent of Lazar Levine & Felix LLP
(filed herewith).
23.2 Consent of BDO Seidman LP (filed herewith).
23.3 Consent of legal counsel (see Exhibit 5.1).
--------------------------------------------------
(1) Filed with Form 10SB/A First Amendment
(2) Filed with Form 10QSB for 3-31-99
(3) Filed with Form 10QSB for 6-30-99
(4) Filed with Form 10K-SB for 12-31-99
(5) Filed with Form 10QSB for 6-30-00
(6) Filed with Form SB-2/A Second Amendment
(7) Filed with Form SB-2/A Third Amendment
(8) Filed with Form 10K-SB 2001
(9) Filed with Form 8K filed October 2, 2002
(10) Filed with Form 10-KSB for 12-31-03
(11) Filed with Form SB-2 filed June 4, 2004
ITEM 28. UNDERTAKINGS.
The undersigned registrant hereby undertakes to:
(1) File, during any period in which offers or sales are being made, a
post-effective amendment to this registration statement to:
(i) Include any prospectus required by Section 10(a)(3) of the Securities Act of
1933, as amended (the "Securities Act");
(ii) Reflect in the prospectus any facts or events which, individually or
together, represent a fundamental change in the information in the registration
statement. Notwithstanding the foregoing, any increase or decrease in volume of
securities offered (if the total dollar value of the securities offered would
not exceed that which was registered) and any deviation from the low or high end
of the estimated maximum offering range may be reflected in the form of
prospectus filed with the Commission pursuant to Rule 424(b) under the
Securities Act if, in the aggregate, the changes in volume and price represent
no more than a 20% change in the maximum aggregate offering price set forth in
the "Calculation of Registration Fee" table in the effective registration
statement, and
17
(iii) Include any additional or changed material information on the plan of
distribution.
(2) For determining liability under the Securities Act, treat each
post-effective amendment as a new registration statement of the securities
offered, and the offering of the securities at that time to be the initial bona
fide offering.
(3) File a post-effective amendment to remove from registration any of the
securities that remain unsold at the end of the offering.
(4) For purposes of determining any liability under the Securities Act, treat
the information omitted from the form of prospectus filed as part of this
registration statement in reliance upon Rule 430A and contained in a form of
prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h)
under the Securities Act as part of this registration statement as of the time
it was declared effective.
(5) For determining any liability under the Securities Act, treat each
post-effective amendment that contains a form of prospectus as a new
registration statement for the securities offered in the registration statement,
and that offering of the securities at that time as the initial bona fide
offering of those securities.
Insofar as indemnification for liabilities arising under the Securities
Act may be permitted to directors, officers and controlling persons of the
registrant pursuant to the foregoing provisions, or otherwise, the registrant
has been advised that in the opinion of the Securities and Exchange Commission
such indemnification is against public policy as expressed in the Securities Act
and is, therefore, unenforceable.
In the event that a claim for indemnification against such liabilities
(other than the payment by the registrant of expenses incurred or paid by a
director, officer or controlling person of the registrant in the successful
defense of any action, suit or proceeding) is asserted by such director, officer
or controlling person in connection with the securities being registered, the
registrant will, unless in the opinion of its counsel the matter has been
settled by controlling precedent, submit to a court of appropriate jurisdiction
the question whether such indemnification by it is against public policy as
expressed in the Securities Act and will be governed by the final adjudication
of such issue.
SIGNATURES
In accordance with the requirements of the Securities Act of 1933, the
registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements of filing on Form SB-2 and authorizes this registration
statement to be signed on its behalf by the undersigned, in the City of North
Palm Beach, State of Florida, on January 20, 2005.
BRAVO! FOODS INTERNATIONAL CORP.
By: /s/ Roy G. Warren
---------------------------------------
Roy G. Warren, CEO and
Secretary
18
In accordance with the requirements of the Securities Act of 1933, this
registration statement was signed by the following persons in the capacities and
on the dates stated.
-----------------------------------------------------------------------------------------------
Name Title Date
-----------------------------------------------------------------------------------------------
/s/Stanley Hirschman Chairman and Director January 20, 2005
-----------------------------------------------------------------------------------------------
Stanley Hirschman
-----------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------
/s/Roy G. Warren Director, CEO and Secretary January 20, 2005
-----------------------------------------------------------------------------------------------
Roy G. Warren
-----------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------
/s/Arthur W. Blanding Director January 20, 2005
-----------------------------------------------------------------------------------------------
/s/Arthur W. Blanding
-----------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------
/s/Robert Cummings Director January 20, 2005
-----------------------------------------------------------------------------------------------
Robert Cummings
-----------------------------------------------------------------------------------------------
/s/Paul Downes Director January 20, 2005
-----------------------------------------------------------------------------------------------
Paul Downes
-----------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------
/s/Phillip Pearce Director January 20, 2005
-----------------------------------------------------------------------------------------------
Phillip Pearce
-----------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------
/s/John McCormack Director January 20, 2005
-----------------------------------------------------------------------------------------------
John McCormack
-----------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------
/s/Tommy Kee Chief Financial/Accounting Officer January 20, 2005
-----------------------------------------------------------------------------------------------
Tommy Kee
-----------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------
/s/Roy D. Toulan Vice President, Corporate Secretary January 20, 2005
and General Counsel
-----------------------------------------------------------------------------------------------
Roy D. Toulan
-----------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------
19